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Abstract 
Vascular surgery is an increasingly data rich speciality.  Planning treatment and assessing 
outcomes are highly dependent on objective assessment of number of imaging modalities 
including duplex ultrasound, CT scans and angiograms which are almost exclusively digitally 
created stored and accessed. Developments such as the national vascular registry mean that 
treatment outcomes are recorded scrutinised electronically. The widespread availability of 
data which is collected electronically and stored for future clinical use has created the 
opportunity to examine the efficacy of investigations and treatments in a way which has 
hitherto not been possible. In addition, new computational methods for data analysis have 
provided the opportunity for the clinicians and researchers to utilise this data to address 
pertinent clinical questions. 
 
This narrative describes 9 studies which utilized data mining methodology to examine a 
range of different clinical problems in the fields of general and vascular surgery. These 
publications have been collectively cited 204 times in the literature. They study the natural 
history and outcomes of treatment for abdominal aortic aneurysms (AAA) in women, 
assessment of risk of failure following infrainguinal vein graft bypass surgery, accurate 
assessment of the degree of internal carotid artery stenosis using Duplex US and prediction 
of outcome following resection of oesophageal carcinoma .These studies utilise 
conventional statistical models such as linear, logistic and Cox’s regression analyses, as well 
as intelligent classification methods such as Classification and regression Trees (CART) and 
Multi-layered Perceptron (MLP) artificial neural network to address each clinical question. 
Some of the clinical problems being addressed by this narrative such as AAAs in women 
iv 
 
have only recently gained their due importance. Others such as being able to accurately 
assess the degree of ICA stenosis using Duplex US have gained prominence because of 
development of the Oxford stroke risk calculator and the realisation that minimising 
symptom to carotid endarterectomy time in reduces risk of stroke.  
 
Above all this narrative illustrates how data mining is fast becoming an essential tool in 
understanding and developing the evidence base for vascular surgery. Understanding the 
main issues underlying data mining processes is important for success in the young but 
expanding fields of medical informatics and vascular surgery. 
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Chapter-1 Background          
Introduction  
Data mining is a search for valuable information in large volumes of data.1 Data mining 
techniques have contributed to every aspect of human endeavour including healthcare.2-5 In 
the twenty first century, health care practitioners require sophisticated decision support 
systems to support their clinical decisions and practice evidence based medicine.6-8 
 
Avedis Donabedian who is considered the father of healthcare improvement defined 
delivery of healthcare in terms of the triad of structures, processes and outcomes.9 
Structure includes the material and human resources as well as the organizational structure 
within which care is delivered.9 Process denotes the steps involved in providing care and 
outcomes are effects of care on the health status of patients and populations.10 Care 
pathways involved in the delivery of care to patients with lower limb ischaemia, stroke or 
abdominal aortic aneurysm falls within the definition of the processes which are followed to 
deliver, safe and effective treatment to this cohort of patients. Care pathways provide a 
portfolio approach for delivery of care which require exactly the same steps to be followed 
in management of each of patient and have been credited with improving patient safety in 
delivery of healthcare.9,10 This has only become possible as the progressive improvements in 
the quality of preoperative investigations have provided the evidence based criteria which 
clinicians can work with (such as the Antero-Posterior diameter of Aorta in case of AAA, the 
degree of ICA stenosis or accurate staging of cancer) and randomized controlled trials which 
have created the evidence base for treatments. Individualizing patient risk in order to 
inform the clinicians and patients as to the relative importance and necessity of each step in 
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the care pathway is a compelling argument10, especially with regards to identifying 
conditions which are likely to remain asymptomatic until they cause a seminal event, such 
as stroke, vein graft stenosis, or ruptured abdominal aortic aneurysm.  
 
Obtaining and maintaining large databases which often include patient sensitive information 
and making the data available for legitimate data mining practices in one hand and 
complying with strict information governance practices in the other is a challenging 
endeavour with many pitfalls having been identified over the last 20 years. The adoption of 
clinical governance in the NHS has mandated the development of appropriate and reliable 
clinical data-sets for use in comparative audit; such data needs to be analysable in a 
meaningful way.11 Real-life data rarely if ever complies with the requirements of statistical 
analysis or data mining tools. It is may be inconsistent, contain redundant attributes or 
missing values. It may be in an unsuitable format for immediate analysis.11-14 Two types of 
databases are available in clinical practice.15-17 The first is the dataset acquired for research 
or as part of a registry of patients with a disease process. One example of this is the national 
vascular registry.16 
 
The other types of databases are hospital information systems or national databases. These 
information registries collect data for clinical use but without a specific research purpose. 
They too contain a wealth of information which is accurate and is collected in a systematic 
way. These types of information systems are often very complex with large numbers of 
datasets, and many attributes for each record. The examples of these databases include 
hospital laboratory systems, electronic patient records, hospital Picture Archiving and 
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Classification Systems (PACS). Other examples include the electronic health records of the 
patients registered with a general practitioner (Family Physician).18 These information 
systems collect accurate data for clinical use. This data is collected in various formats which 
is optimized for use by clinicians including free texts, codes and images and require 
significant pre-processing before it can be used for developing decision support systems. 
 
Since the 1960s all NHS hospitals have been obliged to return standard forms containing 
patients' demographics, co-morbidities, surgical and other interventional procedures, and 
discharge diagnoses which are recorded in coded format, using internationally recognised 
International Classification of Diseases (ICD) system. The funding for these episodes of care 
is contingent upon the return of this data which is recorded in electronic format.  
Historically accuracy of this data related to the quality of coding in each hospital and tended 
to contain missing values, with change in legislation, introduction of healthcare quality of 
care benchmarking and payment by result funding methods, accuracy of national healthcare 
databases has improved significantly. Still some of the data collected may be imbalanced 
with regards to the class label of interest. An example of this would be a patient who suffers 
from heart disease but due to a smoking habit also suffers from chronic lung disease. The 
actual diagnosis resulting in hospital admission or cause of death would be diagnostic 
challenge in the individual case.19 Scrutiny of a national information system which contains a 
large cohort of similar patients creates a significant data imbalance and could affect the 
accuracy of the decision support system created from that data source.20,21  
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I was introduced to data mining in healthcare over 20 years ago as a medical student when 
as a summer project I was involved in developing relational databases for day to day clinical 
use in patients suffering from sarcoidosis and cystic fibrosis. Subsequent to this I trained as a 
general and vascular surgeon in the Republic of Ireland, Edinburgh (Scotland) and Sydney, 
Australia. Parallel to my training in surgery I completed a diploma in medical informatics in 
the Royal College of Surgeons of Edinburgh.  I was introduced to the modern concepts and 
processes of Knowledge Discovery and Data mining in healthcare (KDDM). Putting these 
concepts and processes into practice I developed a research portfolio which includes risk 
assessment models, management of acute pancreatitis using artificial neural networks and 
genetic algorithms and obtained a master’s degree in medical informatics from university of 
Bath.22-37 As my career branched out towards vascular surgery my publications also became 
specialized in that field. This narrative introduces the readers to data mining practices and 
provides a narrative on nine pertinent publications each of which highlight a data mining 
paradigm and how the author’s use of data mining has improved the knowledge or 
informed the debate in the field of vascular surgery.  For the last eight years I have been 
practicing as a consultant vascular surgeon at James Cook University Hospital in 
Middlesbrough, United Kingdom. Vascular surgery is an increasingly data rich environment 
and is highly dependent on objective assessment of a number of imaging modalities 
including duplex ultrasound and is therefore a fertile area for the application of KDDM.  
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The Mission of Data mining: Data mining Paradigms 
Data mining is achieved to fulfil one or 5 different clinical paradigms:38 
• Association 
• Sequence or Path analysis 
• Classification 
• Clustering 
• Forecasting 
These are the clinical missions of a data mining exercises. Depending on the data quality, 
available tools and the needs of the exercise these may be simple and austere or audacious 
and complex.  
Association 
The data mining paradigm that most clinicians are familiar with is studying the association 
between two or more variables unique to a group of patients. These associations can be 
examined only if accurate data pertinent to a clinical condition is available. Such data can be 
collected prospectively, or as is more and more the case be available from local, regional or 
national databases. The convention is to use statistical models which are appropriate to the 
clinical setting to disprove the ‘null hypothesis’ defined as the probability of any association 
between the two variables to be a chance event. More complicated statistical models such 
as logistic regression analysis can relate the relationship between two variables to other 
dependent variables. This paradigm is the most commonly used for data mining in vascular 
surgery, examples of which are in appendices-2 to 6.  
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Sequence or path analysis 
The aim of data mining could be studying a chain of causality or effect of an intervention in 
changing natural history of a disease process. Sequence or path analysis studies a process 
and is a higher order of evidence than a simple association between two factors. These 
relationships may be intuitive such as a relationship between smoking and lung cancer, still 
as ill health which is related to behavioural and environmental factors happens over many 
years or indeed decades of exposure, strong evidence of the association only provides 
circumstantial evidence of causality.39 True chain of causality would involve evidence of a 
temporal association between a putative causative factor with the pre-disease states such 
as pre-cancerous changes and identification of the processes involved in turning healthy 
tissue to cancerous tissue. In the next chapter we examine how a path analysis can identify 
factors which are responsible for infra-inguinal vein graft failure and develop and implement 
a decision tree to aid with graft surveillance and identify a safe treatment modality.  
 
Sequence or path analysis is used extensively is in the study of a consecutive chain of 
activities that cohorts of internet users perform40, improving the rates of return on stock 
market investments41,42  and in clinical psychology 43,44 however its use for development of 
medical or surgical decision support aids is novel. Appendices 4 to 8 constitute a path 
analytical approach which involve a number of publications dealing with the same problem 
each attempting to answer a small but specific part of a question and together work 
towards building a comprehensive big picture which addresses issues regarding the full cycle 
of care (in this case identification and treatment of infrainguinal vein graft stenosis).  
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Clustering and classification are the other paradigms which utilize data mining. Clustering 
involves organizing a group of objects in such a way that the constituents of each group 
have more in common than those in other groups.45 Classification on the other hand is the 
simpler task of identifying which set of categories the observation belongs to.45,46 
Classification is achieved through implementation of a ‘classifier’ which is a mathematical 
function or an algorithm that relates the value of the input variables to a particular 
outcome. The input variables can be categorical, ordinal, or linear and the classifier may be 
deterministic i.e. use a conventional statistical function or an intelligent classifier which 
identifies patterns within the data which are missed by conventional statistical models.46-52 
 
Classification in its simplest form is a two-step process. The first step involves developing 
training the data mining model to identify patterns within the data which can then be 
utilized to develop the classification rules required to make accurate prediction of the 
outcome variable being studied. This is predominantly by exposing the model to data 
datasets for which the classifier label “outcome” is known47,48. The second step is evaluating 
the ability of the classification model in assigning the appropriate label to the unlabelled 
datasets or to “predict outcome”.47,48 By comparing the predicted and actual outcomes 
accuracy of the predictive model is assessed.  Clustering on the other hand is not exposed to 
a training process ordering of patterns into groups or clusters of data50. Cluster analysis is 
often not a single algorithm but a general task that needs resolution, data clusters are 
densities of data points within the dataspace, or a distribution. Clustering models could 
study the connectivity between data-points for example be hierarchical in nature 
(Taxonomy), represent a single data vector (for example K-mean distribution which relates 
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the data points to a central vector which may or may not be a member of that cluster), 
distribution models (for example normal distribution), or identify densely packed areas in 
the dataspace50 (graphical representation of data). Clustering process can be soft (each 
object belongs to a certain cluster to a certain degree such as fuzzy logic algorithms) or hard 
data points belong to a data cluster or not.51 Appendices 7 and 8 are examples of a 
classification problems solved through the use of a classification and regression tree.  
 
Forecasting outcomes is intuitively one of the most useful applications of data mining. Most 
of the other data mining paradigms such as classification, sequence or path analysis or 
association are indirectly linked to forecasting the likelihood of a particular outcome52. This 
may be identifying the risk associated with an adverse outcome such as cancer recurrence, 
death or failure of a treatment. Enumeration of the level of risk allows a clinician to focus 
risk mitigation strategies to cases (datasets) with the highest level of risk51-54. Whilst the holy 
grail of data mining is identification of the exact level of risk, for practical applications 
stratification of cases to high or low risk or identifying the association between a key 
variable and an outcome are more applicable to day to day clinical use46. This is because a 
good outcome is the goal of all forms of treatment and in many cases a bad outcome is a 
self-fulfilling prophecy, i.e. a cancer which has a high risk of recurrence with treatment will 
be associated with a shortened life expectancy if it is deemed untreatable by a clinician who 
then decides not to treat the condition based on the prediction. Appendix 10 is an example 
of a prediction paradigm where the outcome of surgical treatment for oesophageal cancer is 
predicted using a multi-layered perceptron artificial neural network. 
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Data mining Tools:  
Data mining tools are models used in order to implement data mining paradigms. They are 
broadly divided into deterministic and intelligent data analysis models. Deterministic models 
identify variables which impact the eventual output variable independently of each other 
and are incorporated into the model which are often clinical scoring systems.6 Deterministic 
models extract pertinent features of the data using conventional statistical models such as 
regression analysis.6 The independent predictors of an outcome or a diagnosis can then be 
used to construct an overall score which may be weighted. If the value of the overall score 
crosses a threshold value the outcome, diagnosis or disease severity is likely. Examples of 
deterministic classification models include; Glasgow severity scores for pancreatitis47, P-
POSSUM perioperative risk prediction model48 or the Oxford Stroke calculator.49  
 
Intelligent models combine statistical analysis and machine learning to extract hidden 
patterns and relationships which are not recognizable by conventional statistical analysis.3-6 
Intelligent systems include Bayesian models, Decision trees, Fuzzy logic algorithms, artificial 
neural networks and genetic algorithms. These models simulate a trained observer by 
recognizing recurring patterns within the datasets which are not recognizable through 
conventional statistics. In this narrative decision tree analysis and multi layered perceptron 
artificial neural network models are used and therefore these data mining models are 
discussed in some detail preferentially. This does not minimise the value of other intelligent 
analytical systems such as Bayesian models and fuzzy logic algorithms. 
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The success of a data mining model at fulfilling the paradigm assigned to it is a very 
important attribute. If the mission is the study of an association between two variables then 
disproving a null hypothesis may be sufficient. If the mission is classification or prediction, 
assessment of sensitivity, specificity and positive and negative predictive values are used. 
Study of entropy (heterogeneity) is one way of assessing the usefulness of data mining 
model.55 A population of subjects with a binary attribute where 60% of subjects are=0 and 
40% are=1. Entropy of this system without classification would be calculated by the 
equation:    
E(s) =∑ −Pi Log2 Pi  𝑐𝑙=1  or Entropy (0.4, 0.6) which equals 0.97 
A classifier which identifies subjects 0 and has 80% sensitivity and 80% specificity will divide 
them as follows:  
 0 1 Heterogeneity  entropy 
Identified as 0 48 8 56  Entropy (0.85, 0.15) 
Identified as 1 12 32 44 Entropy (0.27, 0.73) 
 60 40 100  
 
Entropy of the system using a classifier would be calculated using this equation:  
 E (Classifier) =∑ P(c)E(c)  
𝑐
𝑙=1
   or E (Classifier) = (0.19)+(0.41) or 0.60 
The net information gain using this classifier is 0.37. The closer to 0 the entropy value is, the 
more homogeneous the classified population are conversely; the closer to one the value is 
the higher the heterogeneity (uncertainty of the observation) will be. The net information 
gain is the value often used by intelligent classification models in selecting the pertinent 
variables, functions or topography to develop the most informationally efficient models.55 
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Decision tree Analysis 
Decision tree analysis is a decision support model which has been developed from the 
decision theory by the distinguished American statistician Leo Breiman. Decision theory is 
the study of optimal actions as determined by considering the probability and utility of 
different outcomes56-60. A decision tree uses a tree like graph model to map observations 
about a target item to conclusions about the value of the target item (Figure-1). Where the 
target value has a finite set of values (ordinal or nominal) the process is known as a 
classification tree. If the Target value is a continuous variable it is called a regression 
tree.58,59 The umbrella term Classification and Regression Tree (CART) is used to group both 
processes. 60 Once created and validates, these algorithms are simple to understand, 
requires little preparation, can use categorical as well as continuous variables and create a 
white box model which is transparent to the user and it is possible to validate using 
statistical analysis such as receiver operator characteristic test. CART models will be 
discussed in the context of infra-inguinal vein graft surveillance (Appendices 7and 8).  
 
Figure-1: Graphic representation of a decision tree Precision tree™ Palisade corporation.   
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Artificial Neural Networks 
Artificial neural networks are a family information processing algorithms, which are 
modelled on the way biological nervous systems process information.61 Artificial neural 
networks like their biological counterparts are composed of many highly interconnected 
processing elements (neurones) working in unison to solve specific problems. Artificial 
neural networks have an ability to drive meaning from imprecise complicated or incomplete 
data. In addition, ANNs exhibit the following features: 
• Adaptive learning 
• Self-organization 
• Real time operation  
• Fault tolerance (redundant information coding) 
 
The neuron (node) is the basic computational unit of an artificial neural network. It receives 
a variety of inputs from other neurons through connections that resemble synaptic 
structures and have a binary output.62 This output is determined by the sum of the inputs as 
well as the synaptic strength (weight) attached to each input variable.62 A wide variety of 
neural network designs with varying degrees of complexity have been described. The 
simplest form of neural network is the multi-layered perceptron (MLP) 62-64 Figure-2. This 
network topography was the one used in this narrative. This is made up of layers 
interconnected of processing units with some pre-processing of input variables. It often has 
a back propagation circuit which allows training of the ANN.  Each of the input nodes in the 
first layer corresponds to a single input variable. Initial values are set for the ‘weights’ 
associated with each link in the network. Input data for which an output is known are 
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presented to the network. If the predicted output from the model does not equal the 
known output, the ‘weights’ within the network are changed so as to narrow this difference.  
This process continues until the prediction errors are minimized.  In this way a trained 
neural network contains knowledge which is stored in the form of weighted connections 
between the neurones in the hidden layers.63 Once the network is trained and validated, it 
may be used on unseen data for prediction or classification purposes.63 In general, neural 
network analysis is more successful than traditional statistical techniques when the 
importance of prognostic variables is expressed as a complex unknown function of the value 
of the variable, when the prognostic impact of a variable is influenced by other prognostic 
variables, or when the prognostic impact of a variable varies over time. These conditions are 
found in complex biological systems. For the purposes of analysis, each variable used for 
outcome prediction can be regarded as a single dimension in a multidimensional space. 
Traditional deterministic statistical techniques are particularly suited to the analysis of data 
with a low dimensional complexity, small number of variables and linear separation 
between different classes. Artificial neural networks have been found to be significantly 
more accurate at predicting outcome than deterministic classification models in patients 
with cancer36,64, critically ill patients65, in the diagnosis of myocardial infarction65and 
assessment of severity of acute pancreatitis.29 
 
The last 2 publications in this narrative discuss the use of MLPs artificial neural networks in 
measuring the degree of internal carotid artery stenosis (Appendix-9) and predicting the 
success of surgical treatment for oesophageal carcinoma (Appendix-10). 
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Figure-2: A schematic of a simple artificial neural network  
 
 
 
 
Input (i) x Weight (w) 
i=1 
 
N 
Sum of weighted inputs goes to 
a transfer function Node output 
i 
i 
i 
n 
n 
n 
n 
n 
n 
n 
n 
n 
n 
n 
n 
n O 
Hidden Layers 
Input Layer Output 
Feed- back 
circuit 
15 | P a g e  
 
Data mining and Decision Support in Healthcare 
Evidence based practice has gained broad based support in healthcare. This has been driven 
though structural changes in delivery of healthcare, development of standardized evidence 
based processes called care pathways which have driven quality improvement in different 
fields of medicine.66 Establishment of the National Institute for Health and Care Excellence 
NICE and its Scottish counterpart SIGN which have placed evidence based guidelines for 
management of a diverse range of medical conditions within easy access of clinicians.67 
 
Clinical decision support systems are electronic systems which are used to facilitate clinical 
decision making process using patient data, models, and structured decision processes.68 
Decision support encompasses a growing group of disciplines including, psychology, 
operations research, data warehousing68-70 The trends in clinical decision support follow 
those in business fields, therefore major future contributions to clinical decision support are 
likely to come from data warehouses, integration with data mining, developments in 
qualitative modelling and “soft “computing.71 Examples of such a data warehouse will be 
demonstrated in the publications discussed in later chapters, specifically in the context of 
infra-inguinal vein bypass grafts (Appendix 7 and 8) and internal carotid artery stenosis and 
the risk of stroke (Appendix-9). 
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There are two commonly used standardized processes for data mining: 
• Cross Industry Standard Process for Data mining CRISP-DM72 
• Sample, Explore, Modify, Model and Assess SEMMA73 
CRISP-DM is the predominant process for knowledge discovery. It was devised in the late 
1990s as a European Union project led by 5 large corporations, SPSS Inc., Teradata, NCR 
Corporation, Daimler AG and OHRA. It was released in 1999 and since then it has become 
"de facto standard for developing data mining and knowledge discovery projects." CRISP-
DM divides the process of data mining into 6 different phases which are illustrated in Figure-
3.72 
 
The processes involved in CRISP-DM flow form generic tasks to specific ones. Generic tasks 
are those which are involved in any data mining such as addressing missing data. Specific 
tasks on the other hand include those processes required to deal with the task at hand and 
process instances which are specific items performed to achieve process definitions 
(objectives) defined by data mining project.73  
 
Arguably the best example of CRISP-DM use is reported by Catley et al. They used CRISP-DM 
to manage a multi-dimensional data stream in a neonatal intensive care. This is a which is a 
very challenging clinical field with regards to the wealth of data, the time dependency of the 
data available and the critical nature of the information gained.74  
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Figure-3 Visual representation of the processes involved in CRISP-DM.72 
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SEMMA is an acronym that stands for Sample, Explore, Modify, Model and Assess (Figure-4). 
It was developed by Statistical Analytics Systems (SAS) inc. The SEMMA model goes through 
a few self-explanatory steps. These steps are illustrated in figure-4.75 SEMMA is different to 
CRISP-DM as it focuses on the data mining process leaving business or the clinical context 
aspects out. For this reason and the fact that SEMMA is a proprietary product we elected to 
use CRISP-DM in the projects described in this thesis 68-73  
 
 
Figure-4 The steps involved in SEMMA data mining methodology 
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Data mining processes are usually dependent on user parameters and context; each data 
mining algorithm has its own theoretical assumptions.75 End-users may not have sufficient 
information about the parameter(s) and their selection; therefore, processes such as CRISP-
DM engage with business and data for understanding prior to design of database and the 
need for validation and quality control. The data used for data mining has traditionally 
needed to be sourced from different sources such as hospital databases which are primarily 
used for billing purposes do not contain information of sufficient quality to be the sole 
source for data mining and are exposed to potential threats such as data imbalance and 
missing data.  Data mining packages require extensive knowledge and expertise, which have 
meant that data mining has remained the domain of enthusiasts and experts. This narrative 
explores how these barriers can be overcome so that data mining can become the core 
technology for the practice of evidence based vascular surgery.  
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The Clinical Context for Included Publications 
Abdominal Aortic Aneurysms 
Over 7000 people die from ruptured AAA in the United Kingdom annually.76 The best 
treatment for AAA is elective repair of pre-symptomatic abdominal aortic aneurysms. Such a 
therapeutic strategy depends on effective identification of patients with AAA and the 
subgroup of patients in whom there is a real risk of aneurysm rupture. Most patients with 
AAAs are asymptomatic, timely identification of AAA may be achieved through targeted 
screening of the at-risk populations. Small abdominal aortic aneurysms can safely be 
followed by ultrasound based surveillance.77-82 Due to several large-scale randomised 
controlled trials a lot is known about AAAs and the timing of treatment, duration of follow 
up and treatment modalities employed.  
 
There is a targeted national screening program for identification of patients with AAAs in 
the United Kingdom. This program is aimed at men above the age of 65 due to the higher 
incidence of AAA in this cohort of patients, consequently less is known about natural history 
of AAAs in women. Health care processes have the potential to generate vast quantities of 
data, much of which has been collected in clinical databases. Over the last two decades 
these databases have accumulated large quantities of information much of which is hidden 
in the relationships and patterns within the data.83 The two publications discussed are 
examples of how large clinical and administrative databases can be successfully mined to 
identify clinically significant associations using structured data mining methodology (Figure-
5)84 whilst dealing with issue such as, noise, missing and incomplete datasets, class 
imbalance and validity of class labels.  
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Figure-5: An overview of the steps involved in data mining process.84  
 
 
 
Observational studies suggest that 25–41 per cent of AAAs larger than 5 cm will rupture 
within 5-yearsif they are not repaired. 85-87  In the United Kingdom management of AAAs 
below this size (5·5 cm in maximum anteroposterior (AP) diameter) is guided by the UK 
Small Aneurysm77 and the US veteran affairs Aneurysm Detection and Management (ADAM) 
trials78, which have revealed that early elective surgery conferred no long-term survival 
benefit over regular surveillance. Following the advent of Endovascular Aneurysm Repair 
(EVAR), further randomised controlled trials in Europe and the United States (ACE, PIVOTAL 
and have revealed that patients with AAAs which are less than 5cms do not benefit from 
endovascular repair compared with ultrasound based follow-up.79-82 
 
The UK Small Aneurysm Trial found that the risk of AAA rupture was independently 
associated with aneurysm size, current smoking, mean blood pressure and female sex.83-86 
Growth rate is one of the factors used to identify patients who are at potential risk of 
aneurysm rupture. It is broadly accepted that growth rate of greater than 1 cm in one year 
indicates a risk of rupture and is an indication for AAA repair regardless of the size of AAA.  
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Figure-6 Serial Ultrasound examinations of the same asymptomatic AAA performed 5 
years apart revealing the gradual increase in the maximum AP diameter from 4.44 cms to 
5.98 cms (leading to its eventual repair).  
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The mean growth rate of AAA is variable depends on the population studied. Reported 
expansion rates vary widely, being up to four times higher in referral-based studies 
compared with community-based screening programmes which detect smaller AAAs.The 
main determinant of growth rate of an AAA is its initial maximum anteroposterior (AP) 
diameter. Other factors such as age, cigarette smoking and severe cardiac disease have also 
been associated with rapid expansion of AAA. Female sex may be an independent risk factor 
for rapid growth of AAA87. A large population based study from Sweden suggests that a 
large number of female subjects with ectatic aorta (46%) go on to develop an AAA within 5 
years of initial US examination. 88 A recent publication by Sidloff et al has revealed that 
women continue to have a higher mortality from AAA repair despite the introduction of 
endovascular techniques and the institution of Vascular Quality Improvement Program.89    
 
The introduction of endovascular aneurysm repair (Figure-7) holds the promise of reducing 
the peri-procedural morbidity and mortality of treatment.91-92 In 2007-8 the impact of these 
advances on national practices and utilization of services were yet to be analysed in 
Scotland. Furthermore, no information was available at that time on whether heightened 
awareness of AAA in primary care has resulted in the desired outcome of reducing 
aneurysm rupture rates. This study is noteworthy as it analyses outcomes following 
treatment for AAA, just prior to the development and implementation of Vascular Surgery 
Quality Improvement Program (VSQIP) and nationwide introduction of population screening 
for AAA, which were measures developed to address deficiencies in care of patients with 
AAA.93Comparing the results of Mofidi et al (Appendix-3) and Sidloff et al89 is sobering and 
suggests that the task of reducing mortality from AAA in women is far from accomplished.   
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Figure-7: Preoperative CT scan of a large intact AAA (Above). Completion angiogram of the 
same AAA following treatment with an endovascular stent EVAR (Below). 
Infra-inguinal vein graft surveillance 
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For over 70 years infra-inguinal vein graft bypass surgery has remained the gold standard 
treatment for management of disabling intermittent claudication and limb threatening 
ischaemia94-95.  Vein grafts are prone to develop stenoses, which may precipitate their 
failure.96-102 Stenosis may develop from technical error, pre-existing vein abnormality or 
myo-intimal hyperplasia. Over time, these grafts are at risk from progression of 
atherosclerotic disease which can result in graft failure by reducing flow across it (Figure-8). 
 
Evidence of these problems is recognisable by duplex ultrasound scanning, a technique 
acknowledged for its accuracy in identifying and grading stenotic lesions that threaten graft 
patency.101 Duplex scanning has been widely used for graft surveillance, the rationale being 
that correction of stenotic lesions is likely to improve graft patency and limb salvage rates 
(Figure-9).102-106 
 
 
 
 
 
 
Figure-8 Aetiology of vein graft stenosis is classified chronologically.  
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The wisdom of duplex vein graft surveillance has been questioned by the Vein Graft 
Surveillance (VGST) trial. It revealed no significant difference in graft patency or limb salvage 
in the medium term between patients who were followed up clinically and those who 
underwent vein graft surveillance.101 The finding of VGST threatened vein graft programs 
which were in place in the most vascular surgery departments in the developed world. 
Although there were some flaws in the design of the VGST, due to its size, the fact that it 
was a randomised controlled trial its and multi-centre nature, it was unlikely to be repeated 
to account for these methodological issues.  
 
Several preoperative factors have been found to influence the outcome of infra-inguinal 
vein bypass.105-109 While many of these factors are endogenous to the patients and beyond 
the direct control of the surgeon, the size and quality of the venous conduit available for 
bypass is considered important factors affecting the outcome of infra-inguinal bypass.108 
Although the use of smaller veins does not invariably result in graft failure,109 grafts with a 
diameter <3.5 mm are at increased risk of failure.110-112 Under these circumstances, the use 
of composite vein , arm vein or prosthetic grafts rather than uninterrupted small-calibre 
long saphenous veins are advocated all of which add to the complexity of the operation and 
are by themselves risk factors for graft failure.113 
 
Operative techniques such as patch angioplasty, interposition graft or replacement graft 
remain the gold standard for the management of vein graft stenosis. These techniques 
require the availability of an additional autogenous vein and carry the risk of morbidity and 
mortality associated with re-operation. In addition, jump and interposition grafts used to 
treat vein graft stenosis may by themselves be at risk of development of vein graft 
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stenosis114-116  The application of angioplasty in the treatment of stenoses in other venous 
conduits such as haemodialysis arterio-venous fistulae117-119had led to the introduction of 
this technique for the management of threatened bypass grafts.120-124 Conventional wisdom 
indicates that a segment of vein which has been afflicted by neoinitimal hyperplasia causing 
a tight stenosis is no longer a suitable conduit for infra-inguinal bypass and needs replacing, 
on the other hand neointimal hyperplasia is often very focal in nature and represents the 
ideal lesion for endovascular intervention. The efficacy of this treatment modality had been 
questioned and at the time of this publication no consensus existed about its primary use in 
the management of vein graft stenosis.123-127 
 
The four studies in this narrative utilized data mining methodology to examine vein graft 
surveillance programs in the east of Scotland Vascular network. These studies have helped 
to inform the debate regarding vein graft surveillance, specifically with regards to 
identification of grafts which are at high risk of failure. In addition, one of the publications 
examined the efficacy of endovascular techniques for treatment of vein graft stenosis.  
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Figure-9: Tight Proximal graft stenosis identified on Duplex US (Above) angiographic 
finding of a stenotic proximal vein graft stenosis in a different graft (Below).  
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Assessment of Degree of Internal carotid artery stenosis 
Randomised controlled trials have confirmed the value of carotid endarterectomy over best 
medical treatments for patients who have significant stenosis in the extracranial carotid 
artery. This benefit is most pronounced for patients who have suffered from recent 
ipsilateral transient ischaemic attacks, minor stroke or ischaemic ocular symptoms 
attributable to the stenosed artery128,129. Together these studies have randomised 5893 
patients with over 33,000 years of follow up. A meta-analysis of the individual patients from 
these studies (NASCET130, ECST131, VA309132) revealed that the degree of ICA stenosis 
measured using digital subtraction angiography was a key determinant of risk of further 
neurological events and by extension the benefit each patient may obtain from timely 
carotid endarterectomy. It revealed that surgery was harmful in patients with less than 30% 
stenosis, of no benefit in those with 30–49% stenosis, of some benefit for 50–69% stenosis, 
and highly beneficial for those with 70% or more stenosis without near-occlusion128. Data 
from these studies has been used to develop risk calculators (Figure-10) which can be used 
to individualise risk of developing further neurological events. A major component of this 
risk calculator is the degree of ICA stenosis.133 NICE guidelines suggest that these risk 
calculators are incorporated into every day clinical decision making. In effect 25 years after 
publication of NASCET and ECST accurate assessment of degree of ICA stenosis is as relevant 
as ever.133 
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Figure-10: Oxford stroke risk calculator 
 
All pertinent randomised controlled trials had utilized digital subtraction angiography to 
measure degree of ICA stenosis (or confirm presence of ICA occlusion). Intra-arterial 
angiography has a significant morbidity and a low but significant mortality rate.134-136 As 
technology has developed and experience has broadened duplex ultrasound scanning has 
been found to provide sufficient information for clinical decision making in patients with ICA 
stenosis.137,138 Assessment of degree of ICA stenosis involves combining the information 
obtained from Peak Systolic Velocity (PSV), End Diastolic Velocity (EDV) at the site of 
stenosis, PSV and EDV at the common carotid artery (CCA) or distal ICA, the ratios between 
ICA and CCA velocities, subjective assessment of the wave form as well as the β-mode US 
appearance of stenotic lesions139-142(Figure-11). Summing up all this information requires 
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significant degree of observer interpretation143 making carotid duplex examination prone to 
inter-observer variability and potential of introducing error.144 
 
 
 
 
 
 
 
 
 
Figure-11: Carotid Duplex Ultrasound exam of right carotid bifurcation (left) together with 
MR angiogram image (right) both showing a tight ICA stenosis.  
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Cut off values for these measurements are selected using receiver operator characteristic 
(ROC) curves are used to define a certain degree of stenosis.139-146 The combination of these 
measurements is based on empirical selection with not enough statistical data to support 
which values best represent the degree of ICA stenosis particularly in presence of 
confounding variables such as contralateral ICA occlusion.139-146 These criteria vary between 
laboratories both in the method of calculation and in the range of degrees of stenosis used 
to describe each stratification or band.139,140 Traditionally banding of the degree of ICA 
stenosis using Duplex criteria usually involves 20-percent bands. These broad bands do not 
allow adequate classification of ICA stenosis to provide all the information needed for 
clinical decision making in patients with symptomatic carotid stenosis139-146 or in patients 
with asymptomatic stenosis who are offered carotid endarterectomy.  139-146 A small 
numbers of criteria exist which stratify the degree of ICA stenosis into 10% bands.140 The 
vascular society of the United Kingdom and Ireland and the Society for Vascular 
Technologists in the United Kingdom have put forward comprehensive reporting standards 
for carotid duplex US examinations which include a standardised criteria.140 However there 
is evidence to suggest that different Duplex criteria are still in use and that the difference 
between the different methods of interpreting the Doppler waveform generated by the 
Duplex US examination (Duplex criteria) , (Figure-11) has clinical significance.139  
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Predicting Outcome following surgery with curative intent for treatment of 
Oesophageal cancer 
Union International Contra Cancrum (UICC) TNM classification system is the most widely 
used method of staging for patients with oesophageal and OG junction carcinoma.147 It is 
purely based on anatomical extent of the disease, therefore, its ability as a predictive model 
is limited to the information obtained from imaging modality148, whilst anatomical extent of 
the disease is of value, a number of other factors, which are amenable to preoperative 
assessment, are known to influence survival following resection with curative intent.149 
These include tumour length measured on contrast swallow,150,151 tumour differentiation152 
and the presence of submucosal lymphocytic infiltration153 as well as involvement of the 
resection margins.154 Addition of these variables to a predictive model for oesophageal 
carcinoma based on conventional statistical models would significantly increase its 
complexity and limit its clinical utility. Artificial Neural Networks have been increasingly 
adapted in medicine as decision support aids153-157 and to predict outcome from using 
complex multivariable prognostic indicators.158–165 
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Chapter-2  Methodology and Results       
This narrative describes the contributions of 9 publications to the fields of general and vascular 
surgery. They cover a diverse set of clinical problems and provide unique solutions through the use 
of data mining techniques. Whilst it would not be practical to discuss these in the context of one 
global methodology there is a lot of commonality between them, not least is the use of CRISP-DM 
processes to implement them. However, the differences between the publications mandate that 
they are discussed separately when it is necessary to highlight their unique feature, such as data 
source or data analysis models. This chapter is divided into 4 different work-streams: 
2.1 Study of Associations Using Deterministic Classification  
2.2 Sequence (Path) Analysis Using a Combination of Deterministic and Intelligent Methods 
2.3 Classification using Intelligent Analysis  
2.4 Prediction of Outcome using Intelligent Analysis  
 
Due to the fact, that CRISP-DM is an integrative data mining process (Figure-12); methodology and 
results are discussed in one unified chapter.  
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Figure-12:  CRISP-DM Process Applied to Study-2 
36 | P a g e  
 
2.1 Study of Associations Using Deterministic Classification 
2.1.1 Assessment of Growth rate of AAAs (Paper-1,  Appendix 2)
This publication sets out to assess the factors that influence the growth rate of AAAs. Hence 
the basic data mining paradigm explored was study of associations between putative factors 
including  gender  and  rate  of  growth  of  AAAs.  This  was  achieved  through  analysis  of  a 
database  of  all  patients  who  have  been  enrolled  and  followed  up  by  an  aneurysm 
surveillance clinic for 20 years. The model used for data mining was CRISP_DM model which 
has already been described in the previous chapter. The methodology  of the study will be 
discussed  under  the  5  main  headings  of  business  understanding,  data  understanding,  data 
preparation,  data  analysis  and  evaluation.  The  last  step  of  the  CRISP-DM  which  is  the 
deployment of findings of each work-stream is discussed in later chapters.
 
2.1.1.1 Business Understanding  
Between January 1985 and August 2005 all patients who had been diagnosed with an AAA 
at the Royal Infirmary of Edinburgh and not considered for early aneurysm repair were 
assessed serially by abdominal ultrasonography. This included all patients with small AAA 
and patients who either refused or were not considered for elective aneurysm repair at the 
time of first presentation. The data on each patient attending the aneurysm surveillance 
clinic was collected prospectively in a Microsoft® Access™ database. The database had been 
administered by the same person (Dr J Kelman) since its inception. As the administrator of 
the database she was responsible for integrity and quality of the data collected. The quality 
of the data had been regularly audited.183      
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The maximum AP diameter abdominal aortic aneurysm was recorded at enrolment and 
during each subsequent visit. Patients were followed up until they died; the AAA was 
repaired or they were discharged from the clinic. All patients were cross referenced against 
the Lothian Audit database166 to see if they had undergone operative interventions 
pertinent to their AAA. 
 
2.1.1.2 Data understanding and preparation 
The dataset consisted of 17 variables of which 8 were continuous variables the rest were 
categorical variables (Table-1) 
Variable Data Type % Missing values 
CHI number Continuous  0 
Date of enrolment Continuous  0 
Date last followed Continuous  0 
Outcome Nominal 0.04% 
Date of birth Continuous 0 
Age Continuous  0 
Postcode Nominal 0 
Gender Binary 0 
Diabetes Binary 29% 
COPD Binary 30.60% 
Ischaemic Heart disease Binary 29.73% 
Smoking  Binary 15.67% 
Hypertension  Binary 18.30% 
Statin Therapy Binary 57% 
Initial AAA AP diameter Continuous  0.00% 
Final AAA AP diameter Continuous 1.8% 
Growth rate Continuous  0.63% 
 
Table-1: Variables included in the AAA surveillance clinic dataset 
 
Issues Regarding the Available dataset were addressed under 3 different settings (Missing 
data, class imbalance and validity of class labels), due to the historical nature of data and 
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the long duration of follow up, minimal pre-processing of available data was performed and 
input variables which were not considered to exhibit sufficient validity for inclusion into the 
analytical model were excluded. 
  
2.1.1.2.1 Missing data: Due to the historical nature of data it was not possible to source 
missing values from other organisational databases. Variables which had more than 20 
percent missing values were excluded from analysis. Although the authors acknowledge that 
20% missing data is an arbitrary value.  
 
2.1.1.2.2 Class imbalance167: As post-mortem examination concerning the cause of death 
was unavailable in a significant number of cases, and “it was believed that knowledge of the 
presence of AAA may have biased the recorded cause of death”22, the risk of rupture of AAA 
was not calculated in this study. Although the authors acknowledge that this may have been 
extra cautious in retrospect as this data was readily available.  
 
2.1.1.2.3: Validity of class labels167: History of hypertension, smoking and renal failure were 
collected as nominal variables at the time of enrolment into the AAA surveillance clinic. As 
there had been no attempt at defining the diagnoses of hypertension or renal failure the 
observations were not thought to be robust enough for inclusion into the model. For 
example, the history of smoking was collected as a binary variable without collecting the 
duration or quantity of smoking (e.g. in pack years). The history of smoking after enrolment 
into AAA surveillance had not been collected either.  These observations together with the 
significant number of missing values (16%) resulted in that value also being excluded from 
the model. The authors acknowledge that whilst accepting limitations imposed by the 
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validity of class labels, hypertension and smoking were two variables which could have been 
included and are putative contributors to growth rates of AAAs.   
 
2.1.1.3 Modelling  
The association between the initial diameter of an AAA and its growth rate was assumed to 
be linear. Therefore the model created was linear regression analysis. The growth rate of 
AAA was selected to be the dependent variable whilst age, sex and initial aneurysm 
diameter the independent variables. The use of linear regression analysis to assess 
expansion of AAAs is likely to be associated with upward bias168, however as this would 
affect aneurysm growth rates in men and women equally, it is unlikely to influence 
comparisons based on sex. 
 
2.1.1.4 Findings 
Over 20 years, 1255 patients who had been diagnosed with AAA were entered into an 
ultrasound based surveillance programme (824 men and 431 women). They were followed 
for a median of 30 months (6–185) or six consecutive ultrasound examinations (range 2–37). 
Median AP diameter on initial AAA examination was 41 (range 25–83) mm. AAAs were 
significantly larger at initial presentation in men compared with women (Figure-13, 
P<0.001).  
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Figure-13 Distribution of anteroposterior diameter of abdominal aortic aneurysm on initial 
presentation in men and women. 
 
The median growth rate of AAAs was 2.79 (range: 4.80–37.02) mm per year. There was a 
significant variation in the growth rate of AAAs. The growth rate of AAAs was higher in 
women than in men(P<0.01), (Figure-15). 
 
 
 
 
 
 
 
Figure-14 Correlation between expansion rate and initial maximum anteroposterior 
diameter of the abdominal aortic aneurysm R2 = 0.22, (P < 0.001). 
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Figure-15: Box and whisker plot illustrating the difference in growth rates of abdominal 
aortic aneurysms between men and women.  
 
 
 
 
 
 
 
 
Figure-16: Growth rates of abdominal aortic aneurysms in men and women according to 
initial anteroposterior diameter. 
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Weighted linear regression analysis revealed that initial AP diameter and female sex were 
signiﬁcant predictors of rapid aneurysm growth (Figure-16), (Table-2). The final disposition 
of patients was as follows: 322 underwent operative repair.  This was performed for 
symptomatic or ruptured AAA in 43 patients (29 men and 14 women) and elective repair in 
279 patients. Three hundred and ninety-one patients died, 195 patients were lost or 
discharged from follow-up, and the remaining 347 patients remained under surveillance at 
the time of publication. 
 
 
 
 
 
 
Table-2: Factors associated with growth rate of AAAs.  
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 2.1.2  Outcome  from  abdominal  aortic  aneurysms  in  Scotland (Paper-2, appendix  3)
Understanding  trends  outcome  (survival)  following  treatment  for  a  disease  process  and 
associations between these outcomes and factors unique to patients is a very powerful tool 
in predicting patient needs and areas of improvement. This is often achieved by scrutinizing 
national registries and databases. This study is an example of the use of datamining in such 
an endeavour. 
2.1.2.1 Data understanding and preparation 
Over  the  past  54  years,  National  Health  Service  (NHS)  hospitals  in  Scotland  have  been 
obliged to return a standard form for all patients admitted to hospital. These data are stored 
electronically by the Information and Statistics Division (ISD) of NHS Scotland. The quality of 
data  collected  on  Scottish  Morbidity  Record  forms  (SMR1)  in  patients  with  AAA  has  been 
shown to match clinical records in over 99% of cases.169
 
Anonymised SMR-1 forms for all patients with the primary diagnosis of AAA from 1/1/1991 
to 31/12/2006 were obtained. The diagnosis for each in-hospital event was classified using 
final hospitalization diagnosis codes of the International Classification of Diseases ninth 
revision (ICD-9). Each patient was assigned a unique identifier, it was possible to follow him 
or her through the healthcare system and remove duplicate records.  
 
SMR-1 forms record secondary diagnoses and co-morbidities. However, there has been long 
lasting concern that unlike the primary diagnosis and treatment there are many instances of 
data imbalance and missing data which have persisted to date.170 Such concerns would have 
meant that data regarding secondary diagnoses could not be used in data analysis. Since 
2008, SMR-1 forms have included calculations of the Charleston comorbidity scores which is 
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a standardized method of collecting the risk to patients’ wellbeing from their 
comorbidities.170   This was not available for the duration of the study. Data obtained from 
the ISD were cross-referenced against the Scottish Audit of Surgical Mortality database to 
assure maximum accuracy. Patients in the database were divided by age, by presentation 
(ruptured versus intact AAA) and by method of repair (open versus endovascular).  
 
2.1.2.2 Data analysis  
Stepwise multivariable logistic regression analysis was carried out with in-hospital mortality 
as the dependent variable, and age, sex, presentation diagnosis and procedure type as 
independent variables.  
 
2.1.2.3 Findings: 
Over the 16 year duration from January 1991 to December 2006, 12,706 patients were 
admitted to Scottish hospitals with a principal diagnosis of AAA (9779 men and 2927 
women). The median age of these patients was 73 (range 17–97) years, [71 (range 17–96) 
years for men and 75 (range 35–97) years for women (P<0.001)], 8818 patients presented 
with intact AAA (69.4 %) whilst 3888 presented with ruptured AAA (30.6%). Figure-17 shows 
the annual rate of admissions and the proportions of ruptured and intact AAAs over the 16 
years examined in this study. 
 
Higher proportion of women presenting with AAA to Scottish hospitals (29.5%) presented 
with ruptured AAA compared with men (27.5%) presenting with the same primary diagnosis 
(χ2=4.1, P=0.043). The incidence of ruptured AAA remained constant over the 16 years of 
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the study, (Figure-18). However, there was a relative reduction in the proportion of patients 
with a ruptured AAA as the rate of elective repair of AAA increased over this time (χ2=17.1, 
P<0.001).  
 
 
 
Figure-17: Annual rate of hospital admissions for abdominal aortic aneurysm in Scotland 
from 1992 to 2006. 
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Figure-18: Annual rates of admission to hospital with a primary diagnosis of Abdominal 
aortic aneurysm stratified by age. 
 
Figure-19: Annual rates of admission to hospital with a primary diagnosis of Ruptured 
abdominal aortic aneurysm stratified by age. 
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A total of 8348 patients underwent surgery for AAA; this included 7466 open repairs (89.4%) 
and 698 endovascular repairs (8.4%). Figure-20 illustrates the estimated yearly rates of open 
and endovascular AAA repair. 
 
 
 
Figure-20: AAA repair in Scotland by modality (open versus endovascular repair) 
 
 
Over the 16-year interval, 2579 patients (20.3%) died within 30 days of admission with an 
AAA. Some 531 (37.7%) of 1410 patients who underwent attempted repair of a ruptured 
AAA died, compared with 362 (5.2%) of 6938 patients who had repair of an intact AAA. The 
30-day mortality rate was significantly higher following open repair of an intact AAA than 
after endovascular repair (5.6% (351 patients) versus 1.6 %(11 patients); χ2 = 19.8, P<0.001). 
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Early postoperative mortality rates were significantly higher in women than in men (29.9% 
(875 women) versus 25.8 per cent (2523 men); χ2 = 19.3, P <0.001). Logistic regression 
analysis revealed that age, sex, admission diagnosis (ruptured versus intact AAA) and type of 
procedure performed (open versus endovascular repair) were independent predictors of 30-
day and in-hospital mortality following AAA repair (Table-3). 
 
 
 
 
 
Table-3 Factors associated with death from AAA 
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2.2 Sequence  (Path)  Analysis  Using  a  Combination  of  Deterministic  and 
Intelligent Methods 
Sequence (path) analysis involves studying a clinical problem in great detail. The information 
collected can then be used to develop a bigger picture which can be used for bench-marking 
of  outcomes  or  designing  decision  support  systems.  It  involves  study  of  associations 
between many pertinent variables (often using deterministic data mining models) but also a 
summative  assessment  to  develop  an  overall  view  which  can  become a  decision  support 
system.  The  paradigm  of  path  analysis  is  applied  to  the  difficult  problem  of  infra-inguinal 
vein graft failure. Data sources are departmental registries of vein graft bypasses in the East 
of  Scotland  Vascular  Network (Royal  Infirmary  of  Edinburgh  and  Ninewells  hospital, 
Dundee). These 2 distinct registries were used for follow-up of patients who had undergone 
vein  graft  bypass  surgery  for  administrative  reasons  such  as  generating  and  regulating 
follow up scans and recording the results of each investigation as well as assisting in periodic 
audit of infra-inguinal bypass procedures. The final decision support tool was validated using 
outcomes  of  patients  in  a different  hospital  in  England (James  Cook  University  Hospital  in 
Middlesbrough). All the 3 databases were developed using Microsoft® Access™.  The first 2 
databases  were  administrative  databases  used  for  audit  of  infra-inguinal  vein  graft 
surveillance with secondary research purposes. The 3rd database was created specifically to 
validate  the  decision  tree  model  which  is  described  in  the  Paper -7,  Appendix-8.  As  Per 
Caldicott’s guidelines the dataset collected and stored was limited to patient demographics, 
atherosclerotic  risk  factors  (Smoking,  diabetes,  hypertension,  hyperlipidaemia,  chronic 
kidney disease), Antiplatelet agent and statin  therapy, the type of  initial bypass operation, 
conduit used and  follow  up  information  including  results  of  consecutive  clinical  and  US 
examinations. 
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2.2.1 Business understanding 
Consecutive patients, who underwent infra-inguinal bypass procedure using autologous 
vein, were enrolled into an ultrasound based graft surveillance program. This involved 
duplex scanning and the measurement of ankle brachial index pressures during each visit.  
 
Ultrasound Examination: Vein graft surveillance protocol was performed before discharge 
from the hospital and at 6 weeks, 3 months, 6 months, 1 year 18 month and 2 years after 
operation. Ultrasound examination began within the inflow artery, progressing down the 
graft and continuing into the outflow artery. The inflow and outflow vessels were assessed. 
Peak systolic velocity was measured at sites of stenosis, at multiple sites within the graft and 
within the outflow vessel. The velocity ratio at the site of stenotic lesions was calculated. 
Grafts were categorized into 3 groups based on duplex findings during each graft 
surveillance visit (Table-4) 
 PSV at the site of stenosis Post stenotic PSV 
ratio 
Drop in ABPI 
 Absolute value 
(cm/s) 
PSV ratio   
Mild stenosis <200 <2 >0.5 <0.15 
Moderate stenosis 200-300 2-3 0.5-0.4 < 0.15 
Critical stenosis >300 >3 <0.4 >0.15 
Occluded N/A 
PSV – Peak Systolic Velocity; ABPI – Ankle Brachial Pressure Index; Post stenotic PSV: The peak 
systolic velocity of blood flow in the graft downstream from the stenotic lesion 
Table-4: The velocity criteria identifying different categories of vein graft stenosis identified 
through duplex surveillance (PSV: peak systolic velocity (cm/s), ABPI: ankle brachial pressure 
index).169 
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Both Royal Infirmary of Edinburgh and Ninewells Hospitals utilized the Lothian Surgical 
Database LSA to document the particulars of the initial operative procedure (in coded 
format as well as the operation note and outpatient clinic visit letters in freehand text).  
 
2.2.2 Data Understanding and processing 
Data collected on the regional vein graft databases was cross referenced and supplemented 
by information obtained from the hospital administrative, radiological and laboratory 
databases. Postoperative hypercholestrolemia was defined as the total cholesterol to high 
density lipoprotein cholesterol (total cholesterol/HDL) ratio of greater than 3.5. Renal failure 
was defined as the Kidney Dialysis Outcomes Quality Initiative (KDOQI) chronic kidney 
disease (CKD)171 stage 4 or 5 at the time of infrainguinal bypass surgery.  
 
Using a combination of data sources, a data warehouse was created by recording patient 
demographics, type of operation, conduit and follow up information which were recorded in 
a computerized database (Microsoft Access and Excel, Redmond, Washington, USA). The 
data warehouse created was a of simple ‘Data Mart’ structure (Figure-21). Data analysis for 
each study was performed retrospectively. Figure-21 illustrates the KDD process, chronology 
of data collection and the sources of information.  
 
For each of the four publications included in this chapter, data analysis and reporting was 
performed in accordance with the reporting standards of the Society for Vascular Surgery 
and the North American Chapter of the International Society for Cardiovascular Surgery.172 
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Figure-21: An overview of the steps involved in data mining (KDD) process and study timelines.  
 
PACS System LSA database Vascular Lab  
 Database 
Hospital 
Administrative 
Database 
Pathology Database 
Data warehouse 
Pre processing  
Deterministic Classification 
Significance of the early post-
operative US scan 
Small vein grafts Endovascular treatment of stenosis 
Intelligent Classification 
Decision tree 
analysis 
Data collection and cross validation 
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Minimal pre-processing of available data was performed and input variables which were not 
considered to exhibit sufficient validity for inclusion into the analytical model were 
excluded. 
  
Missing data: Every effort was made to minimise missing data. This was performed through 
cross referencing of available databases and review of medical records if necessary. Due to 
the contemporary nature of data (Within 5 years) a single attempt was made to contact 
patients and his/her general practitioner to complete the dataset.  
 
Class imbalance: Due to the standardized nature of data collection and the attempts made 
to complete missing or incomplete data sets none of the variables used for data analysis 
(patient demographics, atherosclerotic risk factors, results of vein graft surveillance 
examinations and treatments) where found to exhibit significant class imbalance.   
 
Validity of class labels: Class labels used in each study were kept simple and easily verifiable.  
Cross referencing was used to assure that each class label included met the criteria used to 
define that label. Table 2 lists all the available variables for analysis. 
 
Pre-processing: Minimal pre-processing was performed. The aim of pre-processing was to 
make sure that the data format was usable for statistical analysis, define events such as 
graft occlusion (patency), major amputation and follow up time between the initial 
procedure and these events (timing of the events).  
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2.2.3 Data analysis 
Patients were stratified into two categories based on the pertinent clinical finding which was 
being studied such as the findings of the initial surveillance scan or minimum diameter of 
the long saphenous vein. The groups were compared in terms of stenosis, need for re-
intervention, graft patency, and amputation. Patency and amputation rates were 
determined using Kaplan-Meier analysis. The association of graft patency and limb salvage 
with risk factors for graft failure as ascertained by the site of the distal anastomosis, 
minimum VGD, and other atherosclerotic risk factors was analysed using the Cox 
proportional hazards model. The association between the need for re-intervention due to 
development of a vein graft stenosis and the above variables was assessed using 
multivariate logistic regression analysis. 
  
2.2.4 Evaluation 
Distribution of patient groups by age, gender, diagnoses of diabetes and chronic kidney 
disease and smoking history as well as type of bypasses being performed remained constant 
in the 2 Cohorts of patients being studied. 
 
The full text of the 4 publications included in this work-stream can be found in Appendix (iv-
8). The results of the data mining exercises are discussed under 4 headings: 
2.2.5 Findings of the early postoperative Duplex scan 
2.2.6 Using Small diameter vein grafts for infrainguinal bypass surgery 
2.2.7 Decision tree Analysis 
2.2.8 Endovascular treatment of Vein graft stenosis 
 
55 | P a g e  
 
 2.2.5 Findings of the early postoperative Duplex scan:  (Paper –3, appendix iv)
At the time of the first Ultrasound assessment, 65% had no significant stenosis and 35% of 
grafts  had significant  flow  abnormalities  (stenoses).  The  distribution  of  these  flow 
disturbances  along  the  length  of  the  vein  graft  is  shown  in  Figure-22. Of  the  grafts  with  a 
critical stenoses, (52%) were repaired. A further 38% were not repaired and occluded during 
subsequent follow-up. 
 
 
 
Figure-22 the distribution of duplex related flow abnormalities along the length of the 
graft and their severity based on early postoperative assessment. 
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Forty-three of grafts with severe stenosis were treated, three by intra-luminal angioplasty, 
18 by vein patch, 9 by jump graft, eight by interposition graft and five by revision of the 
bypass. Eight patients required repeat surgical procedures for recurrent graft stenosis; this 
was by repeat vein patch angioplasty in three, jump graft repair in four and interposition 
graft in one patient. Forty-nine limbs with critical or intermediate vein graft stenosis were 
not treated. No statistically significant difference was observed in graft patency (p=0.19) or 
amputation rates(p=0.62) rates between grafts with repaired stenosis and grafts without 
stenosis. Untreated grafts with critical or intermediate stenosis had significantly lower 
patency (p<0.001) and higher amputation rates (p<0.001) rates, (Figures-23 and 24). 
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Figure-23: Kaplan-Meier plots of primary assisted patency over time in grafts enrolled into 
the vein graft surveillance program 
 
Figure-24: Kaplan-Meier plots of limb salvage over time in grafts enrolled into the vein 
graft surveillance program. 
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 A- 2.2.6 Using  Small  diameter  vein  grafts  for  infrainguinal  bypass  surgery (Paper- 4,appendix-6)
Table-5 illustrates patient demographics stratified by diameter of vein graft utilised for the bypass 
procedure. 
 
Table-5: Patient demographics stratified by the minimum internal diameter of venous 
conduit used for operation. 
 
Median preoperative internal diameter of vein grafts used was 3.9 mm (range 2.4-6.7). The 
minimum preoperative internal diameter of the vein graft was <3.5 mm in 36.9% and <=3.5 
mm in 63.1%. The distribution of VGD in each group is illustrated in Figure-25.  
 
Figure-25: Distribution of minimum preoperative VGD in grafts which were <3.5 mm 
compared with grafts which were =>3.5 mm. Mann-Whitney test (P< 0.0001). 
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A higher proportion of bypasses performed with small dimeter vein grafts required 
intervention to maintain their patency compared with those with diameter>3.5 mm (Figure 
26). The difference in primary assisted patency rates between grafts with preoperative VGD 
<3.5 mm and grafts with preoperative VGD diameter equal or greater than 3.5 mm did not 
reach statistical significance (log rank= 2.29, p =0.13) (Figure-27). In addition, there was no 
significant difference in amputation rates between vein grafts which were created using 
veins with a minimum preoperative diameter <3.5 mm compared to those with a minimum 
preoperative diameter equal or greater than 3.5 mm (log rank =1.69, p = 0.35), (Figure-28).  
 
 
Figure-26: Comparison of the proportion of vein grafts requiring re-intervention to 
maintain graft patency, stratified by the minimum preoperative internal diameter of the 
vein graft. 
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Table-6:  Factors affecting the need for re-intervention in infrainguinal vein grafts.  
 
 
 
 
Figure-27: primary assisted patency of vein grafts in patients who underwent infrainguinal vein 
graft bypass, stratified by preoperative minimum internal diameter of the vein graft. 
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Figure-28: Kaplan-Meier plot of amputation rates over time in patients who underwent 
infrainguinal vein graft bypass stratified by preoperative minimum internal diameter of the vein 
graft. 
 
 
There was no significant association between minimum preoperative VGD and reduced 
primary assisted patency (Table-7) or higher amputation rates (Table-8). 
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Table-7: Factors affecting primary assisted patency after infrainguinal bypass assessed 
using Cox’s multivariate regression analysis. 
 
 
 
Table-8: Factors affecting amputation rates after infrainguinal bypass assessed using Cox’s 
multivariate regression analysis. 
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2.2.7 Decision tree Analysis (Paper-5, appendix 7)
A  Classification  and  Regression  Tree  Model  (CART)  was  used  to  identify  patients  who  are 
likely  to  develop  significant  vein  graft  stenosis  or  occlusion  with  the  aim  of  identifying 
patients who would benefit from more intensive duplex ultrasound based follow up. CARTs 
have been  described  in  the  introduction  chapter  (Page-11,  figure-1).  The  variables  used 
were  clinical  and  duplex  ultrasound findings,  which  were  available  at  the  time  of  first 
postoperative  assessment.  The  Gini  coefficient  was  used  to assess  heterogeneity  in  the 
distribution of patients from the parent node to children nodes. The Gini coefficient is zero 
when all observations at a node belong to one level of a dependent variable and is 0.5 when 
observations are equally distributed in various levels of a dependent variable. The best split 
on a variable will be the one that minimizes the Gini coefficient. This process continues until 
a termination criterion is met.173
 
The level of significance of each variable will be adjusted by Bonferroni’s correction; where 
the decision tree is first fitted to the data, with the most complex topography and the 
greatest number of nodes and hence accuracy. Prediction at each node is made based on 
the weight of observations in each category of the dependent variable and misclassification 
cost. The CART then undergoes a process of pruning, during which the terminal nodes will 
be deleted only if its elimination causes a misclassification cost which is significantly lower 
than the reduction in complexity. This process continues to reach the root node. The 
optimal CART is selected as the final predictive model. The optimal CART selected was one 
that prioritized sensitivity over specificity, as its purpose was to relate the decision or an  
attribute to its consequences whilst maintaining the simplest topography.173 
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The aim of the model was to repeatedly divide patients into subgroups, each of which 
consisted of patients with or without severe vein graft stenosis or occlusion. Thereby 
stratifying patients into high-risk groups who should undergo duplex ultrasound based 
surveillance and low-risk groups, who do not require intensive follow up. The CART model 
was then used to describe the possible pathways of different cohorts during the first 2 years 
of vein graft surveillance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-29: Tight Proximal graft stenosis identified on Duplex US, with angiographic views 
of the same stenosis before and after angiographic treatment using drug eluting 4mm x 
4cm balloon angioplasty. 
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The results of Cox regression analysis of potential risk factors associated with infrainguinal vein graft 
bypass graft stenosis or occlusion are shown in Table-9.  
 
 
 
Table-9: Cox regression analysis of potential factors associated with infra-inguinal vein 
graft bypass graft revision 
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Seven hundred and thirty six patients were classified through 5 items into 10 different 
categories with 2-year stenosis or occlusion rates ranging from 5% to 95%. The CART model 
stratified 299 grafts (40.8%) as low-risk and 433 (59.2%) as high risk grafts (Figure-30). 
 
 
Figure-30: Decision tree based on patient profile and first postoperative graft surveillance 
assessments. The table outlines the Gini coefficient* and the accuracy of prediction** for each 
node.  The Gini coefficient* relates the performance of the node in portioning the patients based 
on the eventual outcome.  The accuracy of prediction** is the accuracy of predicting the eventual 
outcome based on a single node.  
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Figure-31 illustrates the final topography of the decision tree and the proportion of patients 
assigned to each group. The model was able to stratify high-risk grafts that were at risk from 
significant vein graft stenosis or occlusion with good accuracy.  Area under the ROC curve 
for prediction of graft stenosis or occlusion was 0.88 (95% Confidence Interval (CI): 0.81-
0.94 percent). The indicators of accuracy of the decision tree model at correctly classifying 
the CART model are listed in Table-10. Figures 31 and 32 illustrate the Kaplan-Meier survival 
curves for primary graft patency and amputation rates for grafts that have been classified as 
high- and low-risk based on the model.  They show that grafts classified as high-risk had 
significantly lower primary patency rate (Log rank=186, P<0.001) and were associated with 
higher risk of amputation (Log rank=118, P<0.001) during follow up.  
 
Value  Estimated value 95-percent Confidence intervals 
Prevalence of high risk grafts 0.27 0.25 0.3 
Sensitivity 0.92 0.88 0.95 
Specificity  0.52 0.45 0.60 
Positive Predictive Value 0.45 0.38 0.54 
Negative Predictive value 0.93 0.89 0.96 
Positive Likelihood ratio  1.55 1.44 1.66 
Negative Likelihood ratio 0.6 0.52 0.66 
 
Table-10 Indicators of accuracy of classification of the CART (decision tree) analysis for prediction 
of development of vein graft stenosis or occlusion within the first 2 years of follow up.  
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Figure-31: Kaplan Meier survival curve showing the primary patency rate in the grafts that have 
been selected to be high-risk versus low-risk by the decision tree 
 
Figure-32: Kaplan Meier survival curve showing amputation rates in the grafts that have been 
selected to be high-risk versus low-risk by the decision tree. 
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A recent study (Paper-7 Appendix-8) has successfully validated the decision tree in a 
completely new population of patients.  The results of this validation study are illustrated in 
figures-31 to 35.  
  
Figure-33 Decision tree based on patient profile and first postoperative graft surveillance 
assessments. (Validation population) 
Grafts classified as high risk:   154 (61.8%) 
Grafts Classified as low risk:    95 (38.2%) 
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70 | P a g e  
 
 
 
 
 0 10 Months 20 Months 30 Months 40 Months 
Low risk 95 83 76 45 31 
High risk 154 79 63 41 28 
 
Figure-34 Kaplan Meier survival curve comparing primary assisted patency (y axis) of 
grafts which were predicted to be high risk (Red) using the decision tree model compared 
with low risk grafts (Black), (Log Rank=70, P<0.001).  
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 0 10 Months 20 Months 30 Months 40 Months 
Low risk 95 83 76 45 31 
High risk 154 79 63 41 28 
 
Figure-35: Kaplan Meier survival curve comparing amputation rates in patients who had 
undergone infra inguinal bypass grafts which were predicted to be high risk (Red) using 
the decision tree model compared with amputation rates in low risk grafts (Black), (Log 
Rank=42, P<0.001)244 
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2.2.8 Endovascular treatment of Vein graft stenosis (Paper-7– appendix 4)
Seventy-six  grafts  underwent  a  total  of  99  endovascular  procedures  (Figures-42  and  43). 
Median age of the grafts at the time of the first angioplasty was 5 months (range: 7 weeks- 
27  months).  Forty-one  primary  angioplasties  were  performed  with  a  standard  balloon  and 
34 with a cutting balloon. Initial technical success was achieved in 60 grafts (78.9%).
 
Of the grafts in which initial technical success had not been achieved, eight underwent 
repeat angioplasty with good technical success and another graft was found to have 
thrombosed the next day. This graft was successfully managed with local catheter 
thrombolysis with good results. Three grafts occluded prior to attempted surgical repair and 
another four grafts were surgically repaired. A total of 27 grafts (45%) developed re-stenosis 
of which 24 underwent a repeat attempt at angioplasty, with technical success in 17 grafts 
(71%). Repeat angioplasties were performed with cutting balloons. Of the grafts that had 
developed re-stenosis three occluded prior to the repeat attempt at angioplasty and a 
further patient was deemed too unfit to undergo further intervention. There was no peri-
procedural mortality. Vein graft angioplasty was associated with two puncture site 
haematomas both of which were treated conservatively; in addition one patient who had 
undergone cutting balloon angioplasty developed a delayed retroperitoneal haemorrhage 
from a contralateral puncture site which was managed by open surgery. 
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Figure-36: Digital subtraction angiograms of a common femoral to below knee popliteal artery 
bypass graft. The left image shows a proximal graft stenosis (arrowhead), whilst the right image 
shows the final result after cutting balloon PTA with a 4.0-mm diameter balloon. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-37:  Digital subtraction angiograms of a common femoral to above knee popliteal artery bypass graft. 
The left image shows two distal anastomotic graft stenoses (arrowhead), whilst the right image shows the 
final result after cutting balloon PTA with a 3.0-mm diameter balloon. 
74 | P a g e  
 
Overall 30-month primary patency, primary assisted patency and secondary patency rates 
were 73.2%, 82.6% and 84.3%, respectively. No significant difference was observed in graft 
patency (log rank=1.83, P=0.08) or amputation rates (log rank=0.89, P=0.32) between the 
grafts requiring intervention to maintain patency and grafts which did not (Figure-38 and 
39).  
 
 
 
Figure-38 Kaplan-Meier survival curves of Primary assisted patency 
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Figure-39 Kaplan-Meier survival curves of amputation rates  
 
 
 
Tables-12 and 13 list the factors affecting primary assisted patency and amputation rates 
after infra-inguinal bypass surgery assessed using Coxs’ multivariate regression analysis.  
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Table-11 
 
Table-12 
 
 
 
 
 
77 | P a g e  
 
 
2.3 Classification using Intelligent Analysis 
2.3.1  Assessment  of  degree  of  ICA  stenosis  using  an  artificial  neural  network  (Paper-8, 
appendix -9)
Consecutive patients who were investigated for ICA stenosis in a tertiary referral vascular 
surgery unit (St Vincent’s University Hospital, Dublin) were studied prospectively. All 
patients underwent carotid duplex ultrasound scanning as well as intra-arterial digital 
subtraction angiography (Figure-40) for assessment of the degree of extracranial carotid 
artery stenosis during the same episode of care. Measurement of the degree of ICA stenosis 
using Intra-arterial digital subtraction angiography was the gold standard against which the 
ANN and duplex velocity criteria were assessed. Patients data including demographics, co-
morbidities, Duplex US cerebral CT results and Intra-arterial digital Subtraction angiography 
were recorded (by Reza Mofidi) in a Microsoft Access database.   
 
Figure-40: Intra-arterial Digital Subtraction angiography of Left Carotid bifurcation  
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2.3.2 Neural Network Design  
Multi Layered Perceptron MLP models were developed using Neuro-SolutionsTM version 4 
software, (NeuroDimension, Gainesville, FL). The MLP models which were developed had six 
input nodes, consisting of entries corresponding to PSV and EDV in the ICA and pre-stenotic 
CCA, presence of contralateral ICA occlusion, and a bias node (figure-41). The MLP layer had 
3 hidden layers. Each node had a sigmoid transfer function of the hyperbolic tangent 
variety. Learning occurred through back propagation of error a process which generated a 
learning curve which plotted the reduction in mean squared error of observations in real-
time (Figure-42). The input data did not undergo any pre-processing steps prior to input into 
the neural network apart from randomisation of data sets.  
 
 
 
Input Variables  Output variable  
ICA Peak Systolic Velocity (cm/s) Continuous Degree of ICA stenosis (%) 
ICA End Diastolic Velocity (cm/s) Continuous Degree of ICA stenosis (Bands) 
CCA Peak Systolic Velocity (cm/s) Continuous  
CCA End Diastolic Velocity(cm/s) Continuous  
Contralateral ICA occlusion  Binary 1 or 0  
Bias node 1  
 
Figure-41 illustrates the graphical representation of a MLP as viewed on the Neuro-
SolutionsTM software user interface. 
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Two sets of ANN models were created the first set was tasked with calculating the exact 
degree of ICA stenosis, whilst the second set was tasked with stratification of degree of ICA 
stenosis to bands of predefined 10% intervals. The available data were randomly divided 
into training and validation data sets. The larger data set (60% of total data set) was used to 
train the model; the other (40% of the total data set) was used to validate the model. These 
were organised into eight different randomly selected reruns of data and were used to train 
eight identical MLP models. Four of these were used for prediction of exact degree of ICA 
stenosis and four to stratify the stenosis according to 10 bands.  
2.3.2.1 Training: The input variables used were PSV and EDV in ICA as well as CCA and 
presence of contralateral ICA occlusion. Sixty percent of the data set was used to train the 
neural network. The training rule was back-propagation of error.174 
2.3.2.2 Validation: As described earlier 40% of the available data was not used for training 
of the neural network model. The mean squared error was used to express the variation 
between the degrees of predicted value compared to the gold standard which was 
angiographic measurement of internal carotid artery stenosis.  
2.3.2.3 Statistical Analysis: The degree of ICA stenosis predicted by the ANN was compared 
with the angiographic measurements using linear regression and Bland-Altman analysis.  
To compare the duplex velocity criteria with the ANN in correct banding of the degree of ICA 
stenosis, a measure of the discriminant power (DP) of a test was used: 
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Evaluation 
Two hundred and eight carotid bifurcations in 104 patients were studied. Eighty-three patients had 
ipsilateral symptoms prior to presentation (hemispheric, 51; ocular, 27; both symptoms, 5), and 21 
patients were asymptomatic. The mean age of subjects was 70.1 years (standard deviation = 10.11); 
38 were female and 66 were male.  
 
Duplex Velocity Criteria and the Degree of ICA Stenosis 
 The overall agreement between the results of duplex ultrasound velocity measurement and 
angiography in determining the correct banding for the degree of ICA stenosis was 91.8% 
(191/208), with a sensitivity of 89.7% [95% confidence interval (CI) 82.8-94] and specificity 
of 93.5% (95% CI 86.5-97) (DP = 1.67). The accuracy of duplex ultrasound criteria at correctly 
identifying >70% ICA stenosis was 95.2%, with sensitivity of 96.3% (95% CI 90.9- 98.6), 
specificity of 94% (95% CI 87.5-97.3), and DP of 3.3. Carotid duplex examination was also 
able to identify over 50% ICA stenosis with reasonable accuracy [sensitivity 96.38% (95% CI 
89.9-97.5), specificity 91.6% (95% CI 82.8-96.1), and accuracy 94.7% (DP = 3.09)]. 
 
Neural Network Analysis 
Two hundred and eight data vectors were randomly divided as follows: 124 (59.6%) were 
used to train the neural network model and 84 (40.4%) were used for model validation. 
Following completion of training, the ANN model was able to predict the degree of ICA 
stenosis with a high degree of accuracy (mean squared error 0.012); cross-validation 
confirmed the validity of the ANN model at predicting the degree of ICA stenosis (Figure-42).  
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Figure-42: The training curve of the ANN used for banding the degree of ICA stenosis showing the 
minimization of mean squared error (MSE, y axis) during the training process (x axis = number of 
epochs). The solid line represents the training process and the broken line, cross-validation. 
 
Good correlation was observed between the degree of ICA stenosis predicted by the ANN 
and that measured angiographically (R2 = 0.9374, p < 0.0001) (Figure-43). Bland-Altman 
analysis revealed a high degree of agreement between the results of ANN and angiographic 
measurements (Figure-44). Furthermore, the ANN model was able to accurately band the 
ICA stenosis according to the predefined 10% intervals with a sensitivity of 97.3% (95% CI 
90.7-99.3), a specificity of 97.7% (95% CI 93.6-99.2), and an overall accuracy of 97.5%.  
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Figure-43: A plot of the angiographic degree of ICA stenosis (x axis) and ANN prediction of ICA 
stenosis in the validation sample (y axis).  
 
Figure-44: Bland-Altman analysis applied to the comparison of predicted degree of ICA stenosis by 
ANN and the angiographic degrees of ICA stenosis. 
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The ANN model was more accurate at correctly banding the degree of ICA stenosis. The DP 
of ANN was 4.11, while that of duplex velocity criteria alone was 1.67 (p < 0.05). The 
accuracy of the ANN at correctly identifying >70% ICA stenosis was 98.4%, with sensitivity of 
96.4% (95% CI 93.8-99.3), specificity of 98.7% (95% CI 93.4-99.8), and DP of 4.21. This was 
comparable to duplex velocity criteria (p = nonsignificant). The accuracy of the ANN at 
correctly identifying >50% ICA stenosis was 97.4%, with a sensitivity of 97.8% (95% CI 93.8-
99.3 and) specificity of 98.2% (95% CI 90.4-99.7), which was not significantly better than the 
duplex velocity criteria. Table-13 illustrates the comparison between duplex velocity criteria 
and ANN at identification of >50% and >70% stenosis as well as correct banding of ICA 
stenosis for >50% ICA stenosis. The use of ANN was associated with altered clinical decision 
in 2.9% of cases (5/208) compared with angiographic findings. This was not significantly 
different from the duplex velocity criteria, use of which was associated with altered clinical 
decision in eight carotid bifurcations (3.8%) compared with angiography (p = NS). 
 
Table-13  
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2.4 Prediction of Outcome using Intelligent Analysis 
2.4.1 Prediction of Outcome following resectional surgery for Oesophageal and OG 
junction carcinoma. (Paper–9 appendix-10) 
2.4.1.1 Data understanding  
Consecutive patients who had undergone resection of carcinoma of the oesophagus and 
gastro–oesophageal junction in a regional specialist oesophago-gastric surgery unit between 
January 1995 and August 2004 were included. The data used was National Minimum Core 
Dataset for Upper GI Cancer which had been developed by the ISD in Scotland.  
 
2.4.1.2 Neural network design 
Multilayer perceptron (MLP), with back propagation circuit were constructed using Neuro-
Solutions version-4 neural network software (NeuroDimension, Inc., Gainesville, FL, USA). 
The ANNs were trained through back propagation of error, which is a process by which the 
error of prediction is minimized by adjusting the weights associated with the synaptic 
connections in the hidden layers of the ANN. The MLP layer had 4 hidden layers. Each node 
had a sigmoid transfer function. Learning occurred through back propagation of error a 
process which is described in the introduction chapter (pages 12-14, figure-2). This process 
generates a learning curve which plotted the reduction in area under the receiver operator 
characteristic curve versus the number of observations used in the training process (figure-
46). 
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Two sets of artificial neural network models were created which were used to predict 
disease free survival at 1 year and at 3 years. The input data did not undergo any pre-
processing steps and were randomly assigned into two mutually exclusive datasets. One of 
these two datasets was used to ‘train’ the ANN (60% of the available dataset), a second to 
assess the accuracy of predictions of ANN trained using the first dataset (40% of the 
available dataset). In order to minimize bias based on selection of cases for training and 
evaluation datasets, panels of 10 identical ANNs were used for each prediction (disease free 
survival at 1 and 3 years). These ANNs were trained and evaluated independently of each 
other. The values pertaining to the accuracy of prediction were the average output for the 
ANN panel (with 95% confidence intervals). The training process was considered complete 
at the end of eight iterations of training or if the mean squared error of predictions was less 
than 0.025. The optimum variables used to construct the artificial neural network were 
selected from 42 potential input variables available using sensitivity analysis. During the 
process of sensitivity analysis, the network learning is disabled so that the weights 
associated with the synaptic connections were not affected. The inputs to the network are 
shifted slightly and the corresponding change in the output is reported as a percentage. The 
values that cause the highest percentage of change are selected to create the model. Using 
sensitivity analysis, input variables are categorized according to their ability in influencing 
outcome. The optimal number of variables for developing the ANN was assessed during 
backward variable selection, a process whereby the variables with the least predictive value 
are consecutively removed and the accuracy of prediction of the ANN model is evaluated by 
receiver operator characteristic analysis, until the ANN with the optimum accuracy of 
prediction is reached. The predictive power of the UICC TNM classification system in 
assessing disease free survival at 1 and 3 years was analysed using stepwise linear 
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discriminant analysis. The variables used to create this model are the T, N and M stage as 
well as clearness of the resection margins (R0: clear margins, R1: microscopically involved 
margins, R2: macroscopic residual disease). The accuracy, sensitivity, specificity, positive and 
negative predictive values as well as likelihood ratios were calculated for the UICC TNM 
staging system and ANN as predictors of disease free survival. To compare the TNM 
classification with ANN in predicting disease free survival a measure of the discriminant 
power (DP) of a test was used.  
 
2.4.1.3 Evaluation 
Two hundred and sixteen patients underwent resectional surgery for oesophageal and OG 
junction carcinoma of whom 155 were male and 61 were female. Median age of the 
patients was 64 years (range: 30–82). One hundred and sixty-one patients underwent 
primary surgical resection of the lesion and 55 received neoadjuvant, cisplatin and 5-
flourouracil based chemotherapy prior to the definitive surgical procedure. One patient 
underwent Argon laser ablation of an early adenocarcinoma of OG junction followed by 
subsequent definitive surgical resection. One-year follow-up data was available in 198 
patients and 126 patients had 3-year follow-up data available. Table-14 describes the 
pathological feature of the lesions based on the examination of the histological specimen. 
The Kaplan–Meier survival curves based on the UICC classification are shown in figure-45. 
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Table-14 
 
Figure-45 Kaplan–Meier survival curves based on the UICC classification, (log-rank test, 
P<0.01). 
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Artificial neural network analysis 
Table-15 illustrates the sample size and composition of training and evaluation datasets for 
the panel of neural networks used to predict disease free survival at 1 and 3 years. Using 
sensitivity analysis 14 input variables were selected to construct the ANN. Table 16 
illustrates the input values which were selected through sensitivity analysis to construct the 
ANN as well as their sensitivity for prediction of disease free survival at 1 and 3 years. 
Figure-46 shows the change in the accuracy of area under ROC curve in response to the 
reduction in the number of input variables. 
 
 
Table-15 
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The mean squared error (MSE) reached at the completion of training of the ANN for 
prediction of survival at 1 year was 0.0082, whilst the final training MSE for prediction of 3-
year survival was 0.006. Figure-43 shows the learning curve of the artificial neural network 
used for prediction of survival at 3 years with minimization of mean squared error during 
training process. ANN was able to accurately predict disease free survival at 1 year 
(accuracy: 88%, DP=2.3). This was significantly more accurate than the 1-year survival 
prediction using the UICC TNM classification system (accuracy: 71.6%, DP=1), (P<0.01). The 
ANN panel was significantly more accurate at predicting survival at 3 years after surgery 
(accuracy: 91.5%, DP=2.72) than the UICC TNM classification system (accuracy: 74.7%, DP=1) 
(P<0.05) (Table-16). 
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Table-16 
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Figure-46: Changes in the accuracy of the ANN survival at 1-year (red line) and 3-year 
(black line), plotted against the number of input variables used to create the ANN. With 
the reduction in the number of variables there is a progressive increase in the accuracy of 
the ANN (Y-axis) until the optimum number of variables is reached. 
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Chapter-3 Discussion                        
Much of practice of general and vascular surgery involves identifying patients with clinical 
conditions in pre-symptomatic state or after a herald event and planning prophylactic 
procedures such as angioplasty, stenting or surgical revision where the indication for 
intervention is preventing a future event such as disabling stroke, rupture of abdominal 
aortic aneurysm, graft occlusion or limb loss. Individualizing patient care to suit their 
condition runs counter to an approach which involves following a care pathway with the 
same steps for each patient once they met predefined criteria such as an AAA greater than 
5.5 cm in diameter, or greater than 70% ICA stenosis. The criteria selected for intervention 
as well as the pathway of care for surveillance are often supported by overwhelming 
evidence. With regards to vein graft surveillance the situation is further complicated by the 
fact that the majority of grafts do not develop stenosis and there is no evidence that beyond 
the early post-operative scan further US based surveillance of vein grafts has any impact on 
graft patency or amputation rates.101 With regards to prediction of future outcome the 
situation is different as the decision to intervene (or not to) can significantly alter the 
outcome.  This narrative set out to examine how data mining tools can help identify and 
individualize risk benefit analysis in each clinical context  
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Studies of association, data mining and management of abdominal aortic aneurysm 
Appendix-2  (Paper-1)  illustrates  the  challenges  involved  in  analysing  longitudinal  data 
collected  over  several decades.  It  also  illustrates  how  such  data  can  provide  clinically 
important  information  once  issues  regarding  missing  data  and  data  imbalance  are 
addressed. This publication reported the natural history of AAA in a large cohort of patients 
over a relatively long duration of time, significantly longer than the duration of follow up of 
any randomised controlled trial and this has proven to be its lasting legacy. Female sex was 
found  to  be  an  independent  risk factor  for  AAA  expansion  rate,  independent  of  initial 
aneurysm size and age on presentation. Another regional community-based AAA screening 
and surveillance programme has reported similar observations on a total of 274 men and 74 
women.176 A similar sized referral-based study also reported that female sex was associated 
with  increased  AAA  growth177.  A  number  of longitudinal  studies  have  revealed  that 
aneurysms  that  rupture  have  signiﬁcantly  higher expansion  rates  than  those  which  do  not 
rupture in  a  specified  time-frame180-184.  Brown  et  al.  reported  that  ruptured  AAAs  had 
signiﬁcantly higher mean expansion rates (0·84 cm per year) than  intact AAAs (0·39 cm per 
year) but did not report a gender difference.185  
 
RESCAN collaboration which was the seminal publication on the frequency of follow up 
scans for patients who have AAA below the size that requires early repair. It was based on a 
meta-analysis of 18 publications worldwide including 15,475 patients under surveillance186. 
It revealed a significant degree of heterogeneity in growth rates of AAA186. This 
heterogeneity was thought to be related to the patient population included in each study, 
i.e. whether patients were identified through screening (these studies were skewed towards 
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the smaller size and included mainly men) or surveillance of patients with small, moderate 
sized AAA and whether the study design included a treatment arm for small-moderate sized 
AAA. A treatment arm would affect the growth rate of AAA as it would reduce the duration 
of follow up in half of patients each study (those randomised to the treatment arm). 187,188 
Duration of follow up is the denominator in the calculation of growth rate of AAA, the rate 
of change in AP diameter of AAA being the numerator for this calculation. Study-1 
(Appendix-2) was one of the 18 seminal publications which contributed to the RESCAN study 
(Figure-44).186 
 
Figure-44: Estimated time for which there is a 10% probability of reaching the threshold diameter 
for surgery (5.5 cm) as a function of baseline diameter and study of origin (in men). Overall results 
are in black diamonds.186 Paper-1 (Appendix-2) is listed as Edinburgh study. 
 
Brown et al.184 studied a cohort of 476 patients with AAA and reported a fourfold higher 
rupture rate in women. The RESCAN collaboration confirmed the higher rupture rates of 
AAA in women compared with men.186 Although we elected not to compare the risk of 
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rupture in men and women with AAA as we were concerned that at face value this data may 
have been imbalanced, the data from our study did contribute to the estimation of rupture 
rates from AAA stratified by size by the RESCAN collaborators186. This was done by knowing 
which patients had died, and the proportion of patients in whom the diagnosis of ruptured 
AAA had been confirmed. Using mathematical modelling the RESCAN collaborators were 
able to estimate the annual risk of rupture in each of the subpopulation of patients 
(classified by class of interest such as gender).  When a large quantity of data is available it is 
possible to use compensate for missing or imbalanced data through pre-processing or 
mathematical modelling.186 
The author acknowledges that with hindsight their approach on Paper-1, appendix-2 which 
was to exclude variables with missing data (or those which we suspected of class label 
imbalance) was too conservative. “Missing data are a recurring problem that can cause bias or 
lead to inefficient analyses.” 189 The purist clinician’s view is if you don’t have the completed data 
you should not do the analysis (or exclude the variables with uncertainty) and this was the approach 
followed by us. Ironically where we to be faced with the same problem today we would employ an 
imputation technique (data mining) to solve the problem. There are number readily available 
imputation methods which use assumptions about missing variables or assigning weights to 
complete datasets or using Bayesian frameworks to address imputation problems. There are a 
number of software programs which are used routinely to deal with the problem of missing data. 189 
 
Data mining exercises in Europe, North America and Australia have provided interesting 
insights into incidence of rupture, modality of treatment and mortality from AAAs.190-198 
They have provided complementary evidence for management of AAA to randomised 
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controlled trials which are discussed in detail in Appendix-1199-202. Screening for AAA with 
abdominal ultrasonography has been shown to be cost-effective in men and has led to a 
reduction in aneurysm-related deaths199-203. Universal screening of men between the ages 
of 65 and 80 years is associated with a significant reduction in the regional incidence of 
ruptured AAA. There is no evidence that screening for AAA in an unselected population of 
women is associated with a reduction even in aneurysm related mortality.22 Scott and 
colleagues55 reported the prevalence of AAA in women to be 1.3%, with other authors 
reporting a similar rate of 0.7–1.3% in unselected populations204-207. Scott et al. did not 
demonstrate a difference in rupture rates between the women randomized to screening 
and control populations of women at 5-and 10-year follow-up206. They concluded that 
screening for women was neither clinically indicated nor economically viable.56 For any 
screening for AAA to be effective in reducing mortality in women, it will need to be 
concentrated on women who are at high-risk of having AAA and are also fit to undergo 
aneurysm repair.207 There is some evidence that women with atherosclerotic disease are at 
significantly higher risk of developing AAA.207-213  
 
The proliferation of endovascular techniques for repair of AAA has had a significant effect 
on reduction of mortality and morbidity from repair of AAA.214,216 Sensi et al revealed a 
significant increase in the number and proportion of patients who underwent endovascular 
repair of AAA between 2006 and 2011 in Italy (Figure-45).214 A recent publication from the 
Vascular Study Group of New England revealed that the gender differences in mortality 
from repair of AAA have persisted in the endovascular era (Figure-46).215 This difference is 
largely attributable to age, type of repair, urgency at presentation and comorbidities.215 
97 | P a g e  
 
Women were less likely to undergo EVAR for intact aneurysms. The most likely reason for 
this is that women less frequently meet the anatomic criteria for EVAR.216 Chung et al 
reported that long term, endovascular repair of AAA is more likely to be associated with 
complications and mortality in women.217 
A recently published study by Sidloff et al suggested that women undergoing elective AAA 
repair in the UK continue to have a significantly higher in-hospital mortality rate compared 
to men after either open repair or EVAR despite the introduction of VSQIP.89 Sidloff and his 
co-workers utilized almost identical methodology to Mofidi et al (Appendix-3). Like Mofidi et 
al. they were unable to explore the reasons for these differences as they existed even after 
adjusting for the known risk factors for mortality of AAA 89,218,219 It appears therefore that 
the introduction of endovascular techniques and quality improvement programs have not 
had the desired effect on in hospital morality for elective or emergency repair of AAA in 
women. A number of authors have reported significantly higher mortality in women 
undergoing elective EVAR as well as elective open repair of abdominal aortic aneurysm.218-
224 
Although aneurysm morphology is difficult to adjust for  in studies, there  is some evidence 
that women are more  likely to  have shorter, more angulated infrarenal necks225 and small 
iliac  arteries225-229,  making  EVAR  more  challenging.  Aneurysms with  shorter  and  more 
angulated  infrarenal  necks  are  more  likely  to  be  outside  of recommendations for use 
for EVAR devices.230These anatomical differences may explain the worse outcomes in 
women and explain why the exact causes for mortality are so difficult to characterise.231,232A 
recent systematic review by Ulug et al suggests that smaller proportion of  women  are  
eligible  for  EVAR  (or  EVAS)  compared  with  men. In  addition  to  higher 
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operative mortality a significantly larger proportion of women are not offered intervention 
due to complexity of their lesion and risk benefit analysis of intervention, which means the 
true difference in aneurysm related mortality between men and women may be higher than 
what is observed by examining hospital statistics or vascular registries.233 
Introduction of VSQIP has resulted in the development of standardised pre-assessment 
processes to assess patients’ fitness for EVAR and open repair of AAA. These processes 
which include cardiopulmonary exercise testing collect objective and reliable measures of 
patients’ cardiopulmonary reserve for vascular intervention. Examination of this data may 
identify subtle differences between men and women which may have not been obvious 
using standard data mining techniques 234  
Without understanding the chain of causality it is difficult to suggest specific strategies to 
improve mortality in women undergoing AAA repair. There are two on-going studies 
examining the value of screening for AAA in women. The first is the National Institute for 
Health Research trial of AAA screening of women (Female Aneurysm Screening Study), the 
other is the (Screening Women for abdominal aortic Aneurysms; SWAN study) which is 
examining the potential clinical benefits and cost-effectiveness of AAA screening in 
women.235 As these studies will collect follow up data on women with AAA they will be able 
to provide valuable prospectively collected data on AAA in women from which the reasons 
for the difference in mortality could be effectively addressed. This will take many years to 
accomplish. 
Around the same time as the study described in Appendix-2, several similar data mining 
exercises were performed in order to answer pertinent questions regarding the 
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management of AAAs. Filipovic and Goldacre used Hospital Episode Statistics (HES) data 
from NHS in England and Wales (analogous to SMR-1 data collected by NHS in Scotland.) to 
examine trends in mortality (Case Fatality Rates: CFR) and hospital admission for AAA for 
elective abdominal aortic aneurysm repair in England and Wales199,236. They observed that 
CFR following AAA repair in England and Wales was higher than expected.237 This finding 
became the main driver for VSQIP program to improve survival and outcomes following 
vascular surgery.  
 
Holt et al examined the relationship between annual number of patients with AAA treated 
in each hospital (case volume) and outcome using similar data mining methodology and HES 
data collected between 2000 and 2005 in England.238 They repeated this data mining 
exercise for the fiscal years 2005 to 2007 using deterministic statistics.239 They found a close 
correlation between volume clinical activity (number of patients treated with primary 
diagnosis of intact AAA) and CFR.238,239Long-term follow up revealed that the survival 
advantage form being treated in a high volume centre was sustained (Figures-47,48).240,241 It 
would have been impractical to any other research methodology to examine real life 
practice in a meaningful way. These findings were confirmed by a worldwide systematic 
review242 and became the main driver for centralizing vascular surgery services and 
contributed to the development of vascular surgery as a speciality in the United Kingdom.  
 
Path analysis and sustainability of infra-inguinal vein grafts  
Vein graft surveillance has remained controversial topic in vascular surgery for 20 years.  
whilst it is true that a significant proportion of vein grafts develop graft threatening stenotic 
lesions within the first year of the initial procedure, there is little evidence outside 
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observational and case control studies which are performed by enthusiasts of vein graft 
surveillance to suggest that duplex surveillance is associated with improved graft patency 
and improved limb salvage.242-248 Duplex surveillance is resource intensive and difficult to 
justify on the basis of cost, unless a large number of vein grafts (limbs) are being saved. 
Publications in Appendix 3 to 7 confirm the finding that many grafts go through vein graft 
surveillance cycle without exhibiting any abnormality on Duplex US.9,112 The nature of the 
problem is that patients / grafts under surveillance exhibit significant differences in risks of 
failure. Risk stratification can be used to focus ultrasound based surveillance on grafts with 
highest risk of failure in order to improve its efficiency.  
 
A significant proportion of vein graft bypasses develop flow disturbance on duplex scanning 
at the time of the early post-operative surveillance examination. Several authors reported 
similar finding and suggested that an early duplex US examination is the most important 
assessment of the graft surveillance11,243-248 Apart from denoting an early threat to patency 
(if these lesions cause severe stenosis), early abnormalities also predict the natural history 
of the graft and outlook for the limb in the medium term. In the present study, vein grafts 
without flow anomalies at 6 weeks ran a benign course. The vast majority of grafts that 
occluded or required intervention exhibited significant anomalies by the time of the 6-week 
scan. It should prove possible to use this finding to select vein grafts at particular risk for 
duplex surveillance, thereby reducing the cost of duplex surveillance.99 
 
The fate of intermediate stenoses has been a matter for debate. This is a topic was not 
addressed by the VGST. VGST resolved the issue by having a very low threshold peak systolic 
velocity for defining clinically significant graft stenosis. This would remove intermediate 
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stenoses as a category and means their natural history would not be addressed. Mofidi et 
al.24, reported that several intermediate stenoses and flow abnormalities did not progress or 
significantly improved during follow-up and therefore require surveillance rather than 
immediate intervention.244,248-251 Vesti et al. studied intermediate stenoses situated within 
the body of the graft that derived from valve cusps.250 They reported that over half of these 
lesions regressed without intervention over the follow-up period.250  
 
Autogenous vein grafts are the preferred conduits for infra-inguinal arterial 
reconstruction.252,253 In the absence of autogenous vein, the use of prosthetic grafts, whilst 
necessary, is associated with a higher incidence of graft occlusion, which can lead to loss of 
the affected limb.254 However, a commonly encountered problem is veins of a small 
diameter identified, which may be considered unsuitable for infra-inguinal arterial 
reconstruction. Previous authors have reported that the incidence of small-calibre vein 
during vein mapping is relatively high and, under these circumstances, contralateral long 
saphenous vein, short saphenous veins, or arm veins are sought as conduits for infra-
inguinal vein graft bypass surgery.255 
 
Previous studies with in situ vein grafts have shown that there is a significant increase in 
diameter of the vein in the early postoperative scan.254 Fillinger et al.255, reported that veins 
of small diameter respond more to shear stress, resulting in a greater increase in size than 
veins with large diameter. Conversely, large-diameter veins with a low initial sheer stress 
showed a decrease in diameter over time.256 A similar but competing process of adaptation 
to arterial circulation is responsible for neointimal hyperplasia, which can result in the 
development of vein graft stenosis.106 Other gross and histological features of vein graft, 
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such as reduced vein compliance, smooth muscle hyperplasia, and inflammatory infiltrates, 
have been associated with the development of vein graft stenosis.98,99 Westerband et al. 
reported a close association between intimal and subintimal angiogenesis and thickness of 
intima in human stenotic vein grafts.244 All of these findings serve to remind that the quality 
of the venous conduit is important in predicting outcome of infra-inguinal bypass surgery.  
 
A significant proportion of infra-inguinal vein graft bypasses develop graft stenosis, which 
threatens graft patency.248 Varty et al. reported that preoperative preoperative vein grft 
diameter is an independent risk factor for development of vein graft stenosis. In this study 
there was a significantly higher re-intervention rate for vein graft stenosis in bypasses which 
were formed using small-calibre vein grafts106. Despite the fact that VGD was an 
independent risk factor for re-intervention, there was no significant difference in primary 
assisted patency or amputation rates between grafts created using vein with a minimum 
preoperative diameter <3.5 mm and those with larger diameter veins. This highlights the 
importance of vein graft surveillance and timely repair of vein graft stenosis in this 
population of patients. 
 
Development of vein graft stenosis or occlusion is multifactorial in nature and the 
implications of vein graft occlusion vary depending on what was the initial indication for the 
bypass procedure. This would mean that a screening test to identify high risk grafts would 
also need to take account of multiple factors.  
 
Classification and regression trees are a novel method of identifying vein grafts which are at 
risk of developing stenosis or occlusion. These grafts can be offered intensive surveillance 
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whilst grafts deemed to be low risk can be followed up clinically.  There are well established 
standards for the development of clinical decision rules.255-261 It is very important that new 
predictive model such as the one discussed in appendix-6 (study-5) is validated using a new 
population of patients (Appendix-7, study6)262. There are limitations to how much is 
extrapolated from any predictive model including the decision tree. In this and all recent 
studies on infra-inguinal vein graft surveillance, stenoses thought to threaten graft patency 
have undergone prophylactic revision. Therefore, the natural history of vein graft stenosis 
cannot accurately be determined, as all subsequent studies have a selected sub-group of 
patients and these selected groups may not be fully representative of the population.  
 
Surgical revision of failing infra-inguinal vein grafts has been the gold standard in the 
management of vein graft stenosis. Techniques of vein patch angioplasty for short stenoses 
and interposition or jump graft repair for longer lesions have been associated with excellent 
medium and long term patency rates.263 Surgical repair of vein graft stenosis is an invasive 
procedure requiring general or regional anaesthesia in a population of patients with 
significant co-morbidity. It is also partly dependent on the availability of an appropriate 
length of an additional venous conduit. Revised vein grafts are themselves at risk of 
development of vein graft stenosis.263 Percutaneous transluminal angioplasty is an attractive 
option for the management of vein graft stenosis. Some years ago Berkowitz et al. reported 
on the results angioplasty as the primary treatment modality in 81% of failing infra-inguinal 
reversed vein grafts,264 They reported a 5-year primary assisted patency rate of 61%. Lesions 
in the proximal graft and proximal anastomosis taken as a group had significantly better 
patency than the mid-graft and distal anastomotic lesions.264 Subsequent authors have 
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reported similar results following vein graft angioplasty.264-267Alexander et al. reported a 
significantly lower primary assisted patency after percutaneous transluminal angioplasty 
(PTA) for the treatment of vein graft stenosis, with failure rates of 31% at 6 months, 55% at 
1 year, and 63% at 2 years.124 
 
A significant proportion of grafts, which had undergone angioplasty with a satisfactory 
technical result, develop re-stenosis, requiring secondary procedures. In the majority of 
patients, the secondary procedure was endovascular with a technical success rate 
approaching that of angioplasty for primary vein graft stenosis. Carlson et al. reported their 
experience of PTA of infra-inguinal vein graft stenoses in 36 patients. Their initial technical 
success rate was 91% and overall graft patency rate was 78% at 24 months.268  
 
Since Mofidi et al23, the interest in endovascular treatment of vein graft stenosis has 
increased as the nuances related to this mode of treatment has become more understood, 
Risk of re-stenosis has led to the need for regular surveillance and repeat procedures, on the 
other hand unlike surgical repair endovascular procedures can be repeated without adding 
to the complexity of the procedure109 Due to the fibrotic nature of vein graft stenosis some 
of these lesions do not respond to standard balloon angioplasty114-123. In these 
circumstances, cutting balloon angioplasty has been used with some success. Short covered 
endovascular stents have been used with success in order to treat this population of 
patients with sustainable results.  
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Critical vein graft stenosis is a complex clinical problem. These series of publications have 
provided valuable and new insight into identification and treatment of vein graft stenosis. 
Ten years ago following the publication of VGST trial surveillance of infra-inguinal vein grafts 
was considered not clinically valuable or cost effective.101 Despite this vein graft surveillance 
has continued and there has been a paradigm shift in the management this condition using 
endovascular techniques.264-270 The recent insight gained has led to re appraisal of the 
processes involved in haemodynamic adaptation of vein grafts271and how that relates to the 
treatment of graft stenosis.272 
 
Artificial Neural Networks and assessment of degree of internal carotid stenosis 
Benefit from carotid endarterectomy in patients who have had recent ipsilateral 
neurological or ocular symptoms depends not only on the degree of carotid stenosis, but 
also on several other clinical characteristics such as delay to surgery after the presenting 
event, in addition to patient characteristics such as age, gender and co-morbidities such as 
diabetes, hypertension and ischaemic heart disease. Decision aids such as the Oxford Stroke 
Risk calculators utilize this information to individualise the risk-benefit calculus.128-130,273,274 
Figure-55 illustrates the interplay between timing of surgery (one of these risk factors) and 
the degree of ICA stenosis in risk reduction afforded by carotid endarterectomy and 
highlights why knowing the exact degree of stenosis in a timely way is an important part of 
this risk reduction strategy.275  
 
Duplex ultrasound scanning is the premier modality of for assessment of degree of ICA 
stenosis276 owing to its non-invasive nature and widespread availability it has been used as a 
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screening tool for assessment of presence and degree of ICA stenosis. Carotid 
endarterectomy can be safely performed without preoperative angiography.133,277-278 
Proliferation of duplex velocity criteria has resulted in lack of uniformity in the 
measurement of ICA stenosis using duplex imaging. This is in direct contrast to the 
standardized nature of angiographic assessment of ICA stenosis during the randomised 
controlled trials, which form the evidence-base for carotid endarterectomy.269,270 
  
 
 
 
 
 
 
Figure-55: Absolute risk reduction afforded by carotid endarterectomy in patient suffering 
from symptomatic ICA stenosis classified by degree of ipsilateral ICA stenosis and 
symptom latency (from Rothwell et al., Lancet 2004; 363(9413):915-24).128 
 
Initially the randomised controlled trials which form the evidence base for the management 
of symptomatic and asymptomatic carotid atherosclerosis identified different threshold 
values for ICA stenosis as representing the indication to perform carotid endarterectomy 
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relating to different way the measurements are performed.128-130 Several previous authors 
have changed their velocity criteria in order to comply with these studies.279-281 Although 
Intersociety recommendations and reporting standards have been put forward on both 
sides of the Atlantic to standardise interpretation of Doppler waveforms by vascular 
technologists, differences between exist and remain clinically significant.139,140,282 Knowing 
the exact degree of stenosis in conjunction with preoperative clinical risk factors will 
influence decision making with regard to surgery, especially in patients with moderate ICA 
stenosis in whom the benefits from intervention may be marginal.140-142 
 
ANNs remain novel approach in the assessment of degree of ICA stenosis. Accurate 
measurement of the degree of ICA stenosis using velocity of blood flow contains an inherent 
degree of variability. This variability increases with progressively lower degrees of stenosis 
in the ICA.281-283 It would be impossible to account for this variability through conventional 
statistical models. ANNs separate background noise (variability) from information 
embedded in the data set. ANNs can be built into duplex devices. In this way, after selection 
of the appropriate sample volume by the operator, the machine could automatically 
calculate the duplex parameters for predicting the probability of threshold ICA stenosis and 
measure the exact degree of ICA stenosis. ANNs have an acceptable degree of accuracy in 
calculating the exact degree of ICA stenosis and represent a modest but significant 
improvement in classification of ICA stenosis into 10% bands. Carotid duplex criteria have 
been proven to be excellent tools in identification of threshold ICA stenosis at the clinically 
significant 70% level used for identification of surgical candidates amongst patients with 
symptomatic disease135-138 and 60% stenosis screening for asymptomatic carotid artery 
stenosis.281,282 However, with increasing use of decision support tools which require the 
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exact degree of ICA stenosis the information demanded from any modality assessing the 
degree if ICA stenosis has increased beyond just thresholding the degree of stenosis.  
 
Other approaches such as multivariate regression have been used in order to assess the 
degree of ICA stenosis283,139 albeit with a moderate degree of correlation with angiographic 
controls whilst novel, these do not offer an improvement over duplex velocity criteria162 or 
an ANN.  
 
Direct measurement of the residual lumen using a combination of β-mode ultrasound and 
colour flow imaging components of duplex investigation has been used to measure ICA 
stenosis.  Despite the advances in β-mode ultrasonography has failed to gain widespread 
use.284,285 B-mode ultrasound and angiography measure the degree of vessel stenosis in 
different ways: duplex ultrasound assesses stenosis by percentage area reduction, whereas 
angiography measures the percentage reduction in luminal diameter. Despite close 
correlation, the two values are not interchangeable.  
 
Previous authors have suggested that duplex velocity profiles may overestimate the degree 
of ICA stenosis in the presence of contralateral occlusion.286,287 This is difficult to adjust for 
when duplex velocity criteria are used alone. However, such an adjustment is possible in an 
ANN model in the form of another input variable (node). Study of Doppler wave form and 
the shape and pattern of the Doppler wave from within the sample volume (Spectral 
Analysis) can be used to analyse the degree of ICA stenosis. This provides subjective 
confirmation of presence of stenosis by a trained observer. ANNs can be used to objectively 
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analyse the Doppler wave from and accurately classify presence of ICA stenosis and 
occlusion.288-291    
 
Muller et al have reported a novel way of addressing the problem of assessing the degree of 
ICA stenosis by using combined modalities of Duplex US and CT angiography and developing 
a semi-automated method. This model combines two non-invasive modalities but has the 
downside of requiring intravenous contrast and exposure of the patient to ionising 
radiation. It also remains to be validated in an external population of patients.292 In absence 
of a single imaging modality approach for measurement of degree of ICA stenosis, multi-
modality strategy can be utilized. A paper by Tholen et al examined the cost effectiveness of 
this approach using a decision tree model and like Muller they suggested that Duplex US (as 
a screening test) followed by CT angiogram and MRA as secondary modalities was the most 
cost effective approach. 293  
  
This publication is unique as it high-lights the supportive role ANNs can play in predictive 
data-mining. Almost everybody who studies in the field of data mining is familiar with the 
use of ANNs as the primary data analysis model for data-mining294.  A PubMed® search using 
the term “Artificial Neural Network” and “Data Mining” as Boolean operators yields 1817 
publications. Rarely, if ever have ANNs been used to provide accurate data for use in 
another risk prediction model. In this case ANNs provide valuable information about the 
degree of ICA stenosis which is a key determinant for the Oxford Stroke Risk Calculator128. 
Although artificial neural networks (ANNs) have been successfully applied in a wide range of 
machine learning applications, they are often regarded as black boxes which provide the 
answers without allowing the user to examine the processes by which ANN reaches the 
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answer. In this paper ANN plays a concise symbolic role which is easily explained and 
verifiable. It plays this role with versatility by producing results that are useful to the 
clinicians involved (degree of stenosis was provided in 10% bands, as exact degree of 
stenosis and as greater than 50% or 70% stenosis by the ANN model) in a verifiable way. 
This is why this publication is as clinically significant today as it has been in the last 10 years.  
 
Artificial Neural Networks and Prediction of outcome from oesophageal cancer 
The use of artificial neural network remains a relatively novel approach for prediction of 
outcome in patients with carcinomas of oesophagus and OG junction almost ten years after 
the publication of this study. As this study illustrates, intelligent data mining methods such 
as artificial neural networks provide an opportunity to improve prediction of outcomes 
following surgical treatment of cancers including cancers of oesophagus and oesophago-
gastric junction. The implication being that targeted administration of adjuvant therapy such 
as radio or chemotherapy to patients with highest levels of risk would reduce the risk of 
recurrence in the high-risk group. Whilst the low risk patients would undergo surgery with 
curative intent. There are many instances where randomised controlled trials have proven 
the efficacy of neo-adjuvant chemo or radiotherapy or the combination of the two in order 
to improve the efficacy of the eventual surgical treatment of solid cancers.  
 
Superior accuracy of ANN models is partly related to superiority of analytical model and 
partly to the increased number of input variables used to develop the ANN. Most clinical 
analytical models such as TNM staging are heavily weighted towards the histopathological 
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interpretation of the anatomical extent of disease. The ANN model in this study selected the 
appropriate input variables using sensitivity analysis. This by itself may be responsible for 
improved accuracy. A large-scale study by examining cancer specific 5-year survival in breast 
and colorectal carcinoma found that the ANN models constructed using TNM staging system 
alone significantly improved the predictive accuracy of TNM staging system.64, 295 
 
Despite the fact that ANNs are well suited to outcome prediction, to date their routine 
clinical use has been limited to the management of prostatic carcinoma.296 Some of the 
resistance to the use of ANNs in the clinical setting relates to the fact that their introduction 
as predictive models involves addition of new nomenclature and methodology, with which 
the clinicians are not familiar. In addition, clinical use of ANNs is tempered by the innate 
suspicion of a computer based system which has a relatively transparent process but cannot 
explain its reasoning in individual cases. There is a lot less reluctance in accepting the result 
of ANN analysis in dealing with problems such as genomics study gene expression in at risk 
populations157,297, structural and functional relationships between genomes or single 
nucleotide polymorphisms298 that due to their complexity defy conventional statistics or 
image analysis where data analysis is a simulation of a cognitive process performed by a 
trained observer.154,155 In these situations, the approach towards ANN is pragmatic and 
result orientated and based on adequate validation of the model without attempts at 
understanding the reasoning on case-by-case basis.299,300 
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This is not to say that using ANN models for outcome prediction in patients with invasive 
cancer is not without its pitfalls. A complex ANN with a large number of input variables can 
be very accurate at identifying patterns within the training dataset. This can result in over 
fitting of the model, whereby the ANN identifies patterns peculiar to the training dataset 
that do not represent the larger population of patients. This is overcome by limiting the 
iterations of training and using adequately sized samples of patients for training and 
validation of the ANN. Model instability is another potential source of inaccuracy, where 
identical independently trained ANNs can have varying predictions for individual patients. 
There are a variety of ways to minimise these risks, in this study, a panel of 10 ANNs trained 
on randomly selected subsections of data. The training and evaluation samples were 
randomly selected and in order to be representative of the patient population. A large 
number of potential input variables are often available in presence of limited number of 
training and evaluation. This is a potential source of model instability. In this study, variable 
selection was performed through the wells established process of sensitivity analysis, which 
limited the number of input variables and selected the optimum combination of variables, 
which was associated with the most accurate predictions. Additional searches for prognostic 
variables for oesophageal carcinoma have identified cellular and histological markers of 
prognostic significance, this is a continuous process.294-306  These variables could easily be 
incorporated into the design of an ANN in order to improve its accuracy.307-309 
 
Any prediction model is as good as the quality of data used to develop and validate it. 
Missing and imbalanced or misclassified data would defeat the purpose of any prediction 
model. This is the main reason why the ISD of NHS in Scotland introduced the mandatory 
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National Minimum Core Dataset for Cancer in order to streamline the flow of information 
and standardize reporting practices. The use of this data supplanted by data from other 
hospital information systems enhanced the accuracy of ANN models. 
 
The use of artificial neural networks as a predictive tool in vascular surgery has been limited. A 
number of years ago Turton et al used a simple 4 variable multi-layered perceptron to predict 
mortality rate from ruptured abdominal aortic aneurysm. They reported that ANN model was 
accurate at predicting in-hospital mortality in this cohort of patients. 310 More recently Wise and his 
co-workers developed a similar ANN to predict mortality from RAAA. They compared the ANN model 
(Simple MLP model with 4 input variables) with multiple logistic regression and Glasgow Aneurysm 
Score and reported that ANN was more accurate than the commonly used Glasgow Aneurysm score 
or the logistic regression model .311 Although the two publications are 15 years apart, they both 
utilize the simplest ANN topography and the minimum number of input variables and, yet they 
report a high degree of accuracy.311 
 
An interesting use of neural networks in vascular surgery was their use in identifying the risks of re-
intervention and mortality after Endovascular repair of abdominal aortic aneurysm. 
Karthikesalingam et. al. developed a relatively complex Bayesian Neural Network (19 input variables) 
using a large cohort of patients with a high degree of accuracy. 312 Although the variables that 
Karthikesalingam utilized for developing their network included generic morphological information 
such as AAA diameter, sac volume, iliac diameter, aneurysm length, thrombus within the sac, neck 
length, angulation and diameter obtained by a trained observer, these values can be obtained 
automatically from the planning CT scan. The implication being that this investigation in addition to 
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being used for planning the EVAR procedure can provide assessment of risk of re-intervention or 
death in the first 5 years following endovascular repair of AAA.312 
 
Bayesian Networks differ from standard ANNs in that they map relationships between events and 
input variables in terms of probability of one event occurring in conjunction with another event as 
well as their mutual contribution to the final output variable. i.e. in a Bayesian network each node 
represents an event and edges represent probabilities of that event occurring (or being true). In 
standard ANN model although an individual node contributes to the predictive model by itself it 
does not have a discernible output. Standard Bayesian networks (such as the one used by 
Karthikesalingam) are unsupervised i.e. they do not require prior training. Bayesian networks are in 
more widespread use than standard multi-layered perceptions. For example, if your email account 
uses a spam filter the chances are that the basis for the classifier used in that filter is a Bayesian 
network.  
 
Artificial Neural Networks are an effective tool for predicting outcomes in patients with 
oesophageal carcinoma and have had some tentative uses in predicting outcomes in 
vascular surgery. In management of cancer can incorporate multiple tumour-related and 
patient-related variables which are not currently part of the NHS minimal cancer dataset.313-
315 In vascular surgery they can include direct imaging data through automated analysis of 
CT scans and Duplex images37 The information provided by these models may improve our 
ability to select appropriate and effective treatments. 
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Concluding Remarks          
It was almost 20 years ago when Leroy Hood questioned the reactive way medicine 
approached health and disease and introduced the concept of precision medicine (P4-
Medicine), healthcare which was predictive, preventative, personalized and participatory 
and focused on the needs of the individual patient rather than a cohort of patients with a 
similar condition(s) and accounts for the diversity of comorbidities and clinical needs.316 
Such an approach starts from genomic and proteomic bases of ill health and builds a 
biological cross disciplinary culture in order to study the complex biological systems 
associated with health and disease.317 Although P4 medicine is some years away from 
implementation, biological systems theory on which P4 depends has been responsible for 
major advances in healthcare from the human genome project318 to control of Ebola and 
SARS where mathematical modelling developed clear strategies for success in preventing 
Pandemics.319 
 
In healthcare as in business the concept of “Big Data” which describes comprehensive and 
systematic exploration of data derived from large cohorts of individuals has become not 
only a buzzword but as an established investigative paradigm320-323 With the advent of 
mobile computing and low cost of storage, big data will become more available and beyond 
the ability of individuals to comprehend, whilst advances in computational tools have 
provided the means by which this data can be analysed.324 Enthusiasts would like to believe 
that these complex models can replace clinicians who as individuals are prone to heuristics 
and cognitive biases in their decision making process. On the other hand, by removing 
human intervention modelling artefacts can develop and grow and analyse data without 
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regards to context.321-323 An integrated approach resulting in creation of decision support 
tools which are used by healthcare practitioners is a marriage of these two approaches 
which helps clinicians in areas of uncertainty. The Oxford stroke risk calculator is an example 
of this.133 
 
Over the last 3 decades new data formats with increasing level of complexity have entered 
the field of data mining. These include two and 3-dimensional images, data clusters, text or 
multi-relational and multi-dimensional data. Many data mining methods are designed for 
collections of objects well-represented in rigid tabular formats.324 Traditional data mining 
tools tend to struggle to deal with complexities of life as it relates to multi-dimensionality of 
the data source. This data may be in the form of massive sets of unstructured information or 
as is more and more the case, objects which have natural representations such as protein 
structure or dynamics of protein interaction networks.325 
 
As illustrated by a number of publications discussed in this narrative, significant quantities 
of high-quality data are available from a number of sources. This mandates the need for 
merging data from multiple sources in as efficient manner as possible, while maximizing the 
accuracy of the result. This is described as the merge and purge problem.326 A number of 
paradigms have been developed in order to address this these include the use of human 
interaction if the size of data source permits, data clustering327 and the Sorted 
Neighbourhood method328 which are automated, but expensive.  
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Entropy-based data mining is an emerging methodology for use in this type of problems 
where complexity, noise and missing data introduce uncertainty and risk of modelling 
artefacts. In 1949 Claude Shannon introduced the information theory in which the concept 
of entropy relates to as a measure for the uncertainty in a message.329 The aim of this type 
of data mining is to discover knowledge that is not only accurate but also comprehensible 
for the users. This type of data mining is used for analysis of biomedical data such as 
electroencephalography (EEG)330, hormone secretion data331, foetal heart rate 
monitoring332assessment of complexity measures of DNA sequences333 and hand writing 
recognition.333 
 
With rapid advances in the fields of bioinformatics and computational biology, healthcare 
and biomedical sciences are becoming data intensive disciplines where the clinicians are 
confronted with increased volume of diverse, multi-dimensional data needing analysis.334-338 
In addition to being increasingly complex and diverse, the data available for analysis, may be 
weakly structured, available from different databases or contain noise. It may be 
imbalanced and missing elements.339 Nonetheless we rely on these data in order to assess 
the performance of clinicians, create safe pathways of care and make meaningful clinical 
decisions and even formulate healthcare policy. Our reliance on this level of evidence is 
likely to grow.  
 
This narrative has highlighted opportunities and pitfalls that knowledge discovery offers for 
healthcare practitioners. This includes quantitative risk assessment of outcomes but is not 
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limited to it.339-341 The discipline of systems medicine is going to lead to a revolutionary 
transformation in the field of healthcare delivery. A transformation which will lead to 
increased understanding of health and disease and will have implications regarding how 
healthcare is delivered and will require considerable changes to how medical education and 
training are provided as well as how clinicians engage with patients in order to make 
healthcare a more effective process.   
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1. Introduction 
Abdominal aortic aneurysm (AAA) is a common life threatening condition in the western 
world. In England and Wales alone, over 2500 patients present to hospital with rupture of 
AAA annually, of whom over two thirds die of their condition1. The best treatment for AAA 
is elective repair of pre-symptomatic abdominal aortic aneurysms. Such a therapeutic 
strategy depends on effective identification of patients with AAA and the subgroup of 
patients in whom there is a real risk of aneurysm rupture. As the vast majority of patients 
with AAAs are asymptomatic, timely identification of AAA may be achieved through 
targeted screening of the at risk populations. Over the last two decades longitudinal studies 
of patients with smaller AAAs have provided insights into the timing of AAA repair and the 
need for and frequency of ultrasound surveillance if an expectant management strategy is 
followed. This chapter discusses the available evidence for screening for AAA as well as all 
the other measures which have helped to optimise therapeutic strategies in the management 
of patients with AAA throughout the patients’ journey from the initial diagnosis to the 
eventual repair of AAA.  
2. Targeted screening for AAA 
In the past 40 years with the advent and generalised use of abdominal ultrasonography 
there has been an accurate, cheap and non invasive tool for the diagnosis of abdominal 
aortic aneurysms. Abdominal ultrasonography has been found to be an accurate and 
reproducible modality in measuring the dimensions of AAA. This has led to the concept of 
its use for screening of at risk populations. In the last 20 years there have been four 
population based randomised controlled trials which have assessed the value of targeted 
screening in reducing mortality from abdominal aortic aneurysms in the unselected elderly 
male population2-5. These trials which have been undertaken in Chichester (England)2, 
England (MASS trial) 3, Viborg County (Denmark) 4 and the city of Perth and suburbs 
(Western Australia)5 have together recruited over 120,000 subjects. All of these studies have 
reported on long term (over 10 years) follow up. Using the predefined criteria set by the US 
Preventative Screening Task Force USPSTF 6 the MASS trial has been classified as good with 
www.intechopen.com
 
Aneurysmal Disease of the Thoracic and Abdominal Aorta 4 
the other three trials classified as fair i.e. not meeting all the criteria but judged to have no 
fatal flaws7.  
The Chichester trial was the first to assess the value of screening for AAA in the at risk 
population. It was also unique as it included women as well as men. It identified all men 
and women aged between 65 and 80 years of age from 9 general practices in the catchment 
area of St Richard’s hospital in Chichester between 1988 and 19912,8,9. The subjects were 
randomised to undergo a single screening ultrasound (US) or a control group who were 
followed up. AAA rupture rates, aneurysm related mortality, and overall mortality was 
compared between the two groups. Upon identification of AAA the therapeutic strategy for 
AAAs with maximum diameters between 30-44mm was once yearly surveillance US, AAAs 
between 44 and 59mm underwent 3 monthly ultrasound scans, whilst aneurysms greater 
than 60mm in diameter were considered for repair2.8.9. Overall 6040 men were randomised, 
the authors reported a significant reduction in aneurysm related mortality which has been 
maintained over 15 years. However, to date this study has demonstrated no difference in the 
all cause mortality between the two groups. The Chichester trial has been criticized for its 
relative small size, a relatively high aneurysm diameter threshold for repair and including 
75-80 year old patients in whom the benefits of screening are marginal. In addition 27-
percent of subjects who were invited for screening refused to participate thereby diluting 
the benefits of screening. Despite these criticisms the Chichester study remains a land mark 
as it demonstrated the feasibility of US screening for AAA and its potential value and 
remains a blue print for other aneurysm screening studies. This study identified a low but 
none the less troubling rate of AAA rupture in patients who had a non aneurysmal aorta on 
the first screening study2. A population based screening study in Gloucester demonstrated 
that 2.2-percent of men aged 65-73 years have a maximal aortic diameter of 2.5 to 2.9 mm 
and suggested that this group of patients should undergo repeat US scanning at 5 yearly 
intervals10. 
The second RCT to study the value of population based screening for AAA was carried out 
in Viborg County of Denmark. In 1994 all men aged between 65 and 74 were randomised to 
either undergo a single screening US or the control group. In all 12639 patients were 
randomised4,11,12. This study reported a 66-percent reduction in the aneurysm related 
mortality which has been maintained over 14-years. In addition they reported a 2-percent 
reduction in overall mortality after long term follow-up which did not reach significance4.  
The Western Australia population based screening was a study of similar design. It 
randomised 41000 men between the ages of 65 and 85 years to a single US screening and a 
control groups. They reported no difference in aneurysm outcomes in the full study 
population but when the analysis was restricted to 65-74 year old men they reported a 
significant reduction in aneurysm related mortality after 5 years of follow-up5. Long term 
follow-up results of this study have not been published as a separate publication to date, 
however in a reply to a correspondence by Lederle, Norman and Lindholt did report a 
surprisingly high, 3-percent reduction in overall mortality in the restricted (65-74 year old) 
patient population after 10 years of follow-up from the Western Australia trial which was 
statistically significant13.  
The MASS trial which was a population based screening RCT for men aged between 65 and 
74 years of age included 4 screening centres in the United Kingdom. This study randomised 
67770 patients again to single screening ultrasound or a control group and was designed to 
study cost effectiveness of screening in addition to reductions aneurysm related and overall 
mortality3,14,15. This study reported a 48-percent relative risk reduction in aneurysm related 
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mortality as a result of screening. This benefit was present at 4 years 14 and was maintained 
at 10 years (Figure-1)3. There was a reduced AAA rupture rate in the patients who were 
invited for screening. Most of these ruptures occurred in patients who were excluded from 
the potential benefits of screening, such as patients who refused or did not attend screening, 
patients who were lost to follow-up and those who either refused or deemed not fit for 
surgery3. The MASS trial also reported a small rate of AAA rupture in patients who did not 
have an AAA on the screening scan, this rate was reported as 3 per 10,000 person years after 
10 years of follow up3. 
 
 
Fig. 1. Cumulative deaths related to abdominal aortic aneurysm, by time since 
randomisation (MASS Trial) 3. From: Thompson SG, Ashton HA, Gao L, Scott RA and 
Multicentre Aneurysm Screening Study Group, Screening men for abdominal aortic 
aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre 
Aneurysm Screening Study, BMJ 2009; 338: b2307. 
In addition to the above RCTs a number of systematic reviews and meta-analyses have 
attempted to assess the value of population based screening in the medium and long term. 
Cosford and Leng in a Cochrane systematic review reported that there was significant 
evidence of reduction in aneurysm related mortality from AAA in men aged 65 to 80 years 
who undergo population based ultrasound screening, but no significant reduction in all 
cause mortality16. This review was based on the 3-5 year follow up data from the above 
RCTs. Subsequent to this Norman and Lindholt published a meta-analysis which showed 
that population based AAA screening after 7-15 years of follow up resulted in a reduction of 
both AAA and all cause mortality17. Their findings were contested as the reported 3-percent 
all cause mortality reduction was larger than what was expected by an approximately 50-
percent reduction in aneurysm related mortality, bearing in mind that the mortality from 
AAA in the patient population is reported to be between 1.1 to 3-percent18.  
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Takagi et al. conducted a further meta-analysis of US screening in the male population over 
the age of 65years using long term 10 to 15 year follow up data from the RCTs. They 
reported an absolute risk reduction in aneurysm related mortality of 4 per 1000 subjects 
screened (Figure-2). They also revealed a strong trend towards a significant reduction in all 
cause mortality7. The latter finding was surprising for the reasons mentioned already. The 
authors hypothesized that screening may coincide with the asymptomatic at risk population 
for cardiovascular disease coming in contact with health care professionals and becoming 
aware of smoking risk, their blood pressure etc.  The resultant reduction in cardiovascular 
risk factors may be in part responsible for additional reduction in all cause mortality. Such a 
hypothesis opens the door to the possibility of risk factor alteration and institution of 
secondary prevention measures such as commencement of anti-platelet agents and statin 
therapy during screening programmes thereby increasing the value of the screening7.  
 
 
Fig. 2. Forrest Plot of illustrating the reduction in aneurysm related mortality (A) and the 
trend towards a reduction in overall mortality (B) as a result of population based screening 
of men between the ages of 65 and 80 years after 10 years of follow up7. 
From: Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A further meta-analysis of 
population-based screening for abdominal aortic aneurysm. J Vasc Surg. 2010; 52(4):1103-8. 
Cost effectiveness of a population based screening programme is calculated by measuring the 
costs of ultrasound screening as well as the extra procedures and surveillance that is required 
for the screen identified AAA and subtracting them from the costs of treating ruptured AAA. 
It is expressed in cost per life year gained. As the survival advantage in terms of life year 
gained continues to increase with time, the cost effectiveness of screening continues to 
improve. A comprehensive analysis of costs of screening was performed by the MASS trial 
participants. They calculated the cost per life year gained to be £41,000 after 4 years14, £14,000 
after 7 years 15and £7600 after 10 years3. Using the estimated life span of men aged 65 years the 
cost per life year gained is estimated to be in the region of £2300, which is well below the 
guideline figure of £25,000 which is considered acceptable for the adaptation of new medical 
technologies and interventions in the National Health Service of the United Kingdom19. 
Lindholt et al. also performed a comprehensive cost analysis of population based AAA 
screening using data obtained from the Viborg trial. They reported cost per Quality 
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Adjusted Life Year (QALY) gained as a result of screening to be €179 albeit with relatively 
wide 95% confidence intervals (€-4083 to €4682) 4. Both of these values for costs of screening 
are much lower than the cost analysis carried out by the USPSTF using primarily economic 
modelling in 2003 and suggest that population based AAA screening in men is more cost 
effective than the initial assessments suggested20. 
The role of screening for AAA in women remains controversial. To date there is no evidence 
that screening for AAA in an unselected population of women is associated with a reduction 
even in aneurysm-related mortality. Scott and colleagues conducted the only RCT 
(Chichester trial) which studied the value of screening in women over the age of 65 in an 
unselected population (n=9342) 21. They reported the prevalence of AAA in women to be 1·3 
percent, with other authors reporting a similar rate of 0·7–1·3 percent in unselected 
populations22-24. Scott et al. did not demonstrate a difference in rupture rates between the 
women randomized to screening and control populations of women at 5- and 10-year 
follow-up21. They concluded that screening for women was neither clinically indicated nor 
economically viable21. This study was limited by high rate of non attendance of women for 
AAA screening which ranged between 27 and 42-percent depending on patients age. They 
screened an unselected population of women without consideration of risk factors for 
aneurysm disease and fitness for repair; consequently a large proportion of women who 
were found to have an AAA did not undergo aneurysm repair25. The UK Small Aneurysm 
Trial revealed that female sex was an independent risk factor for AAA rupture; the rupture 
rate in women was three times higher than that in men, despite a smaller initial AP 
diameter. Furthermore, mean AP diameter preceding rupture was significantly lower in 
women than men26. A number of other authors have reported a higher growth and rupture 
rate of AAA in women 27-33. A Finnish community-based follow-up study reported that the 
aortic diameter was less than 5·5 cm in 24 per cent of women with a ruptured AAA, 
compared with only 5 per cent of men21. In light of these findings the 6 cm cut off value for 
repair of AAA in Chichester trial may have been too large to prevent aneurysm rupture in a 
proportion of screened women thereby reducing the value of screening in women.  
For screening to be effective in reducing aneurysm-related mortality in women, it will need 
to be limited to high-risk women who are fit to undergo aneurysm repair22. There is 
increasing evidence that women with atherosclerotic disease are at significantly higher risk 
of developing AAA. Derubertis and colleagues22 reported that the prevalence of AAA in 
women with multiple (more than three) atherosclerotic risk factors was 6·4 per cent. When 
these findings are considered in conjunction with the increased growth rates of AAA26 and 
higher aneurysm rupture rate in women, screening in women with multiple risk factors for 
AAA may become clinically and economically viable34-36. 
3. Optimum therapeutic strategy for small AAAs 
Abdominal aortic aneurysms are treated in order to prevent rupture and the associated 
mortality. Aneurysm treatment has its own associated morbidity and mortality. Open 
surgical repair is an invasive procedure which is tolerated poorly by the subgroup of 
patients with multiple medical co-morbidities. Even endovascular repair cannot be 
accomplished without an obligatory complication rate as a result of the initial deployment 
of the stent graft, in addition to which a proportion of patients require secondary 
procedures necessary to address complications such as endoleaks, device migration and 
stent thrombosis requiring long term close surveillance37. A small proportion of patients 
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who have undergone endovascular repair (EVAR) succumb to rupture. Therefore the 
natural history of the AAA needs to be balanced against the risk associated with treatment.  
Aneurysm diameter is one variable which has been consistently associated with the risk of 
rupture and has therefore been used to stratify patients into risk categories which decides 
whether US based surveillance or intervention is required to repair the aneurysm. In 
patients who are entered into surveillance programmes the maximum diameter of the 
aneurysm is used to decide on the frequency of scanning. In case of aneurysms greater than 
5.5 cm there is consensus that risk of rupture mandates repair if the patient is fit to undergo 
the procedure. In the case of aneurysms less than 4.0 cm in diameter, most clinicians agree 
on a watchful waiting approach. The evidence for the optimum therapeutic strategy in the 
mid-sized aortic aneurysms (maximum diameter between 4.0 to 5.5 cm in diameter) has 
been strengthened by a number of randomised controlled trials in the last 20 years which 
have consolidated the modern management of AAA26,38-41.  
The UK small aneurysm trial (UKSAT) was a multicentre RCT which randomised 1090 
patients, who were diagnosed as having an AAA with maximum AP diameter of 4.0 to 
5.5cm and were deemed fit to undergo an open repair of AAA to either immediate open 
repair or 3 monthly ultrasound surveillance. They reported the rupture rate of these AAA in 
the surveillance group to be in the 1-percent per year. They did not find any significant 
difference in aneurysm related or all cause mortality between the two groups after a follow 
up period of 7 years (Figure-3)26. During the follow up period over two thirds of patients 
who were randomised to surveillance had undergone repair of their aneurysms based on 
clinical grounds. 26 Long term follow up data from the small aneurysm trial has confirmed 
the initial findings of the UKSAT38.  
 
 
Fig. 3. Kaplan-Meier survival curves comparing survival of patients with small abdominal 
aortic aneurysms randomised to ultrasound surveillance and early surgery from UK small 
aneurysm trial26. From: United Kingdom Small Aneurysm Trial Participants. Long-term 
outcomes of immediate repair compared with surveillance of small abdominal aortic 
aneurysms. Lancet 1998;352: 1649-55. 
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A number of years after the publication of the UKSAT, the Veterans Affairs Cooperative 
Study group published the Aneurysm Detection and Management ADAM study39. This 
study involved screening of 126,196 veterans aged between 50 and 79 years of age for AAA 
with a single abdominal US. Those with AAA measuring 4.0 to 5.4 cm in diameter were 
offered entry to the trial. In all, 1136 subjects were randomly assigned to undergo early 
elective repair or ultrasound surveillance. Annualized rupture rate in the surveillance arm 
of the study was 0.6-percent, with no difference in aneurysm related and overall mortality 
between the two arms of the study 39. In this study as in UKSAT the majority of patients in 
the surveillance arm of the study had undergone elective repair after 8 years of follow up 
based on clinical grounds (symptomatic aneurysm, growth to greater than 5.5cm in 
diameter or rapid expansion by greater than 1 cm per year) 39. Completion of these two 
landmark trials which utilised open elective repair coincided with the advent and 
generalised use of endovascular repair as a primary  modality treatment of AAA. This 
resulted in some authors questioning the validity of these landmark trials in the era of 
endovascular repair and suggested that as endovascular repair can be performed with 
significantly lower peri-procedural morbidity and mortality a policy of surveillance for 
smaller AAAs should be examined against endovascular repair. 
To date two randomised controlled trials (PIVOTAL40 and CAESAR41) have been conducted 
to compare early endovascular repair of small AAAs with ultrasound surveillance. The 
prerequisite for both studies was that the patients which were randomised had AAAs which 
were anatomically suitable for endovascular repair.   
The PIVOTAL trial which was published in 2010, randomised 728 patients with AAAs 
measuring 40 to 50 mm in diameter to ultrasound based surveillance or early 
endovascular repair40. The mean duration of follow up was 20 months (+/-12 months) 
they found no difference in all cause or aneurysm related mortality between the two 
groups 40. At the end of the relatively short follow up duration almost one third of 
patients who were in the surveillance group had undergone an aneurysm repair based on 
clinical grounds40. The other study of a similar design was the CAESAR trial which 
randomised 360 patients with AAAs measuring between 40 and 54 mm to early 
endovascular repair or a watchful waiting strategy. 41 After 54 months of follow up there 
was no significant difference in rupture rates, aneurysm related and overall mortality 
between the two groups (Figure-4). This study revealed that the probability of the patients 
in the surveillance arm of the study requiring delayed repair based on clinical grounds 
during the duration of follow up was 60-percent41. In addition they reported that 16.4-
percent of aneurysms which upon entry into the trial were suitable for endovascular 
repair will be no longer suitable for EVAR after 36 months41.  
A constant finding in these trials has been that a significant proportion of AAAs under 
ultrasonographic surveillance come to require repair within the duration of the study26,39. 
This, taken together with the low but present annual risk of rupture has lead to differing 
interpretations of the results of these trials with some authors still advocating in favour of 
early repair of small AAA using the justification that a policy of early EVAR is as safe as a 
policy of US Surveillance42. To date there is no objective data to recommend either open or 
endovascular repair of smaller AAAs over a policy of watchful waiting and US surveillance. 
A policy of early EVAR is associated with a risk of early and delayed complications and a 
need for secondary procedures, thus mandating the need for close surveillance in patients 
who undergo early EVAR. It is therefore unlikely that there will be an economic justification 
for early endovascular repair.   
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Fig. 4. Kaplan–Meier estimates of survival at 54 months from time of randomisation in 
EVAR versus Surveillance groups. P = 0.6. Numbers at risk are shown. CAESAR trial41. 
From:Cao P; DeRango P, Verzini F, Parlani G et al. Comparison of surveillance vs Aortic 
Endografting for Small Aneurysm Repair (CAESAR) trial: results of a randomised 
controlled trial. Eur J Vasc Endovasc Surg. 2011; 41(1): 13-25. 
4. Open versus endovascular repair of AAA 
Ever since its inception, EVAR has offered the promise of reducing the perioperative 
morbidity and mortality which has been associated with open elective repair. By the end of 
last century, data from EVAR registries such as RETA 43and EUROSTAR 44 suggested that 
endovascular repair, although safe was associated with an immediate complication rate in 
addition to events such as endoleak and device migration which mandate lifelong 
surveillance and in a group of patients re-intervention. As with any new or emerging 
technology or intervention the case for primacy of EVAR over open repair in terms of 
perioperative mortality rate, post operative complications and cost effectiveness needs to be 
made using good quality evidence. A number of trials with a similar design have been 
commissioned in order to compare the outcomes following EVAR and open repair of AAA 
in patients who are anatomically suitable to undergo endovascular repair and fit to undergo 
open repair. These include the Dutch Randomised Endovascular Aneurysm Management 
(DREAM) 45,46trial, EVAR-1 Trial (United Kingdom) 47, ACE trial (France) 48 and Open 
Versus Endovascular Repair (OVER) of abdominal aortic aneurysms trial (United States) 49. 
The DREAM trial which was the first to report its results enrolled 351 patients between 
November 2000 and December 2003 from 24 centres in the Netherlands and 4 centres in 
Belgium. This study focused on short term combined mortality and morbidity outcomes45. It 
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reported a significantly lower operative mortality and severe complication rates in the 
EVAR group compared to the patients who had been randomised to open repair. At 2 years 
follow up aneurysm related mortality following EVAR was still significantly lower than 
open repair (2.1% versus 5.7%) however after 2 years of follow up there was no significant 
difference in the overall survival rates or freedom from moderate to severe complications 
between the two groups. The conclusions drawn from this trial was that there was a 
significant reduction in early morbidity and mortality following EVAR compared to open 
aneurysm repair but this difference is not sustained past 2 years45,46. 
EVAR-1 trial was a multicentre RCT which was conducted in 37 hospitals in the UK. It 
randomised 1252 patients with large AAA to either open or endovascular repair. Unlike the 
DREAM trial, EVAR-1 was designed to perform a comparison of long term survival, graft 
durability, quality of life and hospital costs associated with open repair and EVAR in 
addition to comparing short term mortality and morbidity between the two groups47.  They 
reported a significantly lower in perioperative morbidity and mortality following EVAR. 
Four years after randomisation, all cause mortality was similar between the two groups, 
although there was a persistent reduction in aneurysm related mortality in the EVAR 
group,(Figure-5)47. After 12 months there was no difference in quality of life scores between 
the two groups with a greater number of complications and re-interventions at 4 years in the 
EVAR arm of the study. The hospital costs of EVAR were 25-percent higher than open 
repair47. 
 
 
Fig. 5. EVAR-1 Kaplan-Meier survival curves comparing aneurysm related and overall 
mortality between patients who have been randomised to open elective and endovascular 
(EVAR) repair of AAA (EVAR-1 trial)47. From: EVAR trial participants. Endovascular 
aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 
1): randomised controlled trial. Lancet 2005; 365(9478): 2179-86. 
The OVER trial is a RCT which included 42 Veterans Affairs medical centres in the United 
States. It randomised 881 patients who had AAA with a greater than 50 mm in maximal 
diameter, an iliac aneurysm greater than 30mm in diameter or rapid sac expansion, to 
elective open repair or EVAR. The preliminary results from this study indicated that the 
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EVAR group had significantly lower 30-day mortality as well as all cause mortality49. After a 
mean follow up of 1.8 years the complication rate was not significantly different between the 
two groups nor was the secondary reintervention rate. As in the DREAM trial, the 
reintervention following EVAR was mainly due to a device related complications whereas 
the commonest reason for reintervention following open repair was for incisional hernia46,49. 
Early results from the ACE trial suggest similar early mortality benefit following 
endovascular repair which is lost after medium term follow up48. 
Some subgroups of patients such as those who have significant co-morbidities such as 
cardiovascular or respiratory disease, octogenarians and women with AAA, require an 
individualised approach and revised criteria for the management of AAA. From its 
inception EVAR has provided the promise of repairing AAA in patients in whom open 
repair poses a high risk. Therefore armed with the knowledge that smaller AAAs are best 
managed by a policy of watchful waiting, EVAR appeared to be an ideal modality for the 
management of patients with larger AAAs which are anatomically suitable for endovascular 
repair, have a reasonable predicted longevity but are unfit to undergo open repair. The 
EVAR-2 trial was designed to answer this question. EVAR-2 trial was a randomised 
controlled trial of 338 patients who had an AAA with a maximum diameter of greater than 
5.5cm and their aneurysm morphology was anatomically suitable for EVAR, but were 
medically unsuitable to undergo open repair. Primary endpoint was all-cause mortality, 
with secondary endpoints of aneurysm-related mortality, health-related quality of life, 
postoperative complications, and hospital costs50. 
The 30-day operative mortality in the EVAR group was 9.0-percent and the no intervention 
group had an annual rupture rate of 9·0-percent per year. Aneurysm related mortality in the 
patient population was 13-percent and all cause mortality after 4 years of follow up was 64-
percent 50.  
 
 
Fig. 6. Kaplan-Meier curves comparing aneurysm related and overall mortality between 
patients who have been randomised to EVAR and no intervention group (EVAR-2 trial)50. 
From: EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit 
for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. 
Lancet 2005; 365(9478): 2187–92. 
www.intechopen.com
The Evidence for Management of Abdominal Aortic  
Aneurysms: Lessons Learned from Randomised Controlled Trials 13 
There was no significant difference in all-cause mortality between the EVAR group and the 
no intervention group (hazard ratio 1·21, 95% CI 0·87–1·69). There was no difference in 
aneurysm-related mortality (Figure-6) 50. A policy of early endovascular repair was 
significantly more expensive than expectant management and was associated with a higher 
complication and reintervention rate. There was no difference in quality of life scores 
between the two arms of the study50. Therefore the conclusion drawn by the authors was 
that this population of patients are best served by conservative treatment. Clearly the design 
of such a study provides one difficulty and that is the definition of not fit for open AAA 
repair is subject to clinical opinion and may be related to factors that do not affect patient’s 
longevity. The other group of patients are those with one organ morbidity such as 
respiratory disease or border line medical fitness, who have a large AAA and favourable 
anatomy for endovascular repair. Therefore clinical judgement is exercised in the 
application of results of EVAR-2 trial.  
5. Medical treatment of patients with AAA 
In addition to risk of growth and rupture, patients with AAA are at risk from other 
cardiovascular events by the virtue of their age, medical co-morbidities and male 
preponderance of AAA. Medical management of patients with known AAA follows two 
parallel but different aims, reducing cardiovascular event rates perioperatively and during 
follow up in addition to aneurysm specific therapy which is aimed at slowing aneurysm 
growth and reducing the risk of rupture51-53. 
Hyperlipidaemia, a known modifiable risk factor in the development of cardio-vascular 
disease, can be treated with the use of drugs such as the statins (3-hydroxyl-3-
methylglutaryl coenzyme A reductase inhibitors). Patients with AAA are known to be at 
high risk of cardio-vascular disease as well as increased risk of cardio-vascular 
complications following AAA repair 54. Statin therapy has been associated with improved 
survival due to decreased risk of cardio-vascular complications, in both open and 
endovascular repair 54-58.  Although the primary mechanism of statins is in reducing low 
density lipoproteins and total cholesterol levels along with increasing levels of high density 
lipoproteins, other protective non lipid mechanism may be at work. These so called 
pleiotropic effects describe a diversity of cellular events which have an effect on several 
components of the arterial wall, including: endothelial cells; smooth muscle cells; platelet 
function, monocytes and macrophages, which together help to modify the inflammatory 
process in the vessel wall. Statins have been shown to be beneficial in the secondary 
prevention of coronary heart disease even in those patients with normal lipid profiles59-60. 
Matrix Metallo Proteinase-9 (MMP-9) expression is closely linked to aneurysm formation in 
animal models. In vitro experiments have shown that addition of Cerivstatins to human 
organ cultures from AAA reduces tissue levels of both total and active MMP-9 in a 
concentration dependent manner. Evans et al reported significantly reduced MMP-9 levels 
in excised tissue obtained from the aneurysm sac at the time of the aneurysm repair in 
patients who had been started on statins 3-weeks preoperatively compared with controls59. 
Schouten et al monitored 150 patients with small AAAs for 12 months and reported a 
reduction in the aneurysm expansion rate in patients receiving statin therapy60. In an 
observational study of 130 patients under surveillance, Sukhija reported no aneurysm 
expansion in 75 patients who were on statin therapy over a 2 year follow up period61. 
Schlosser et al in an analysis of the results of a large observational cohort study which 
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involved 5057 patients with vascular disease (Second Manifestation of ARTerial disease 
(SMART) study) and included 230 patients with small AAA revealed an independent 
association between statin therapy and reduced aneurysm growth rate. This reduced growth 
and rupture rates were independent of serum lipid values62,63.  
Over the years there has been some interest in β-blockers, both to slow the growth rate of 
AAA and to reduce perioperative morbidity form cardiovascular events. The benefit was 
postulated partly due to their haemodynamic properties and partly due to the effect of β-
blockers on matrix proteins. In a trial reported by Lindholt and colleagues the use of 
Propranolol did not reduce the rate of expansion of AAA, admittedly in the treatment arm 
of the study the compliance was poor with only 22-percent continuing on Propranolol by 2-
years64. Another trial which was carried out in Canada came to a similar conclusion owing 
to poor patient compliance in the treatment arm of the study65.   
In the last 15 years there has been significant interest in using peri-operative β-blockade as a 
means of increasing myocardial oxygen delivery thereby reducing the risk of perioperative 
myocardial infarction and death.  Mangano et al randomised 200 patients who were 
undergoing major elective non-cardiac surgery to either receive Atenolol or placebo. This 
was started before the induction of anaesthesia. Patients with evidence of congestive cardiac 
failure, systolic blood pressure of less than 100mmHg orpulse rate of less than 55 beats 
/minute, 3rd degree heart block or broncho-spasm were excluded. This treatment was 
continued for 6 months postoperatively. They reported a significant reduction in 
cardiovascular event rate and death from cardiac causes66. 
Poldermans and colleagues performed a similar study in patients undergoing elective 
aneurysm or infrainguinal arterial reconstruction. They screened 1351 patients for cardiac 
disease using Dobutamine stress testing, 173 patients had a positive test of whom 59 were 
randomised to receive Bisoprolol and 53 placebo67.  They also reported a significant 
reduction in non fatal cardiac events as well as cardiac death. In these patients β-blockade 
was started at least a week in advance of the operation and they were screened for 
bradycardia and hypotension preoperatively67.  
POISE was a large international randomised controlled trial of the use of extended release 
Metoprolol in patients undergoing non-cardiac surgery, the study randomised 8351 patients 
to either receive Metoprolol or placebo which was started 2-4 hrs before surgery and 
continued for 30 days. They reported a significantly reduced risk of myocardial infarction in 
the Metoprolol group but at the expense of higher mortality and stroke rate in the treatment 
arm of the study68. Similarly, Yang et al randomised such patients undergoing major 
vascular surgery, not already β-blocked, to dose adjusted Metoprolol or placebo 2 hours 
prior to surgery and until discharge or maximum of 5 post-operative days, and found no 
protective effects of β-blockade in terms of 30 day myocardial infarction and death rates69. β-
blockade did result in significantly more episodes of bradycardia and hypotension. In light 
of these findings the American Heart Association guidelines regarding perioperative β-
blocker therapy in patients undergoing non cardiac surgery have been altered to be more 
cautious and circumspective (Table-)70. 
In a large observational study, Hackham et al have shown that the use of Angiotensin 
Converting Enzyme Inhibitor (ACEI) therapy taken 3-12 months prior to data analysis 
significantly reduced the risk of rupture from AAA, independently of blood pressure71. This 
data was obtained from a large administrative database of 3379 patients with ruptured and 
11947 with non ruptured AAA. Other anti-hypertensive medications had no such effect 71. 
Interestingly, patients who had stopped ACEI therapy prior to admission were more likely 
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to present with ruptured AAA 71. The effect of ACEI on expansion of AAA is still equivocal, 
with some studies demonstrating no protective effect of ACEI therapy 72-73. Thompson et al 
in a recent observational study of 1269 patients with small AAA who were followed up for a 
mean of 3.4 years, reported a significant reduction in aneurysm growth rate as a result of 
ACE inhibitor therapy72. The follow up data from UK small aneurysm trial does not support 
the above finding74. 
Infection with Chlamydiae pneumonia has been postulated as a risk factor for AAA 
expansion, as the organism has been isolated from atherosclerotic plaque and the walls of 
AAA 75,76. Three small trials have aimed to elucidate the effect of the antibiotics Doxycycline 
and Roxithromycin in AAA growth, two of which have shown reduced aortic expansion 
associated with treatment 77,78, whilst another one by Baxter and colleagues showed no effect 
of doxycycline on aortic diameter 79. These three trials were limited by their small numbers. 
In addition administration of Doxycycline has been shown to suppress MMP-9 in both 
human and animal studies 79-81, suggesting that the reduction in aneurysm expansion rate 
with administration Doxycycline may be mediated through a mechanism which is 
independent from treatment of Chlamydiae pneumoniae infection. 
To date there is no conclusive evidence that any medical therapy is associated with a 
reduction in aneurysm growth or risk of rupture. However diagnosis of AAA provides a 
forum for instituting appropriate secondary prevention therapies, which will reduce 
morbidity and mortality in the peri-operative period as well reduce long term cardio-
vascular risk. There is some evidence that instituting some of these treatments such as statin 
therapy, ACE inhibitors may well have an effect on aneurysm growth and rupture rates.  
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Background: The UK Small Aneurysm Trial suggested that female sex is an independent risk factor for
rupture of abdominal aortic aneurysm (AAA). This study assessed the effect of sex on the growth rate
of AAA.
Methods: Between January 1985 and August 2005 all patients who were referred to the Royal Infirmary
of Edinburgh with an AAA who were not considered for early aneurysm repair were assessed by serial
abdominal ultrasonography. Maximum anteroposterior and transverse diameters of the AAAs were
measured.
Results: A total of 1255 patients (824 men and 431 women) were followed up for a median of 30
(range 6–185) months. A median of six examinations (range 2–37) was performed for each patient.
Median diameter on initial examination was 41 (range 25–83) mm. Median growth rate overall was
2·79 (range −4·80–37·02) mm per year. Median growth rate of AAA was significantly greater in women
than men (3·67 (range −1·2–37·02) versus 2·03 (range −4·80–21·00) mm per year; P < 0·01). Weighted
linear regression analysis revealed that large initial anteroposterior AAA diameter and female sex were
significant predictors of faster aneurysm growth rate (P < 0·001 and P = 0·006 respectively).
Conclusion: The growth rate of AAA was significantly greater in women than in men. This may have
implications for the frequency of follow-up and timing of repair of AAA in women.
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Introduction
Ruptured abdominal aortic aneurysm (AAA) is a catas-
trophic event; many patients die without reaching appro-
priate medical help and only 50 per cent of those under-
going surgical repair survive beyond 30 days1,2. This is
in contrast to the elective repair of AAA, which can be
achieved with a mortality rate of less than 5 per cent3.
Longitudinal observational studies suggest that
25–41 per cent of AAAs larger than 5 cm will rupture
within 5 years4–6. The management of AAAs that measure
4–5·5 cm in maximum anteroposterior (AP) diameter is
guided by the UK Small Aneurysm Trial7, which revealed
that early elective surgery conferred no long-term survival
beneﬁt over regular surveillance. A follow-up publication
from the participants of the UK Small Aneurysm Trial
found that the risk of AAA rupture was independently
associated with aneurysm size, current smoking, mean
blood pressure and female sex8. The risk of aneurysm
rupture in women was three times higher than in men.
Growth rate is one of the factors used to identify patients
who are at potential risk of aneurysm rupture. The mean
growth rate depends on the population studied. Reported
expansion rates vary widely, being four times higher in
referral-based studies compared with community-based
screening programmes. The growth rate of an AAA is
associated with its initial size. Other factors such as age,
cigarette smoking and severe cardiac disease have also been
associated with rapid expansion of AAA. More recently
a community-based screening programme has suggested
that female sex may be an independent risk factor for
rapid growth of AAA9. The aim of this study was to assess
the inﬂuence of sex on growth rate in a large series of
referral-based infrarenal AAAs.
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Patients and methods
Between January 1985 and August 2005 all patients
who were referred to the Royal Inﬁrmary of Edinburgh
(a supraregional vascular surgery service covering a
population of 1·2 million) with AAA and not considered for
early aneurysm repair were assessed serially by abdominal
ultrasonography. This included all patients with small AAA
and patients who either refused or, owing to a range of
co-morbidities, were not considered to be candidates for
elective aneurysm repair. Maximum AP and transverse
diameters of AAAs were measured. The maximum AP
diameter was used to assess changes in aneurysm size.
All patients with aneurysms smaller than 4 cm in AP
diameter underwent yearly ultrasonography and clinical
follow-up, whereas patients with an AAA with a maximum
AP diameter greater than 4 cm had ultrasonography every
6 months.
As post-mortem examination concerning the cause of
death was unavailable in most cases, and it is believed that
knowledge of the presence of AAA may have biased the
recorded cause of death, the risk of rupture of AAA was
not calculated in this study.
The data were stored in an Access database (Microsoft,
Redmond, Washington, USA). Calculation and organi-
zation of the data were performed in Excel
TM
spread-
sheets (Microsoft) Statistical analysis was performed using
SPSS
TM
version 12 software (SPSS, Chicago, Illinois,
USA). The association between the initial diameter of
an AAA and its growth rate was assumed to be linear and
was modelled using linear regression analysis. The growth
rate of AAA was considered to be the dependent variable,
and age, sex and initial aneurysm size the independent
variables. Although the use of linear regression analysis
to assess expansion of AAAs may be subject to upward
bias10, as this would affect aneurysm growth rates in men
and women equally, it is unlikely to inﬂuence comparisons
based on sex.
Results
A total of 1255 patients with an AAA were not considered
for early repair and had regular follow-up ultrasonography;
there were 824 men (65·7 per cent) and 431 women
(34·3 per cent). The median age of the patients was 72
(range 41–94) years, 71 (range 41–94) years for men and
74 (range 51–89) years for women (P = 0·031). These
patients were followed for a median of 30 (range 6–185)
months. The median number of examinations per patient
was six (range 2–37).
Of the patients under surveillance, 322 underwent
operative repair of the AAA (233 men and 89 women).
This was performed for symptomatic or ruptured AAA
in 43 patients (29 men and 14 women). The remaining
279 patients underwent elective repair of AAA (204 men
and 75 women). Three hundred and ninety-one patients
died during follow-up, 195 patients were lost or discharged
from follow-up, and the remaining 347 patients remain
under surveillance.
Median AP diameter on initial AAA examination was 41
(range 25–83) mm. It was 43 (range 25–83) mm in men
and 39 (range 25–72) mm in women (P < 0·001). Fig. 1
illustrates the distribution of AP diameters of AAA in men
and women on initial presentation.
The median overall growth rate was 2·79 (range
−4·80–37·02) mm per year. A signiﬁcant correlation was
observed between the growth rate of AAAs and their
initial size (R2 = 0·22, P < 0·001) (Fig. 2). The median
growth rate of AAA was signiﬁcantly higher in women
than in men (3·67 (range −1·20–37·02) versus 2·03 (range
−4·80–21·00) mm per year; P < 0·01) (Fig. 3). Fig. 4
illustrates the expansion rates of AAA according to initial
AP diameter. Weighted linear regression analysis revealed
that initial AP diameter (odds ratio (OR) 3·83 (95 per cent
conﬁdence interval (c.i.) 3·12 to 4·55); P < 0·001) and
female sex (OR 2·04 (95 per cent c.i. 1·68 to 2·40);
P = 0·006) were signiﬁcant predictors of rapid aneurysm
growth. Age at initial presentation was not signiﬁcantly
associated with increased aneurysm growth (OR 1·06
(95 per cent c.i. 0·90 to 1·22); P = 0·420) (Table 1).
Discussion
In the present study female sex was found to be an
independent risk factor for AAA expansion rate. Median
growth rate of AAA in women was almost twice that
in men. This was independent of initial aneurysm size
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Fig. 1 Distribution of anteroposterior (AP) diameter of
abdominal aortic aneurysm on initial presentation in men and
women
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Fig. 2 Correlation between expansion rate and initial maximum
anteroposterior (AP) diameter of the abdominal aortic aneurysm
R2 = 0·22, (P < 0·001)
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Fig. 3 Box and whisker plot illustrating the difference in growth
rates of abdominal aortic aneurysms between men and women.
The thick black lines represent median values, boxes the
interquartile range, whiskers the range and open circles the
outlying values
and age on presentation. A regional community-based
AAA surveillance programme has recently reported similar
observations on a total of 274 men and 74 women9. Being
a community-based study the AAAs identiﬁed were heavily
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Fig. 4 Growth rates of abdominal aortic aneurysms in men and
women according to initial anteroposterior (AP) diameter. The
thick black lines represent median values, boxes the interquartile
range, whiskers the range, open circles the outlying values and
asterisks the extreme values
Table 1 Factors associated with growth rate of abdominal aortic
aneurysm
Factor Odds Ratio (95% CI) P
Age 1·06 (0·90–1·22) 0·420
Initial AP Diameter 3·83 (3·12–4·55) 0·001
Female sex 2·04 (1·68–2·40) 0·006
weighted towards small size (less than 4 cm in diameter). A
recent similar sized referral-based study also reported that
female sex was associated with increased AAA growth20.
The evidence for timing of intervention in patients
with asymptomatic AAA derives mainly from the UK
Small Aneurysm Trial and the Veterans Administration
aneurysm trial, both of which suggest that ultrasonographic
surveillance is appropriate for AAAs less than 5·5 cm in AP
diameter7,11. The use of expansion rate as an indication for
intervention makes sense but has never been validated12.
A few large-scale longitudinal studies have revealed
that aneurysms that rupture have signiﬁcantly greater
expansion rates than non-ruptured AAAs12,13. Brown
et al.12 reported that ruptured AAAs had signiﬁcantly
higher mean expansion rates (0·84 cm per year) than
non-ruptured AAAs (0·39 cm per year). Lederle et al.13
described similar ﬁndings, although in a population
consisting predominantly of men.
AAA growth has been shown more closely to ﬁt an
exponential curve14. Yet, in many cases AAA growth
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follows a staccato or discontinuous pattern with periods
during which the aneurysm size remains unchanged15.
Growth is closely associated with initial AAA size, which is
probably themain reason behind the higher growth rates in
referral-based studies than screening-based studies. Other
factors associated with aneurysm growth include smoking
and increasing age. A few studies have reported that AAAs
appear to expand faster in current smokers16–18. Analysis
of the patients from the Small Aneurysm Trial by Brady
et al.10 showed that smoking increased AAA growth rates
by 15–20 per cent. Although data on smoking history were
not available in the present study, there is some evidence
that women with an AAA are more likely to be current
smokers than men19. Although a difference in smoking
patterns has not been reported in a Scottish population,
it is possible that the result of this study could have been
confounded by higher smoking rates in the women.
Brady et al.10 did not ﬁnd any evidence to link
hypertension or hyperlipidaemia with AAA growth.
Although they did not ﬁnd any signiﬁcant difference in
growth rates between men and women10, analysis of the
same cohort of patients revealed that hypertension and sex
were independent risk factors for AAA rupture8. In a recent
study of 150 consecutive patients with AAA, Schouten
et al.20 reported that statin use might be associated with
signiﬁcantly slower aneurysm growth. These ﬁndings
suggest that improvement in cardiovascular risk factors of
patients enrolled in surveillance programmes, in addition
to improving cardiac survival, may lead to slower AAA
growth and a reduced risk of rupture.
All guidelines for management of AAA have included
both men and women, and offered identical thresholds for
intervention. The UK Small Aneurysm Trial revealed that
female sex was an independent risk factor for AAA rupture;
the rupture rate in women was three times higher than that
in men, despite a smaller initial AP diameter. Furthermore,
mean AP diameter preceding rupture was signiﬁcantly
lower in women than men8. Brown et al.12 studied a
cohort of 476 patients with AAA and reported a fourfold
higher rupture rate in women. A Finnish community-based
follow-up study reported that the aortic diameter was less
than 5·5 cm in 24 per cent of women with a ruptured AAA,
compared with only 5 per cent of men21.
Although surgical decisions regarding elective repair
of AAA remain complex, this study adds weight to the
view that AAA is a more rapidly progressive condition in
women. This observation suggests that women with an
AAA should have more frequent follow-up and be offered
elective intervention at a reduced AP diameter than men.
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Outcome from abdominal aortic aneurysms in Scotland,
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Background: This study assessed the impact of sex, presentation and treatment on outcome from
abdominal aortic aneurysm (AAA) in Scotland.
Methods: All patients admitted from January 1991 to December 2006 with a primary diagnosis of AAA
were identified. Patients were stratified by age, sex, admission diagnosis (ruptured versus intact) and
procedure performed (endovascular versus open repair). Multivariable logistic regression analysis was
used to determine predictors of mortality.
Results: Some 9779 men and 2927 women were admitted with a principal diagnosis of AAA. Women
were significantly older than men (median (range) age 75 (35–97) versus 71 (17–96) years; P < 0·001).
A higher proportion of women presented with a ruptured AAA (29·5 versus 27·5 per cent; P = 0·043).
Age (odds ratio (OR) 2·52 (95 per cent confidence interval 2·36 to 2·74); P < 0·001), female sex (OR
1·63 (1·48 to 1·78); P < 0·001) and admission diagnosis (OR 10·49 (9·53 to 11·54); P < 0·001) were
independent predictors of early death, whereas endovascular repair predicted survival (OR 0·67 (0·58 to
0·76); P < 0·001).
Conclusion:Women presenting with an AAA were older and more likely to be admitted with a ruptured
aneurysm. Female sex was an independent risk factor for death from AAA.
Paper accepted 8 September 2008
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Introduction
The possibility of sex differences in outcome following
abdominal aortic aneurysm (AAA) repair has been a matter
of debate for the past decade1–10. It has been suggested
that female sex not only adversely affects selection for
AAA repair5 but is also associated with signiﬁcantly poorer
outcome following surgical intervention3,4,6.
The past two decades have witnessed major advances in
understanding of the natural history of AAA, preoperative
assessment and the appropriate timing of intervention11,12.
In addition, the introduction of endovascular aneurysm
repair holds the promise of reducing the periprocedural
morbidity and mortality of treatment13,14. The impact
of these advances on national practices and utilization of
services has yet to be analysed in Scotland. Furthermore,
no information is yet available on whether heightened
awareness of AAA in primary care has resulted in
the desired outcome of reducing aneurysm rupture
rates.
The aim of the present study was to examine the trends
in open and endovascular AAA repair, and outcomes over
the past 16 years in Scotland, and to explore the possible
impact of sex on outcome from AAA.
Methods
Over the past 46 years, National Health Service (NHS)
hospitals in Scotland have been obliged to return a
standard form (Scottish Morbidity Record form) for all
patients admitted to hospital. Patients’ demographics, co-
morbidities, surgical and other interventional procedures,
and discharge diagnoses are recorded on these forms in
coded format. These data are stored electronically by the
Information and Statistics Division (ISD) ofNHS Scotland
and are used to conduct nationwide audits of patient care,
and to steer national and regional healthcare policy. The
quality of data collected on Scottish Morbidity Record
forms (SMR1) in patients with AAA has been audited
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previously and shown to match clinical records in over
99 per cent of cases15.
Data regarding admissions for all patients with the
primary diagnosis of AAA from 1 January 1991 to 31
December 2006 were obtained from the ISD of NHS
Scotland. The diagnosis for each in-hospital event was
classiﬁed using ﬁnal hospitalization diagnosis codes of
the International Classiﬁcation of Diseases ninth revision
(ICD-9). These were 441·3/441·5 for ruptured AAA or
441·4 for intact AAA. The primary procedure performed
during the inpatient event was recorded from the ICD-9
primary procedure codes: 38·34 (aorta resection and
anastomosis), 38·36 (abdominal vessel resection with
anastomosis), 38·44 (resection of abdominal aorta with
replacement), 38·64 (excision of aorta), 39·25 (aorta-to-
iliac or femoral bypass) and 39·52 (aneurysm repair not
otherwise speciﬁed) for open repair of AAA, and 39·71 for
endovascular AAA repair.
All transfers between hospitals and wards were scru-
tinized using an anonymized unique database identiﬁer,
so only the record of the pertinent admission for an
AAA was included for each patient. As each patient was
assigned a unique identiﬁer, it was possible to follow him
or her through the healthcare system and remove duplicate
records.
Discharge datawere grouped into the following outcome
categories: discharge to home, transfer to a short-term care
facility, transfer to a long-term care facility and death. In-
hospital death was deﬁned as death recorded during the
in-hospital event, within 30 days of admission to hospital
or within 7 days of discharge. Data obtained from the ISD
were cross-referenced against the ScottishAudit of Surgical
Mortality database16 to assure maximum accuracy. Patients
in the databasewere divided by age (less than 75 years versus
75 years or more), by presentation (ruptured versus intact
AAA) and by method of repair (open versus endovascular).
Statistical analysis
The data were stored in a Microsoft Access database
(Microsoft, Redmond, Washington, USA). Organization
of the data and calculations were performed in Microsoft
Excel spreadsheets. Statistical analysis was performed using
SPSS version 10 software (SPSS, Chicago, Illinois, USA).
To avoid distributional assumptions, values were stated
as median (range) and non-parametric statistical tests
(χ2, Mann–Whitney, Kruskal–Wallis tests) were used.
Stepwise multivariable logistic regression analysis was
carried out with in-hospital mortality as the dependent
variable, and age, sex, presentation diagnosis and procedure
type as independent variables. P < 0·050 was considered
signiﬁcant.
Results
Over the 16-year interval, 12 706 patients were admitted
with a principal diagnosis of AAA, 9779 of whomwere men
and 2927 women. The median age of all the patients was
73 (range 17–97) years, 71 (range 17–96) years for men
and 75 (range 35–97) years for women (P < 0·001).
The diagnosis was intact AAA in 8818 patients
(69·4 per cent) and ruptured AAA in 3888 patients
(30·6 per cent). Fig. 1 shows the overall annual rate of
admissions for AAA in Scotland as well as the proportions
with the primary diagnosis of intact and ruptured AAA.
A total of 2694 men (27·5 per cent) had a ruptured AAA,
whereas 7085 had an intact AAA. In contrast, 863 women
(29·5 per cent) had a ruptured AAA and 2064 had an
intact AAA (χ2 = 4·1, 1 d.f., P = 0·043). The absolute
rate of ruptured AAA remained relatively constant over the
16 years of the study (Fig. 1). However, there was a relative
reduction in the proportion of patients with a ruptured
AAA in the last 5 years compared with the ﬁrst 5 years
(1431 (28·2 per cent) of 5068 versus 1296 (32·3 per cent)
of 4017 respectively; χ2 = 17·1, 1 d.f., P < 0·001). Figs 2
and 3 illustrate the trends in age-speciﬁc rate of admission
for intact and ruptured AAA.
A total of 8348 patients underwent surgery for AAA;
this included 7466 open repairs (89·4 per cent) and 698
endovascular repairs (8·4 per cent). An additional 184
patients (2·2 per cent) underwent laparotomy without AAA
repair. Of patients who underwent open AAA repair, 4441
had a tube graft, 2278 an aortoiliac repair and 508 an
aortobifemoral bypass. In 239 procedures the type of open
repair was not speciﬁed. Fig. 4 illustrates the estimated
yearly rates of open and endovascular AAA repair.
No surgical procedure was documented for a further
4358 patients. The recorded diagnosis for this group was
ruptured AAA in 2254 patients and intact AAA in 2104.
Over the 16-year interval, 2579 patients (20·3 per cent)
died within 30 days of admission with an AAA. Some 531
(37·7 per cent) of 1410 patients who underwent attempted
repair of a ruptured AAA died, compared with 362
(5·2 per cent) of 6938 patients who had repair of an
intact AAA. The 30-day mortality rate was signiﬁcantly
higher following open repair of an intact AAA than
after endovascular repair (5·6 per cent (351 patients) versus
1·6 per cent (11 patients); χ2 = 19·8, 1 d.f., P < 0·001).
Early postoperative mortality rates were signiﬁcantly
higher in women than in men (29·9 per cent (875 women)
versus 25·8 per cent (2523 men); χ2 = 19·3, 1 d.f., P <
0·001). Logistic regression analysis revealed that age, sex,
admission diagnosis (ruptured versus intact AAA) and type
of procedure performed (open versus endovascular repair)
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Fig. 2 Annual rate of hospital admission with a primary diagnosis
of intact abdominal aortic aneurysm stratiﬁed by age
were independent predictors of 30-day and in-hospital
mortality following AAA repair (Table 1).
Discussion
Until recently, the incidence of AAA has risen steadily
over the last two and a half decades in Scotland17, in
line with similar reported increases in Europe9,16–20,
North America9,10,21,22 and Australia23. There has been
a parallel rise in the number of hospital admissions and
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Fig. 3 Annual rate of ruptured abdominal aortic aneurysm
stratiﬁed by age
mortality rates from this condition8,11,18–23. Best and co-
workers17 reported a signiﬁcant increase in mortality from
AAA between 1981 and 2000, although they noted that
the mortality from AAA reached a plateau in the mid-
1990s. This is in contrast to the ﬁndings of Semmens and
colleagues23, who reported a steady reduction in the rates of
emergency surgery and mortality from AAA between 1985
and 1994 in Western Australia. McPhee and co-workers9
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Table 1 Factors associated with death after abdominal aortic
aneurysm repair
Odds ratio P*
Age (< 75 or ≥75 years) 2·52 (2·36, 2·74) <0·001
Sex 1·63 (1·48, 1·78) <0·001
Admission diagnosis (ruptured
versus intact)
10·49 (9·53, 11·54) <0·001
Operation (endovascular
versus open repair)
0·67 (0·58, 0·76) <0·001
Values in parentheses are 95 per cent conﬁdence intervals. *Stepwise
multivariable logistic regression analysis.
also reported a signiﬁcant reduction in the incidence of
ruptured AAA in North America. In the present study,
the absolute number of patients with a diagnosis of
ruptured AAA remained relatively constant over the past
16 years. However, this represented a signiﬁcantly smaller
proportion of patients admitted with an AAA in 2002–2006
compared with 1992–1995 (Fig. 1).
There is accumulating evidence to suggest that AAA is a
more sinister disease process in women, although it is less
common than in men. Longitudinal studies have shown
that AAAs may grow faster in women24. In the UK Small
Aneurysm Trial, despite the smaller AAA size, women
were three times more likely to develop a ruptured AAA
than men, and the mean diameter of the AAA at the time
of rupture was smaller: 50 versus 60 mm4,12. In addition,
women with a ruptured AAA have a signiﬁcantly higher
mortality rate10. This difference may partly be due to the
fact that women with a ruptured AAA are less likely to be
treated and more likely to die in the community, before
reaching hospital10. Evans and colleagues1 did not ﬁnd any
signiﬁcant difference in mortality rates between men and
women who underwent surgical repair of a ruptured AAA,
although this has not been a universal observation2,9,11.
Screening for AAA with abdominal ultrasonography has
been shown to be cost-effective and has led to a reduction in
aneurysm-related deaths in men25–29. Universal screening
of men between the ages of 65 and 80 years is associated
with a signiﬁcant reduction in the regional incidence of
ruptured AAA30. However, the role of screening for AAA in
women remains controversial. To date there is no evidence
that screening for AAA in an unselected population of
women is associated with a reduction even in aneurysm-
related mortality. Scott and colleagues29 reported the
prevalence of AAA in women to be 1·3 per cent, with
other authors reporting a similar rate of 0·7–1·3 per cent
in unselected populations23,28–30. Scott et al.29 did not
demonstrate a difference in rupture rates between the
women randomized to screening and control populations
of women at 5- and 10-year follow-up.They concluded that
screening for women was neither clinically indicated nor
economically viable. However, they screened an unselected
population of women without consideration of risk factors
for aneurysm disease and ﬁtness for repair; consequently
a large proportion of women who were found to have an
AAA did not undergo aneurysm repair.
For screening to be effective in reducing aneurysm-
related mortality in women, it will need to be limited
to high-risk women who are ﬁt to undergo aneurysm
repair30. There is increasing evidence that women with
atherosclerotic disease are at signiﬁcantly higher risk of
developing AAA. Derubertis and colleagues30 reported
that the prevalence of AAA in women with multiple (more
than three) atherosclerotic risk factors was 6·4 per cent.
When these ﬁndings are considered in conjunction
with the increased growth rates of AAA24 and higher
aneurysm rupture rate in women, screening in women
with multiple risk factors for AAA may become clinically
and economically viable3,4,6,10,12,14,30,31 .
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in Infrainguinal Vein Bypass Surveillance*
R. Mofidi,* J. Kelman, O. Berry, S. Bennett, J.A. Murie and A.R.W. Dawson
Department of Vascular Surgery, The Royal Infirmary of Edinburgh, 51 Little France Crescent,
Edinburgh EH16 4SA, UK
Background. Duplex surveillance of infrainguinal vein grafts may not be efficient.
Methods. Consecutive patients who had received infrainguinal vein grafts were enrolled in a duplex surveillance program.
A first scan at 6 weeks after surgery categorized grafts into four groups: (a) low risk grafts, (b) mild flow disturbance,
(c) intermediate stenosis and (d) critical stenosis. Disease progression was assessed over time.
Results. Of 364 grafts followed-up for a median of 23 months, 236 (65%) had no flow abnormality at 6-weeks, and had
a 40-month cumulative patency rate of 82%. The remaining 128 (35%) grafts had a flow disturbance. Of 29 critical
stenoses, 15 were repaired, 11 occluded and three did not change. Of 57 intermediate lesions, 32 progressed to critical,
nine occluded, two were repaired and 14 did not change or improved. Of 42 mild lesions, 16 progressed to a higher grade,
four occluded and 22 did not change or improved. There was no significant difference in graft patency between grafts with
repaired stenoses and those without stenoses, but grafts with untreated critical stenoses were associated with lower patency
(p< 0.001).
Conclusions. A duplex scan 6 weeks after operation can predict those patients who require continuing duplex surveillance.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Infrainguinal bypass using autogenous vein is an es-
tablished treatment for critical ischaemia of the leg.1
Vein grafts are prone to develop stenoses, which
may precipitate failure of the bypass.2e5 Stenosis
may develop from technical error, vein valve leaflets,
pre-existing vein abnormality and myointimal hyper-
plasia. Evidence of most of these problems may be
recognisable by duplex ultrasound scanning, a tech-
nique acknowledged for its accuracy in identifying
and grading stenotic lesions that threaten graft pa-
tency.6 Duplex scanning has been widely used for
graft surveillance, the rationale being that correction
of stenotic lesions is likely to improve graft patency
and limb salvage rates.7e9
The wisdom of duplex vein graft surveillance has
been recently questioned. The Vein Graft Surveillance
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E-mail address: rmofidi@doctors.net.uk1078–5884/000327+ 06 $32.00/0  2007 European Society for Vascu(VGST) trial has revealed no significant difference in
graft patency or limb salvage in the medium term
between patients who were followed up clinically
and those who underwent vein graft surveillance.8
This study, however, recruited patients at 6 weeks
after operation, following the first postoperative
surveillance scan. It is possible that some grafts with
significant early stenosis may have been treated early,
effectively excluding them from further follow-up in
the trial.9 Most duplex surveillance protocols are not
initiated until 3 months after surgery and, as a conse-
quence, relatively little is known about the incidence
and nature of early vein graft stenosis. However, a sig-
nificant number of bypasses contain stenotic lesions
by 6 weeks after operation.10
This study assesses the nature of early flow distur-
bance and stenosis after infrainguinal bypass using
autologous vein.
Patients and Methods
Consecutive patients, who had an infrainguinal by-
pass procedure using autologous vein between 1st
January 2000 and 31st December 2005, were enrolledlar Surgery. Published by Elsevier Ltd. All rights reserved.
328 R. Mofidi et al.in a graft surveillance program. This involved duplex
scanning at 6 weeks, 3 months, 6 months and 1 year
after operation, after which surveillance continued
by clinical examination and measurement of ankle-
brachial pressure index at intervals of 6 months. Extra
duplex scanning outside the surveillance program
was performed on clinical grounds.
Ultrasound examination used angle of insonation as
close to 60 as possible and began within the inflow ar-
tery, progressing down the graft and continuing into
the outflow artery. The inflow and outflow vessels
were assessed for quality of flow based on velocity,
waveforms and colour flow characteristics. Peak sys-
tolic velocity was measured at sites of stenosis, at mul-
tiple sites within the graft and within the outflow
vessel. The velocity ratio at the site of stenotic lesions
was calculated. Grafts were categorized into four
groups based on duplex findings at the first scan: (a)
low risk grafts, (b) mild flow disturbances, (c) interme-
diate stenosis and (d) critical stenosis. Table 1 shows the
duplex parameters used to define these groups.
Patient demographics, type of operation, conduit
and follow-up information were recorded prospec-
tively in a computerized database (Microsoft
Access and Excel, Redmond, Washington, USA).
Data analysis was performed retrospectively. Statisti-
cal analysis was performed using Statistical Package
for Social Sciences version 12 SPSS (SPSS, Chicago,
Illinois, USA) statistical software. The groups were
compared in terms of stenosis, need for intervention,
graft patency and amputation. Patency and limb sal-
vage were determined using KaplaneMeier analysis.
Difference between groups was assessed using the
log rank test. P< 0.05 was considered significant.
Results
The initial patient group of 371 comprised 238 men
and 133 women who had 385 bypass procedures in
Table 1. The velocity criteria identifying different categories of
vein graft stenosis identified through duplex surveillance (PSV:
Peak Systolic Velocity (cm/s), ABPI: Ankle: Brachial Pressure
Index)
PSV at the site
of stenosis
Post stenotic
PSV
Drop in
ABPI
Absolute
value
PSV
ratio
Critical stenosis >350 3.5 <40 >0.15
Intermediate
stenosis
250e350 3 40e45 <0.15
Mild flow
disturbance
200e250 2 >45 <0.15
Low risk grafts <200 <2 >45 <0.15
Eur J Vasc Endovasc Surg Vol 34, September 2007total. During the first 6 weeks after operation 21 grafts
occluded and were excluded from further study, leav-
ing 364 vein grafts in 352 patients (225 men and 127
women). The median (range) age of the patients was
71 (37e88) years; 148 (41%) were current smokers,
158 (43%) had diabetes and 32 (9%) had chronic
renal failure. The indications for surgery are shown
in Table 2. Three hundred and fifty eight bypasses
were reversed vein grafts and six were in-situ by-
passes. Three hundred and forty one bypasses had
their origin at the femoral artery in the groin
(93.7%), nine from the external iliac artery (2.5%)
and 14 bypasses (3.8%) had their proximal anastomo-
sis from the superficial femoral artery. The distal anas-
tomoses were to the above knee popliteal (139, 38%),
the below knee popliteal (154, 42%), and the tibial
arteries (71, 20%). Overall 40-month primary patency,
primary assisted patency and secondary patency rates
were 73, 79 and 80 per cent, respectively.
The 364 bypasses underwent surveillance and the
median (range) follow-up was 23 (2e60) months.
The first postoperative vein graft surveillance scan
was performed at a median of 6 weeks (range 4e9
weeks). At the time of the first duplex scan, 236 grafts
(65%) had no significant stenosis; these grafts ran a be-
nign course with a 40-month cumulative patency rate
of 82 per cent and a limb salvage rate of 93 per cent.
The first postoperative scan identified 128 grafts
with a significant flow abnormality (Table 3). The dis-
tribution of these flow disturbances along the length
of the vein graft is shown in Fig. 1. Of the 29 grafts
with a critical stenoses, 15 (52%) were repaired. A fur-
ther 11 (38%) grafts with critical stenoses were not re-
paired and occluded during subsequent follow-up; in
six a clinical decision was made not to intervene, three
had been scheduled for repair but occlusion super-
vened, and two patients refused surgery. A final three
(10%) grafts with critical stenosis were not repaired
but did not change during follow-up.
Of 57 grafts with an intermediate stenosis at 6
weeks, 32 (56%) had lesions that progressed to a criti-
cal stenosis; nine (16%) lesions did not progress but
the graft occluded during follow-up. Two grafts
were repaired and 14 (25%) did not change or
Table 2. Indication for infrainguinal vein graft bypass in the study
population
Indication Number (%)
Intermittent claudication 64 17.6
Critical ischaemia 279 76.6
Popliteal artery aneurysm (asymptomatic) 7 2
Popliteal artery aneurysm (symptomatic) 12 3.3
Popliteal artery aneurysm (ruptured) 2 0.5
Total 364 100
329Significance of the Early Postoperative Duplex Resultappeared to improve during follow-up. Of the 42
grafts with mild flow abnormalities at 6 weeks, 16
(38%) had lesions that progressed to a more severe
category, four (10%) occluded and 22 (52%) did not
change or appeared to improve.
Over the whole study period 92 (25%) of the 364
grafts developed a critical or intermediate stenosis.
Only 11 of the 92 limbs had any recurrence of symp-
toms, but 26 had a reduction in ankle-brachial pres-
sure index. Forty-three of these grafts were treated,
three by intra-luminal angioplasty, 18 by vein patch,
9 by jump graft, eight by interposition graft and five
by revision of the bypass. Eight patients required re-
peat surgical procedures for recurrent graft stenosis;
this was by repeat vein patch angioplasty in three,
jump graft repair in four and interposition graft in
one patient. Forty-nine limbs with critical or interme-
diate vein graft stenosis were not treated.
No statistically significant difference was observed
in graft patency (p¼ 0.19) or amputation rates
(p¼ 0.62) rates between grafts with repaired stenosis
and grafts without stenosis. Untreated grafts with
0
5
10
15
20
25
30
35
40
Proximal
anastomosis
Proximal 1/3 Middle 1/3 Distal 1/3 Distal
anastomosis
Pre-occlusive lesions
Intermediate occlusive lesions
Mild Flow Abnormalities
Fig. 1. Distribution of duplex scan-detected velocity distur-
bance at early surveillance.
Table 3. Duplex findings at the first postoperative surveillance
visit (PSV: absolute peak systolic velocity values at the site of
stenosis)
Number of
grafts
PSV at the site of stenosis
(cm/s) Median (range)
Critical stenosis 29 355 cm/s (310e508)
Intermediate stenosis 57 316 cm/s (240e345)
Mild flow disturbance 42 212 cm/s (181e245)
Low risk grafts 236 ecritical or intermediate stenosis had significantly
lower patency (p< 0.001) and higher amputation rates
(p< 0.001) rates (Figs. 2 and 3).
Discussion
Duplex surveillance of infrainguinal vein grafts
remains a controversial issue. While it is true that a
significant proportion of vein grafts develop graft
threatening stenotic lesions within the first year of
the initial procedure, there is little evidence outside
observational and case control studies to suggest
that duplex surveillance is associated with improved
graft patency and improved limb salvage.11e14 Duplex
surveillance is resource intensive and difficult to jus-
tify on the basis of cost, unless a large number of
vein grafts, and by extension, limbs are being saved.
A recent multi-centre randomized controlled trial,
the VGST trial, showed no benefit from duplex
scanning in terms of graft patency, limb salvage or
quality-of-life, despite significantly increased costs.8
This study recruited patients at the time of the first
postoperative scan, which was performed at a median
of 6 weeks after surgery. The reasoning behind this
was to exclude grafts occluding within 6 weeks, as
affected patients would not benefit from surveillance.
The definition of a graft at risk used in the VGST trial
was doubling of peak systolic velocity at the site of the
stenosis or a post stenotic PSV less than 0.45 m/s.8
Such a definition would have selected grafts with
mild and intermediate lesions as well as those grafts
with critical stenoses.
In the present study five per cent of grafts failed
within the first 6 weeks e a much smaller proportion
than the 33 per cent that contained a significant flow
disturbance on duplex scanning at 6 weeks after oper-
ation. Therefore the early postoperative duplex scan is
of more value in identifying grafts at risk of early fail-
ure than excluding grafts that have already occluded
by the time of the patient’s first postoperative follow-
up visit. Ferris et al. reported a relatively high inci-
dence of vein graft stenosis in the first 6 weeks and
suggested that an early scan is the most important
scan for graft surveillance. It would identify grafts
that are likely to occlude by 3 months, when the first
surveillance scan is usually performed.10 Other au-
thors have reported a similar incidence of vein graft
stenosis within the first 6 weeks of operation.15e18
Apart from denoting an early threat to patency,
early abnormalities also predict the natural history
of the graft and outlook for the limb in the medium
term. In the present study, vein grafts without flow
anomalies at 6 weeks ran a benign course. The vast
Eur J Vasc Endovasc Surg Vol 34, September 2007
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Fig. 2. KaplaneMeier plots of primary assisted patency over time in grafts enrolled into the vein graft surveillance
program.majority of grafts that occluded or required interven-
tion exhibited significant anomalies by the time of the
6-week scan. It should prove possible to use this find-
ing to select vein grafts at particular risk for duplex
surveillance, thereby reducing the cost of duplex
surveillance.8
This is in agreement with the findings of the VGST
trial which was in reality a comparison of intensive
duplex based vein graft surveillance versus a single
early postoperative duplex scan performed at six
weeks followed by clinical follow-up.8 Although
Davies et al. did not elaborate on the management of
the patients with ‘at risk grafts’ which were identified
by pre-randomization duplex scan, it seems improba-
ble that these grafts would have been randomized
without receiving appropriate surgical or endovascu-
lar correction. Since no mechanism existed in the
design of VGST trial, for re-including grafts with early
stenosis in the study after corrective treatment, it is
probable that some or all of these grafts were
excluded from randomization.
In the present study, several intermediate stenoses
and flow abnormalities did not progress or resolved
during follow-up. This finding has been reported pre-
viously.13,17,18 Versti et al. studied 17 vein graft
Eur J Vasc Endovasc Surg Vol 34, September 2007intermediate stenoses, situated within the body of
the graft that derived from valve cusps. They reported
that over half of these lesions regressed without inter-
vention over the follow-up period.18
Most patients with graft stenoses did not ex-
perience any recurrence of symptoms throughout
follow-up, and only 27 per cent of all critical or inter-
mediate stenoses were associated with a significant
drop in ankle-brachial pressure index. This makes it
improbable that a useful number of such lesions could
be detected by clinical follow-up alone. This is in
accordance with the findings of others.10e19
This study is a real life review of vein graft surveil-
lance rather than a trial of one follow-up strategyversus
the other. There are two steps to vein graft surveillance.
The first step is the identification of patients who have
or are likely to develop vein graft stenosis. In that re-
gard the early postoperative duplex scan can play a sig-
nificant role. The second step is repairing the stenoses
that are identified, whilst accepting that this may not
be possible in every case. The Kaplan-Meier survival
curves are therefore useful in order to illustrate the nat-
ural history of vein grafts with no stenosis, vein grafts
with significant stenosis which is repaired and vein
grafts with significant stenosis which for one reason
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Fig. 3. KaplaneMeier plots of limb salvage over time in grafts enrolled into the vein graft surveillance program.or another are not intervened on rather than a direct
comparison between the groups. Factors such as qual-
ity of graft and run off, the site and number of stenoses
play an important role in selecting patients for repair of
vein graft stenosis.
In summary, flow abnormalities detected at 6
weeks after operation can predict the natural history
of a vein graft and such abnormalities can be used
to select grafts for continued duplex surveillance.
Sub-critical stenosis does not necessarily progress to
a higher grade and may actually regress with time.
For grafts without any flow abnormality at 6 weeks,
the yield from continuing with duplex surveillance
is likely to be low and probably little better than
what is achievable by simple clinical follow-up.
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Bypasses Performed with Small-Diameter
Vein GraftsR. Mofidi, S. Pandanaboyana, M.M. Flett, J. Nagy, G.D. Griffiths, and P.A. Stonebridge,
on behalf of the East of Scotland Vascular Network Dundee, United KingdomWe assessed the impact of preoperative diameter of the venous conduit on reintervention rate
and outcome following infrainguinal vein graft bypass. Consecutive infrainguinal vein bypasses
between January 2001 and December 2006 were reviewed. All patients underwent preoperative
measurement of vein graft diameter (VGD). Grafts were classiﬁed into those with VGD <3.5 mm
and those with VGD 3.5 mm. All patients were enrolled in a duplex surveillance program. The
association between VGD and reintervention rate was assessed. Graft patency and amputation
rates were compared. There were 377 bypasses followed up for a median of 23 months (range 8-
67). VGD was <3.5 mm in 139 grafts (36.9%) and 3.5 mm in 238 grafts (63.1%). A higher pro-
portion of smaller vein grafts (32.3%) required reintervention to maintain graft patency compared
with larger conduits (20.2%) (c2 ¼ 7.7, p < 0.001). VGD (odds ratio [OR] ¼ 2.87, 95% conﬁdence
interval [CI] 1.63-3.81; p < 0.001), smoking (OR ¼ 1.83, 95% CI 1.39-3.20; p ¼ 0.02), and type of
bypass (OR ¼ 1.86, 95% CI 1.49-2.47; p ¼ 0.02) were variables associated with higher reinter-
vention rate. There was no difference in graft patency (p ¼ 0.13) or amputation rates ( p ¼ 0.35)
between the two groups. Use of smaller vein grafts was associated with a higher reintervention
rate. Provided that these grafts are surveyed and where necessary repaired, the use of smaller
vein grafts is successful and expands the availability of autogenous conduit for infrainguinal
arterial reconstruction.INTRODUCTION
Infrainguinal bypass using autogenous vein is well
established in the management of disabling inter-
mittent claudication or critical ischemia of the leg.1
These vein grafts are prone to develop stenosis,
which may precipitate failure of the bypass.2-5 Ste-
nosis may develop from technical error, vein valve
leaflets, preexisting vein abnormality, and myointi-
mal hyperplasia.
Several factors have been found to influence the
outcome of infrainguinal vein bypass.4-7 While
many of these factors are endogenous to the patients
and beyond the direct control of the surgeon, thet of Vascular Surgery, Ninewells Hospital, Dundee DD1
ence to: Reza Mofidi, 27-14 Hawthornbank Lane, Edin-
H, UK, E-mail: rmofidi@doctors.net.uk
2009; 23: 17-23
j.avsg.2008.04.013
ascular Surgery Inc.
ne: July 10, 2008size and quality of the venous conduit available for
bypass have been considered important factors
affecting the outcome of infrainguinal bypass.7 Al-
though the use of smaller veins does not invariably
result in graft failure,8 a number of authors have
suggested that grafts with a diameter <3.5 mm are
at increased risk of failure.9-11 Under these circum-
stances, the use of composite vein or arm vein grafts
rather than uninterrupted small-caliber long saphe-
nous veins is advocated.12
The aim of this study was to assess the signifi-
cance of minimum vein diameter measured at
preoperative vein mapping on early and medium-
term outcomes of infrainguinal vein bypass and to
assess the extent of postoperative increase of vein
diameter.METHODS
Consecutive patients who underwent infrainguinal
bypass using autologous vein between January 1,17
18 Mofidi et al. Annals of Vascular Surgery2001, and December 31, 2006, were identified from
a prospectively collected database. Data from the
database were supplemented by retrospective chart
review and cross-referenced against the hospital
laboratory databases.
All patients underwent preoperative vein map-
ping, using duplex ultrasound (Sequoia; Acuson,
Redwood, CA) with a 5 MHz linear transducer, by
two experienced vascular technologists. Ultrasound
examination used an angle of insonation as close to
60 as possible and examined the long and short sa-
phenous veins bilaterally; upper limb veins were ex-
amined if the latter two were not available or were
of dubious quality. The venous conduit was exam-
ined along its length with the patients in the stand-
ing position. The maximum internal diameter of the
vein was recorded at the proximal and distal thigh,
at the knee, and at the ankle. Patients were stratified
into two categories based on theminimum diameter
of the long saphenous vein in the standing position:
<3.5 and 3.5 mm. The appropriate length of
ipsilateral long saphenous vein was harvested and
examined intraoperatively for distensibility and
general quality. If this was found unsuitable, the
contralateral long saphenous vein was used. Short
saphenous and arm veins were used in patients
who had previous harvesting of long saphenous
vein or in whom long saphenous vein had been
found to be unusable as a conduit for bypass surgery
by preoperative vein mapping.
Thereafter, all patients were enrolled in a graft
surveillance program. This involved duplex scan-
ning and measurement of ankle brachial pressure
index (ABPI) before discharge from hospital and at
6 weeks, 3 months, 6 months, 1 year, and 2 years
after operation. Extra duplex scanning outside the
surveillance program was performed on clinical
grounds.
Duplex scanning protocol during vein graft sur-
veillance included assessment of the vein graft along
its full length together with examination of inflow
and outflow vessels for quality of flow based on ve-
locity, waveforms, and color flow characteristics.
Peak systolic velocity (PSV) was measured at sites
of stenosis and at multiple sites within the graft
and within the outflow vessel. The velocity ratio
at the site of stenotic lesions was calculated. Data
regarding any postoperative complications and
further surgical and radiological interventions
were recorded. The postoperative complications,
30-month cumulative patency rates, and amputa-
tion rates were calculated in relation to the mini-
mum preoperative vein graft diameter (VGD).
Critical vein graft stenosis was defined as PSV
>300 cm/sec or a 3.5-fold increase in PSV at thesite of stenosis in comparison to prestenotic PSV,
a PSV <40 cm/sec downstream from a stenotic
lesion, or a drop of >0.15 in the postoperative
ABPI measurements.
Patient demographics, type of operation, con-
duit, and follow-up information were recorded in
a computerized database (Access and Excel; Micro-
soft, Redmond, WA). Data analysis was performed
retrospectively. Statistical analysis was performed
using the Statistical Package for Social Sciences,
version 12 (SPSS, Inc., Chicago, IL). Results were
analyzed and reported in accordance with the
reporting standards of the Society for Vascular Sur-
gery and the North American Chapter of the Inter-
national Society for Cardiovascular Surgery.12 The
groups were compared in terms of stenosis, need
for reintervention, graft patency, and amputation.
Patency and limb salvage were determined using
Kaplan-Meier analysis. The association of graft pa-
tency and limb salvage with risk factors for graft
failure as ascertained by the site of the distal anasto-
mosis, minimum VGD, and other atherosclerotic
risk factors was analyzed using the Cox propor-
tional hazards model. The association between the
need for reintervention due to development of
a vein graft stenosis and the above variables was
assessed using multivariate logistic regression anal-
ysis. Differences between groups were assessed us-
ing the log rank test. p < 0.05 was considered
significant.RESULTS
There were 377 infrainguinal vein graft bypasses
performed in 351 patients during the study period,
of whom 238 (67.7%) were men and 113 (32.3%)
were women. The median age of the patients was
73 years (range 37-92). One hundred and ninety
seven patients (56.1%) were current smokers, 150
(42.7%) had diabetes, and 33 (9.4%) had chronic
renal failure. The indication for surgery was critical
limb-threatening ischemia in 330 cases (87.5%)
and disabling intermittent claudication in 48 cases
(12.5%). Three hundred and forty-six bypasses
(92.1%) had their origin at the femoral artery in
the groin, eight had their origin at the external iliac
artery (2.1%), and 23 (5.8%) had proximal anasto-
mosis from the superficial femoral artery. The distal
anastomoses were to the above-knee popliteal in
125 bypasses (33.2%), the below-knee popliteal
in 135 (35.8%), and the crural arteries in 117
(31.0%). Three hundred and twenty-six bypasses
were reversed vein grafts and 51 were in situ vein
graft bypasses. We utilized uninterrupted ipsilateral
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Fig. 1. Distribution of minimum preoperative VGD in
grafts which were <3.5 mm compared with grafts which
were 3.5 mm. Mann-Whitney test ( p < 0.0001).
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conduit in 321 bypasses (85.1%). In 29 bypasses
(7.7%) composite long saphenous vein graft was
used, while in 18 (4.8%) short saphenous venous
conduit was used; in nine patients (2.4%) upper
limb veins were used to perform the bypass
procedure.
Median preoperative internal diameter of vein
grafts used was 3.9 mm (range 2.4-6.7). The mini-
mum preoperative internal diameter of the vein
graft was <3.5 mm in 139 vein grafts (36.9%) and
3.5 mm in 238 grafts (63.1%). The distribution
of VGD in each group is illustrated in Figure 1. Table
I denotes the demographics of patients with preop-
erative VGD <3.5 mm compared to those with pre-
operative VGD 3.5 mm.
Median duration of follow-up was 23 months
(range 8-67). Eighty-four patients (24%) died dur-
ing the follow-up. Overall Kaplan-Meier estimates
at 40 months of the proportions with primary, pri-
mary assisted, and secondary patency rates were
73%, 79%, and 83%, respectively.
Eight grafts required reintervention during the
early postoperative period for critical flow abnor-
malities, which were identified in the early postop-
erative period. Seven of these were in vein grafts
which were <3.5 mm in diameter. Eighty-seven
grafts developed critical vein graft stenosis (22.5%)
during the follow-up period. Twelve patients
(13.8%) developed recurrent symptoms, and 27 pa-
tients (31%) had a significant drop in postoperative
ABPI measurements. The remainder of patients
remained asymptomatic with no clinical evidence
of vein graft stenosis.
Of the 87 patients who developed critical vein
graft stenosis, nine grafts occluded prior to sched-
uled repair, another one graft occluded following
diagnostic angiography which revealed that the ste-
notic lesion identified was not amenable to angio-
plasty, and one graft was not intervened upon.
Thirteen grafts underwent open repair, and a further
63 grafts underwent endovascular repair by a mix-
ture of standard and cutting balloon angioplasty.
A significantly higher proportion of vein grafts
which were created using veins with preoperative
VGD <3.5 mm required reintervention to maintain
graft patency compared with vein grafts which were
3.5 mm in diameter (c2 ¼ 7.7, p < 0.001) (Fig. 2).
Preoperative VGD (odds ratio [OR] ¼ 2.87, 95%
confidence interval [CI] 1.63-3.81; p < 0.001),
smoking (OR ¼ 1.83, 95% CI 1.39-3.20; p ¼ 0.02),
and type of bypass (OR ¼ 1.86, 95% CI 1.49-2.47;
p ¼ 0.02) were the only variables associated with
greater risk of requiring reintervention in order to
maintain graft patency (Table II).The difference in primary assisted patency rates
between grafts with preoperative VGD <3.5 mm
and grafts with preoperative VGD 3.5 mm did not
reach statistical significance (log rank ¼ 2.29, p ¼
0.13) (Fig. 3). In addition, there was no significant
difference in amputation rates between vein grafts
which were created using veins with a minimum
preoperative diameter <3.5 mm compared to those
with a minimum preoperative diameter 3.5 mm
(log rank ¼ 1.69, p ¼ 0.35) (Fig. 4). There was no
significant association betweenminimum preopera-
tive VGD and reduced primary assisted patency
(Table III) or higher amputation rates (Table IV).DISCUSSION
Autogenous vein grafts are the preferred conduits
for infrainguinal arterial reconstruction.2,3 In the
absence of autogenous vein, the use of prosthetic
grafts, while necessary, is associated with a higher
incidence of graft occlusion, which can lead to loss
of the affected limb.13 However, a commonly en-
countered problem is veins of a small diameter
identified during preoperative vein mapping, which
may be considered unsuitable for infrainguinal
arterial reconstruction. Previous authors have
reported that the incidence of small-caliber vein
during vein mapping is relatively high and, under
these circumstances, contralateral long saphenous
vein, short saphenous veins, or arm veins are sought
as conduits for infrainguinal vein graft bypass
surgery.14
The premier modality used for preoperative vein
mapping is B-mode Doppler ultrasound. Preopera-
tive measurements are oftenmade while the patient
Table II. Factors affecting reintervention rate
after infrainguinal bypass assessed using
multivariate logistic regression analysis
Variable OR (95% CI) p
Vein graft diameter 2.87 (1.63-3.81) <0.001
Diabetes 0.89 (0.71-1.05) 0.160
Renal failure 1.16 (0.85-1.30) 0.310
Smoking 1.83 (1.39-3.20) 0.022
Hyperlipidemia 1.39 (0.90-2.33) 0.113
Type of bypass 1.86 (1.49-2.47) 0.019
Table I. Demographics of patients with preoperative VGD <3.5 mm compared to those with VGD 3.5
mm
VGD <3.5 mm
(n ¼ 139)
VGD ‡3.5 mm
(n ¼ 238) Significance
Median age, years (range) 72 (39-95) 72 (44-89) p ¼ 0.85
Gender (M:F) 93:46 171:67 c2 ¼1.02, p ¼0.717*
Indication (claudication:rest pain:tissue loss) 9:81:49 31:115:84 c2 ¼8.4, p ¼0.010
Diabetes (%) 62 (44.9) 88 (37.0) c2 ¼2.24, p ¼0.130*
Smoker (%) 74 (53.6) 123 (51.7) c2 ¼0.13, p ¼0.776
Hyperlipidemia (%) 31 (22.3) 48 (20.2) c2 ¼0.24, p ¼0.623*
Renal failure (%) 13 (9.4) 20 (9.2) c2 ¼0.51, p ¼0.475*
Type of bypass (AK fem-pop:BK fem-pop:crural) 77:88:73 44:47:48 c2 ¼0.66, p ¼0.720
Hyperlipidemia was defined as high-density/low-density lipoprotein ratio >3.5 or fasting cholesterol level >5 mmol/L, and severe renal
failure was defined as estimated glomerular filtration rate <20 mL/min or on permanent renal replacement therapy.
AK, above-knee; BK, below-knee; fem-pop, femoropopliteal.
*Yates’ correction.
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Fig. 2. Comparison of the proportion of vein grafts re-
quiring reintervention to maintain graft patency, strati-
fied by the minimum preoperative internal diameter of
the vein graft.
20 Mofidi et al. Annals of Vascular Surgeryis in the standing position in order to increase its di-
ameter. However as these measurements are made
while the vein is in the low-pressure venous system,
they may not reflect the true distended diameter of
a vein after it is placed in the arterial system.11 Pre-
vious studies with in situ vein grafts have shown
that there is a significant increase in diameter of
the vein in the early postoperative scan.11 Interest-
ingly, the percentage increase in vein diameter
was more profound with small-diameter veins com-
pared to large-diameter veins.11
Fillinger et al.,15 investigating vein adaptation to
the hemodynamic environment of infrainguinal
grafts, reported that veins of small diameter re-
spond more to shear stress, resulting in a greaterincrease in size than veins with large diameter. In-
terestingly, large-diameter veins with a low initial
sheer stress showed a decrease in diameter over
time.15 However, a similar but competing process
of adaptation to arterial circulation is responsible
for neointimal hyperplasia, which can result in
the development of vein graft stenosis.16 Other
gross and histological features of vein graft, such
as reduced vein compliance, smooth muscle hyper-
plasia, and inflammatory infiltrates, have been
associated with the development of vein graft ste-
nosis.17-19 In addition, Westerband et al.20 reported
a close association between intimal and subintimal
angiogenesis and thickness of intima in human
stenotic vein grafts.
In this study the use of venous conduit with min-
imum preoperative diameter <3.5 mm was associ-
ated with satisfactory 40-month graft patency and
limb salvage rates.21,22 The use of veinwith a smaller
preoperative diameter meant that most (85%)
infrainguinal bypass procedures were performed
with uninterrupted long saphenous vein, consider-
ably reducing operative time as well as the need
for spliced grafts. The alternative to this approach
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Fig. 4. Kaplan-Meier plot of amputation rates over time
in patients who underwent infrainguinal vein graft by-
pass stratified by preoperative minimum internal diame-
ter of the vein graft.
Follow-up (months) 0 10 20 30 40 50
VGD 3.5 mm 238 217 148 96 57 34
VGD <3.5 mm 139 126 79 60 36 21
Table III. Factors affecting primary assisted
patency after infrainguinal bypass assessed using
Cox’s multivariate regression analysis
Variable OR (95% CI) p
Vein graft diameter 1.34 (0.94-2.55) 0.0901
Diabetes 2.40 (1.39-4.13) 0.0017
Renal failure 2.90 (1.65-5.10) 0.0002
Smoking 2.46 (1.49-4.06) 0.004
Hyperlipidemia 0.97 (0.44-2.16) 0.95
Type of bypass 0.85 (0.47-1.54) 0.2776
Table IV. Factors affecting amputation rates after
infrainguinal bypass assessed using Cox’s
multivariate regression analysis
Variable OR (95% CI) p
Vein graft diameter 1.33 (0.78-2.29) 0.295
Diabetes 2.81 (1.62-4.88) 0.002
Renal failure 3.93 (2.02-7.66) <0.001
Smoking 2.29 (1.29-4.05) 0.005
Hyperlipidemia 0.8339 (0.37-1.87) 0.659
Type of bypass 0.5876 (0.29-1.19) 0.138
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or short saphenous, cephalic, or basilic veins instead
of smaller-caliber uninterrupted long saphenous
veins. When following the latter strategy, the length
of conduit required often cannot be obtained bya single segment of vein, and two or more segments
have to be used. This raises concerns that such veno-
venostomy may be a site of intimal hyperplasia. De-
spite their complexity, patency rates achieved with
arm veins are similar to those achieved using unin-
terrupted long saphenous vein.23
A significant proportion of infrainguinal vein
graft bypasses develop graft stenosis, which
threatens graft patency.24 Varty et al.8 reported
that preoperative VGD is an independent risk factor
for development of vein graft stenosis. In this study
there was a significantly higher reintervention rate
for vein graft stenosis in bypasses which were
formed using small-caliber vein grafts. However, de-
spite the fact that VGD was an independent risk
factor for reintervention, there was no significant
difference in primary assisted patency or amputa-
tion rates between grafts created using vein with
a minimum preoperative diameter <3.5 mm and
those with a diameter 3.5 mm. This highlights
the added importance of vein graft surveillance
and timely repair of vein graft stenosis in this popu-
lation of patients.
Vein graft surveillance has been a controversial
topic. Although there is ample evidence that a signif-
icant proportion of vein grafts do develop stenosis
and that the natural history of vein graft stenosis is
graft occlusion,12-20 to date there has been no defin-
itive evidence to suggest that duplex surveillance is
22 Mofidi et al. Annals of Vascular Surgerysuperior to clinical follow-up in improving vein graft
patency or reducing amputation rates. Ihlberg
et al.25 studied 185 vein grafts, which were random-
ized to duplex or clinical follow-up. They did not
find any significant difference between the two
groups in graft patency or limb salvage at 1 year.
In a study of similar size, Lundell et al.26 reported
a significant improvement in graft patency in pa-
tients who had been recruited into duplex surveil-
lance after 3 years of follow-up. More recently, the
Vein Graft Surveillance Randomized Trial (VGST)
reported no significant improvement in outcome
following duplex surveillance of infrainguinal vein
grafts.27 All patients who were recruited into the
VGST underwent a duplex scan upon recruitment,
which was 6 weeks following the bypass procedure.
There is increasing evidence thatmany patients who
develop vein graft stenosis have significant evidence
of vein graft stenosis by 6 weeks.28,29 Conversely,
the outcome in vein grafts that do not have evidence
of vein graft stenosis in the early postoperative scan
is relatively good, and these patientsmay not benefit
from intensive surveillance.29 The natural history of
vein grafts which develop critical stenosis, especially
those occurring early, is graft failure, which is asso-
ciated with a high rate of limb loss.29
While VGD is one of the factors associated with
increased risk of vein graft stenosis, other factors,
such as continued smoking,30,31 serum fibrinogen
levels,31,32 and serum C-reactive protein levels,30,31
have been associated with the development of pro-
gressive neointimal hyperplasia and vein graft fail-
ure. In this study, in addition to VGD, continued
smoking and distal anastomosis of the bypass were
associated with increased incidence of vein graft ste-
nosis. In addition, history of diabetes, smoking, and
renal failure were associated with reduced graft pa-
tency and increased risk of amputation. While these
are not novel observations,30-35 they do serve as a re-
minder of the importance of risk factor modification
in the maintenance of graft patency and limb sal-
vage in patients who have undergone infrainguinal
vein graft bypass. Vein graft surveillance visits pro-
vide an ideal opportunity for secondary prevention
of atherosclerotic risk factors, which will have a di-
rect impact on graft patency and limb salvage rates.
The results from this study have shown that
small-caliber veins can be used safely for infraingui-
nal arterial reconstruction, albeit with a significantly
higher rate of reintervention in order to maintain
graft patency in comparison to larger-caliber veins.
Provided that these grafts are entered into a vein
graft surveillance program and repaired when
necessary, infrainguinal bypass using smaller vein
grafts is successful and expands the availabilityof autogenous conduit for infrainguinal arterial
reconstruction.
The authors acknowledge the significant contribution of the
vascular technologists Ms. Rosie Levison, Ms. Rose Ross, and
Mr. Scott Steedman, who performed the preoperative vein
mapping and vein graft surveillance scans.
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1078-5884/$34 ª 2008 Published by E
doi:10.1016/j.ejvs.2008.10.018Abstract Background: We sought to evaluate the role of balloon angioplasty as the primary
modality in the management of vein graft stenoses.
Methods: Patients who underwent infrainguinal vein graft bypass from January 2002 to
December 2007 were enrolled into a surveillance program. Grafts which developed critical
stenoses were identified and underwent urgent angiography with a view to angioplasty of
the stenotic lesion. Lesions which were deemed unsuitable for angioplasty underwent urgent
surgical repair.
Results: Four hundred and eleven grafts were followed up for a median of 19 months (range:
2e61). Ninety-six grafts (22.6%) developed critical stenosis. Twelve grafts occluded prior to
repair and one was not intervened upon electively. Eight grafts underwent primary surgical
repair. Seventy-six grafts underwent 99 endovascular procedures. Technical success was
achieved in 60 grafts (78.9%). Of the grafts in which technical success had not been achieved,
eight underwent repeat angioplasty and three were surgically repaired. Twenty-four grafts
underwent repeat angioplasty for re-stenosis with a technical success rate of 71%. No differ-
ence was observed in graft patency (PZ 0.08) or amputation rates (PZ 0.32) between the
grafts requiring intervention to maintain patency, and grafts which did not. Smoking [OR:
2.61 (95% CI: 1.51e4.53), (PZ 0.006)], diabetes [OR: 2.55 (95% CI: 1.49e4.35), (PZ 0.006)],
renal failure [OR: 1.89 (95% CI: 1.19e3.38), (PZ 0.040)] and recurrent stenosis [OR: 3.22
(95% CI: 1.63e4.69), (P< 0.001)] were risk factors for graft occlusion.
Conclusions: Balloon angioplasty of failing infrainguinal vein bypass grafts is safe and can be
performed with an acceptable medium term patency rate, albeit with a significant risk of
re-stenosis which can be successfully treated in most patients using repeat endovascular
intervention.
ª 2008 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.-14 Hawthornbank Lane, Edinburgh, EH4 3BH, United Kingdom.
et.uk (R. Mofidi).
Vascular Network.
lsevier Ltd on behalf of European Society for Vascular Surgery.
Angioplasty, the Treatment for Vein Graft Stenosis 199Introduction
Maintaining patency of infrainguinal vein bypass grafts has
been a challenging task for vascular surgeons for decades.1
These grafts are prone to the development of vein graft
stenosis, which may precipitate failure of the bypass.1e4
Features associated with the development of vein graft
stenosis are recognisable by duplex ultrasound scanning.5
Duplex scanning has been widely used for graft surveil-
lance, the rationale being that correction of stenotic
lesions is likely to improve graft patency and reduce the
risk of amputation.6e13 Considerable uncertainty still exists
about the optimal management of these threatened bypass
grafts once they are identified. Traditional operative
techniques such as patch angioplasty, interposition graft or
replacement graft remain the gold standard for the
management of vein graft stenosis. However these tech-
niques require the availability of an additional autogenous
vein and carry the risk of morbidity and mortality associ-
ated with re-operation. In addition, jump and interposition
grafts used to treat vein graft stenosis may by themselves
be at risk of development of vein graft stenosis.13 Increased
experience with the application of angioplasty in the
treatment of stenoses in other venous conduits such as
haemodialysis arterio-venous fistulae14,15 has led to the
introduction of this technique for the management of
threatened bypass grafts.16e20 However the efficacy of this
treatment modality has been questioned21 and to date no
consensus exists about its primary use in the management
of vein graft stenosis.
The aim of this study was to assess the efficacy and
safety of balloon angioplasty as the primary modality in the
management of vein graft stenoses, which are identified as
a result of duplex vein graft surveillance.
Methods
Consecutive patients, who underwent infrainguinal bypass
procedure using an autologous vein between 1st January
2002 and 31st December 2007 were studied. Infrainguinal
vein bypass grafts were performed with a variety of tech-
niques including reversed and in situ bypass grafts. The
ipsilateral long saphenous vein was the conduit of choice
for bypass. If this was found unsuitable the contralateral
long saphenous vein was used. Short saphenous and arm
veins were used in patients who had previous harvesting of
the long saphenous vein or in whom the long saphenous vein
had been found to be unusable.
Thereafter all patients were enrolled in a graft surveil-
lance program. This involved duplex scanning and the
measurement of ankle brachial index pressures before
discharge from the hospital and at 6 weeks, 3 months, 6
months, 1 year and 2 years after operation. Duplex exam-
ination was performed by two experienced vascular tech-
nologists using an Acuson Sequoia duplex ultrasound system
(Acuson, Redwood, California, USA) using a 5 MHz linear
transducer. The duplex scanning protocol during vein graft
surveillance included the assessment of inflow and outflow
vessels for quality of flow based on velocity, waveforms and
colour flow characteristics. Peak systolic velocity was
measured at the sites of stenosis, at multiple sites withinthe graft and within the outflow vessel. The velocity ratio
at the site of stenotic lesions was calculated. Any bypass
grafts with sub critical flow abnormalities found on duplex
scanning were studied more frequently at 3-month inter-
vals, whilst all grafts with critical vein graft stenosis were
referred for urgent angiography with a view to primary
endovascular treatment. Table 1 shows the duplex param-
eters used to classify vein graft stenosis and indications for
treatment.
Antegrade ipsilateral puncture was the preferred
angiographic technique. Mixtures of standard and cutting
balloon techniques were used. The size and the type of
balloon (cutting versus standard balloon) used for angio-
plasty were based on the angiographic appearance and the
site of the stenotic lesion within the vein graft. All inter-
ventions were evaluated with completion angiograms.
Technical success was defined as a less than 20% stenosis
remaining on completion angiogram (in keeping with the
PTA guideline of the Society of Cardiovascular and Inter-
ventional Radiology).22 Vascular laboratory evaluations,
including duplex scans, ankle brachial indices, were
obtained prior to discharge. Thereafter all patients re-
entered the surveillance programme at the starting point.
Patients with an unsuccessful endovascular procedure were
admitted for urgent surgical correction of vein graft
stenosis whilst those with residual stenosis were studied
more frequently: at 2 weeks, 6 weeks and then, at 3-month
intervals. This process was repeated for all patients who
developed recurrent vein graft stenosis. Postoperative
hypercholestrolemia was defined as the total cholesterol to
high density lipoprotein cholesterol (total cholesterol/HDL)
ratio of greater than 3.5. Renal failure was defined as the
Kidney Dialysis Outcomes Quality Initiative (KDOQI) chronic
kidney disease (CKD)23 stage 4 or 5 at the time of infrain-
guinal bypass surgery.
Patient demographics, type of operation, conduit and
follow up information were recorded in a computerized
database (Microsoft Access and Excel, Redmond,
Washington, USA). Data analysis was performed retrospec-
tively. Results were analysed and reported in accordance
with the reporting standards of the Society for Vascular
Surgery and the North American Chapter of the Interna-
tional Society for Cardiovascular Surgery.24 Statistical
analysis was performed using Statistical Package for Social
Sciences version 12 SPSS (SPSS, Chicago, Illinois, USA)
statistical software. Patency and limb salvage were deter-
mined using KaplaneMeier analysis. The difference in
primary assisted patency and amputation rates between
patients who underwent angiography with a view to inter-
vention for vein graft stenosis and patients who did not
develop vein graft stenosis was assessed using the log rank
test. P< 0.05 was considered significant.Results
The initial patient group of 389 patients comprised 263 men
(67.6%) and 126 women (32.4%) who underwent 411 bypass
procedures. These grafts were followed up for a median of
19 months (range: 2e61). The median (range) age of the
patients was 72 years (range: 38e87); 219 (56.3%) were
current smokers, 168 (43.2%) had diabetes and 35 (9%) had
Table 1 The velocity criteria identifying different categories of vein graft stenosis identified through duplex surveillance
(PSV: peak systolic velocity (cm/s), ABPI: ankle brachial pressure index)
PSV at the site of stenosis Post stenotic PSV Drop in ABPI
Absolute value PSV ratio
Critical stenosis (urgent treatment) >300 3.5 <40 >0.15
Mild flow disturbance (intensive surveillance) 200e300 2 >45 <0.15
Low risk grafts (standard surveillance) <200 <2 >45 <0.15
Follow up (months) 0 10 20 30 40
Grafts requiring no intervention 272 206 160 85 49
Grafts requiring intervention to
maintain patency
96 75 49 33 18
60
200 R. Mofidi et al.chronic renal failure. Three hundred and three patients
(77.9%) were on statin therapy. Ninety-eight patients (25%)
had hypercholestrolemia on follow up [median post-
operative TC/HDL ratio: 3.1 (range: 0.8e4.3)]. The indi-
cations for surgery are shown in Table 2. Three hundred and
fifty six bypasses were reversed vein grafts and 55 were in
situ vein graft bypasses. Three hundred and fifty five
bypasses (86.6%) had their origin at the femoral artery in
the groin, 16 from the external iliac artery (3.9%) and 40
bypasses (9.7%) had their proximal anastomosis from the
superficial femoral artery. The distal anastomoses were to
the above knee popliteal (132, 34%), the below knee
popliteal (148, 35%), and the tibial arteries (131, 31%).
During the follow up period, 272 grafts did not develop
significant vein graft stenosis and therefore did not require
intervention in order to maintain graft patency, whilst 96
grafts (22.6%) developed critical vein graft stenosis. A
further 43 grafts (10.4%) occluded prior to the early post-
operative (6 week) follow up scan The distribution of these
stenoses along the length of the vein graft is shown in
Fig. 1. Of these 12 grafts occluded prior to angiography and
another graft occluded following diagnostic angiography,
which revealed that the stenotic lesion identified, was not
amenable to angioplasty. One graft was found to be
stenotic for a significant proportion of its length and was
electively not intervened upon. Eight grafts underwent
open repair after diagnostic angiography, which identified
lesions not amenable to angioplasty. This was due to
inability to traverse the stenosis angiographically in three
cases, an unfavourable proximal anastomotic lesion in two
cases and external compression in a further three.
Seventy-six grafts underwent a total of 99 endovascular
procedures (Figs. 2 and 3). Median age of the grafts at the
time of the first angioplasty was 5 months (range: 7 weekse
27 months). Forty-one primary angioplasties were per-
formed with a standard balloon and 34 with a cutting
balloon. Initial technical success was achieved in 60 graftsTable 2 Indication for infrainguinal vein graft bypass in
the study population
Indication Number (%)
Intermittent claudication 39 9.5
Critical ischaemia 340 82.7
Popliteal artery
aneurysm (asymptomatic)
18 4.4
Popliteal artery
aneurysm (symptomatic)
14 3.4
Total 411 100(78.9%). Of the grafts in which initial technical success had
not been achieved, eight underwent repeat angioplasty
with good technical success and another graft was found to
have thrombosed the next day. This graft was successfully
managed with local catheter thrombolysis with good
results. Three grafts occluded prior to attempted surgical
repair and another four grafts were surgically repaired. A
total of 27 grafts (45%) developed re-stenosis of which 24
underwent a repeat attempt at angioplasty, with technical
success in 17 grafts (71%). Repeat angioplasties were per-
formed with cutting balloons. Of the grafts that had
developed re-stenosis three occluded prior to the repeat
attempt at angioplasty and a further patient was deemed
too unfit to undergo further intervention. There was no
peri-procedural mortality. Vein graft angioplasty was asso-
ciated with two puncture site haematomas both of which
were treated conservatively; in addition one patient who
had undergone cutting balloon angioplasty developed
a delayed retroperitoneal hemorrhage from a contralateral
puncture site which was managed by open surgery.Overall 30-month primary patency, primary assisted
patency and secondary patency rates were 73.2%, 82.6%
and 84.3%, respectively. No significant difference was
observed in graft patency (log rankZ 1.83, PZ 0.08) or
amputation rates (log rankZ 0.89, PZ 0.32) between the0
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Figure 1 Distribution of duplex scan-detected stenoses
identified during the surveillance program.
Figure 2 Digital subtraction angiograms of a common femoral to below knee popliteal artery bypass graft. The left image shows
a proximal graft stenosis (arrowhead), whilst the right image shows the final result after cutting balloon PTA with a 4.0-mm
diameter balloon.
Angioplasty, the Treatment for Vein Graft Stenosis 201grafts requiring intervention to maintain patency and grafts
which did not (Figs. 4 and 5). Smoking [odds ratio: 2.61 (95%
CI: 1.51e4.53), (PZ 0.006)], diabetes [odds ratio: 2.55
(95% CI: 1.49e4.35), (PZ 0.006)] and persistent hyperlip-
idemia [odds ratio: 1.89 (95% CI: 1.19e3.38), (PZ 0.04)]Figure 3 Digital subtraction angiograms of a common
femoral to above knee popliteal artery bypass graft. The left
image shows two distal anastomotic graft stenoses (arrow-
head), whilst the right image shows the final result after
cutting balloon PTA with a 3.0-mm diameter balloon.were associated with reduced graft patency whilst the need
for intervention in order to maintain graft patency was not
[odds ratio: 1.41 (95% CI: 0.79e2.60), (PZ 0.180)].
However recurrent graft stenosis was an independent risk
factor for vein graft failure [odds ratio: 3.22 (95% CI: 1.63e
4.69), (P< 0.001)] (Table 3). Similarly, continued smoking
[odds ratio: 4.03 (95% CI: 2.07e7.84), (P< 0.0001)], dia-
betes [odds ratio: 2.86 (95% CI: 1.65e4.97), (PZ 0.0002)]
and persistent hyperlipidemia [odds ratio: 2.49 (95% CI:
1.39e4.47), (PZ 0.021)] were associated with an increased
risk of amputation, whereas the need for intervention in
order to maintain graft patency was not [odds ratio: 1.24
(95% CI: 0.68e1.91), (PZ 0.32)]. Recurrent vein graft
stenosis was a risk factor for amputation of the ipsilateral
limb [odds ratio: 2.51 (95% CI: 1.41e4.32), (PZ 0.002)]
(Table 4).Follow up (months) 0 10 20 30 40
Grafts requiring no intervention 272 206 160 85 49
Grafts requiring intervention to
maintain patency
96 75 49 33 18In addition vein graft surveillance identified two pseudo-
aneurysms associated with the proximal anastomosis, which
were successfully treated with jump graft repair and three
grafts with threatened inflow, which were treated with
balloon angioplasty with successful technical results.
Discussion
The optimal treatment of a threatened vein graft bypass
has been a source of debate for several decades. The
controversy remains about the definition of a threatened
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Figure 4 KaplaneMeier plots of primary assisted patency over time in grafts which did not require intervention (black),
compared with grafts which developed a significant stenotic lesion and underwent angiography with a view to endovascular
intervention (PZ 0.08).
202 R. Mofidi et al.infrainguinal vein bypass graft and also the clinical signifi-
cance of the stenotic lesions once they are identified
through duplex vein graft surveillance.7 The authors offer
graft surveillance to all patients who have undergone
infrainguinal vein graft bypass procedures and this study
relates to the efficacy of angioplasty for the management
of these lesions rather than a discussion regarding the
efficacy of duplex vein graft surveillance.
Surgical revision of failing infrainguinal vein grafts has
been the gold standard in the management of vein graft
stenosis. Techniques of vein patch angioplasty for short
stenoses and interposition or jump graft repair for longer
lesions have been associated with excellent medium25 and
long term patency rates.26 Repair of critical vein graft
stenosis has been shown to return patency and amputation
rates of the affected vein grafts to levels approaching that
of vein grafts with no significant stenosis.13 On the other
hand surgical repair of vein graft stenosis is an invasive
procedure requiring general or regional anaesthesia in
a population of patients with significant co-morbidity. It is
also partly dependent on the availability of an appropriate
length of an additional venous conduit. In addition revised
vein grafts are themselves at risk of development of vein
graft stenosis.13,26e28 Therefore percutaneous transluminal
angioplasty, if successful, is an attractive option for the
management of vein graft stenosis.
Some years ago Berkowitz et al. reported on the results
of selective use of angioplasty for the management of vein
graft stenosis. They performed angioplasty as the primary
treatment modality in 81% of failing infrainguinal reversed
vein grafts.28 The rest were repaired by short jump grafts.They reported a 5-year primary assisted patency rate of
61%. Lesions in the proximal graft, proximal anastomosis,
and distal graft taken as a group had significantly better
patency than the mid-graft and distal anastomotic
lesions.28 Subsequent authors have reported similar results
following vein graft angioplasty.29e32 Alexander et al.
reported a significantly lower primary assisted patency
after percutaneous transluminal angioplasty (PTA) for the
treatment of vein graft stenosis, with failure rates of 31% at
6 months, 55% at 1 year, and 63% at 2 years.21 The main
reason for failure of PTA in their series was the develop-
ment of recurrent vein graft stenosis.
In this study a significant proportion of grafts, which had
undergone angioplasty with a satisfactory technical result,
developed re-stenosis, requiring secondary procedures. In
the majority of patients the secondary procedure was
endovascular with a technical success rate approaching
that of angioplasty for primary vein graft stenosis. Carlson
et al. reported their experience of PTA of infrainguinal vein
graft stenoses in 36 patients. Their initial technical success
rate was 91% and overall graft patency rate was 78% at 24
months.31 However, nine bypasses (25%) required further
attempts at angioplasty for recurrent vein graft stenosis
and seven grafts required secondary procedures.31 This
high-lights the importance of continued graft surveillance
and maintenance intervention in patients in whom
successful endovascular repair of vein graft stenosis has
been achieved. After successful treatment of vein graft
stenosis our practice was to re-enter the graft at the starting
point of vein graft surveillance. This resulted in most
re-stenoses being identified and treated in a timely manner.
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Figure 5 KaplaneMeier plots of amputation rates over time in grafts which did not require intervention (black), compared with
grafts which developed a significant stenotic lesion and underwent angiography with a view to endovascular intervention
(PZ 0.32).
Angioplasty, the Treatment for Vein Graft Stenosis 203A number of authors have reported that, notwith-
standing the higher re-stenosis rates and the need for
re-intervention, the results of endovascular treatment for
vein graft stenosis are equivalent to open surgical
repair.18,32,33 Although most of these observations were
performed in small studies with heterogenous patient
groups which were not randomized, they were potentially
subject to type II error. Avino et al. reviewed a series of
144 infrainguinal vein graft stenoses from a population of
528 grafts, which were under surveillance over a period
of 6 years.26 Seventy-seven of the failing grafts were
treated with open surgical repair and 67 were treated
using PTA. They reported similar stenosis free patency
rates of 63% for both groups26 and no significantTable 3 Factors affecting primary assisted patency after
infrainguinal bypass assessed using Cox’s multivariate
regression analysis
Variable Hazard ratio (95% CI) Significance (P)
Age 1.03 (0.62e1.36) 0.85
Gender 0.98 (0.71e1.10) 0.61
Diabetes 2.55 (1.49e4.35) 0.006
Smoking 2.6133 (1.51e4.53) 0.006
Renal failure 0.80 (0.36e1.80) 0.592
Hyperlipidemia 1.89 (1.19e3.38) 0.040
Intervention to
maintain graft
patency
1.41 (0.79e2.60) 0.18
Recurrent stenosis 3.22 (1.63e4.69) <0.001difference in patency rates between interventions for
primary versus recurrent vein graft stenoses or between
infra-genicular and supra-genicular bypasses.26 However
this has not been a universal observation; Berceli et al.
reported that open surgical revascularization imparts an
improved graft survival over endovascular interventions.
They also observed no significant difference in the
hospital length of stay or global quality of life between
the two groups.34 One might postulate these outcomes
would be potential benefits of endovascular interven-
tion.34 In this study renal failure was a risk factor for vein
graft failure.
The use of cutting balloon angioplasty is a relatively new
development for the management of vein graft stenosis.Table 4 Factors affecting amputation rates after
infrainguinal bypass assessed using Cox’s multivariate
regression analysis
Variable Hazard ratio (95% CI) Significance (P)
Age 1.12 (0.41e1.53) 0.41
Gender 0.86 (0.51e1.21) 0.52
Diabetes 2.8618 (1.65e4.97) 0.002
Smoking 4.03 (2.07e7.84) <0.001
Renal failure 0.93 (0.42e2.057) 0.852
Hyperlipidemia 2.49 (1.39e4.47) 0.021
Intervention to
maintain graft
patency
1.24 (0.68e1.91) 0.310
Recurrent stenosis 2.51 (1.41e4.32) 0.002
204 R. Mofidi et al.Engelke et al. reviewed their preliminary experience in the
use of cutting balloon PTA for the treatment of infraingui-
nal vein graft stenosis.20 They reported 18-month primary
assisted and secondary patency rates of 67% and 83%
respectively. A larger study by Garvin et al. appears to
confirm that cutting balloon angioplasty is associated with
a high technical success rate but they reported relatively
low term patency and higher complication rates. They
therefore cautioned against its widespread use for the
treatment of vein graft stenosis.35
In this study in 16 grafts (20.6%) at the time of initial
attempt at angioplasty satisfactory technical success was
not achieved. These grafts are at a significant risk of early
graft occlusion. Therefore consideration should be given to
immediate or early surgical or endovascular re-interven-
tion. Our practice was to perform duplex reassessment of
the stenotic lesion following the angioplasty attempt.
Grafts, which had a persistent severe stenosis, underwent
urgent surgical repair. Whilst grafts with intermediate
residual stenosis underwent early duplex follow up with
a repeat attempt at angioplasty if clinically indicated.
Experience with other arterialized venous conduits suggests
that immediate attempts at repeat angioplasty of venous
conduits with cutting balloons are associated with a risk of
graft rupture.36e38
Multivariate analysis offers some interesting insight into
the factors that may influence outcomes after endovascular
intervention. Not unexpectedly, smoking and diabetes were
significant risk factors for graft occlusion and amputation.
In addition hypercholestrolemia during follow up was
associated with increased risk of graft occlusion and
amputation. The authors used this as a surrogate marker of
compliance with statin therapy. Berceli et al. reported that
statin therapy was associated with improved graft dura-
bility after both endovascular and surgical revision. In
addition they found that the diagnosis of hypertension was
also associated with improved primary assisted patency
following open and endovascular intervention for vein graft
stenosis. They postulated that the reason for the latter
observation may have been related to the treatment the
patients were receiving for hypertension such as angio-
tensin converting enzyme (ACE) inhibitors or calcium
channel blockers.34 Chronic renal failure is a recognised risk
factor for vein graft failure; a recent publication by Arvela
et al. reports that the estimated glomerular filtration rate
predicts the predictor of survival, leg salvage and ampu-
tation free survival in patients with critical lower limb
ischaemia.39
Critical vein graft stenosis is a complex clinical problem.
Provided that grafts are surveyed closely, primary endo-
vascular treatment of failing infrainguinal vein grafts
appears to be safe and is associated with acceptable early
and medium term patency rates.
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Infrainguinal Vein Graft SurveillanceOlivia M.B. McBride,1 Reza Mofidi,2 Gareth D. Griffiths,2 A. Raymond Dawson,1
Roderick T.A. Chalmers,1 and Peter A. Stonebridge,2 Edinburgh and Dundee, United KingdomBackground: Duplex ultrasound (DU) remains the gold standard for identification and grading
of infrainguinal vein graft stenosis. However, DU-based graft surveillance remains controversial.
The aim of this study was to develop a decision tree to identify high-risk grafts which would
benefit from DU-based surveillance.
Methods: Consecutive patients undergoing infrainguinal vein graft bypass were enrolled in a
DU surveillance program. An early postoperative DU was performed at a median of 6 weeks
(range 4e9). Based on the findings of this scan and 4 established risk factors for graft failure
(diabetes, smoking, infragenicular distal anastomosis, revision bypass surgery), a classification
and regression tree (CART) was created to stratify grafts into grafts which are at high and low
risk of developing severe stenosis or occlusion. The accuracy of the CART model was evaluated
using area under receiver operator characteristic curve (ROC).
Results: Of 796 vein graft bypasses performed (760 patients), 64 grafts were occluded by the
first surveillance visit and 732 vein grafts were entered into surveillance program. The CART
model stratified 299 grafts (40.8%) as low-risk and 433 (59.2%) as high-risk grafts. One hundred
twenty-six (17.2%) developed critical vein graft stenosis. Overall, 30-month primary patency,
primary-assisted and secondary patency rates were 76.2%, 83.6%, and 85.3%, respectively.
The area under ROC curve for the CART model was 0.88 (95% confidence interval 0.81e
0.94). Primary graft patency rates were higher in low-risk versus high-risk grafts (log rank
186, P < 0.0001). Amputation rates were significantly higher in the high-risk grafts compared
with low-risk ones (log rank 118, P < 0.0001).
Conclusion: A clinical decision rule based on readily available clinical data and the findings of
significant flow abnormalities on an early postoperative DU scan successfully identifies grafts at
high risk of failure and will contribute to safely improving the efficacy of infrainguinal vein graft
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Infrainguinal bypass using autologous vein is an
established treatment for critical lower limb
ischemia and disabling intermittent claudication.1
Despite advances in surgical technique and im-
provements in preventative medical therapy for
atherosclerosis, these grafts are prone to developing
stenoses, which may precipitate failure of the
bypass.2e6 Over the past 30 years, little has changed,
with 25e40% of infrainguinal bypasses demon-
strating a significant flow disturbance within the
graft by 6 weeks after operation and these are often
asymptomatic.3,7e9
Volume 36, October 2016 Decision tree for infrainguinal vein graft surveillance 183Recognition of risk factors for vein graft failure is
essential for risk-factor modification and identi-
fying individuals who would benefit from more
intensive surveillance protocols. It is evident that
graft failure is multifactorial and factors are often
viewed along temporal lines with respect to the
postoperative period; the early failures are largely
attributable to technical issues and operative tech-
nique and this group present acutely requiring
intervention. In the early to intermediate postoper-
ative period vascular remodeling occurs leading to
the development of myointimal hyperplasia and
late graft failure is commonly attributed to progres-
sion of atherosclerosis.10 The contribution of
patient-related factors to graft failure is complex.
There is no doubt that smoking plays a significant
role and that diabetes and renal failure are associ-
ated with increased mortality and amputation
rates.11e15
Evidence of most of these abnormalities are
recognizable by duplex ultrasound scanning, a mo-
dality acknowledged for its accuracy in identifying
and grading stenotic lesions that threaten graft
patency.9 In addition to clinical examination and
measurement of ankle brachial pressure index
(ABPI), duplex ultrasound scanning has been
widely used for graft surveillance. The aim of this
is to identify grafts at risk of failure, as intervention
in a patent but failing graft results in improved long-
term patency and limb salvage rates compared with
rescue of an occluded graft.16e19
Surveillance programs are resource intensive and
put a considerable strain on the workload of a
vascular unit. The necessity of repetitive testing
over long periods of time is expensive and time
consuming. In the modern climate of increasing
cost-awareness, these observations highlight the
need for an improvement in the rationalization of
vein graft surveillance.
Recursive partitioning is a multivariable analysis
model; it creates a decision tree, which strives to
correctly classify members of the population based
on several dichotomous variables.20 Decision (Clas-
sification) trees are often used as a clinical decision
support tool, where theymap clinical and therapeu-
tic decisions and the consequences of these decisions
in a graph or tree-like manner, from which a thera-
peutic algorithm can be created. Such a model is
ideally suited to the problem of identifying grafts
that are at the highest risk of developing graft steno-
sis and failure.
The aim of this study was to create and validate a
simple clinical decision support tool to stratify vein
grafts into the appropriate surveillance program,
based on the level of risk.MATERIALS AND METHODS
Consecutive patients who underwent infrainguinal
bypass procedures using autologous conduit in 2 ter-
tiary vascular surgical units in the United Kingdom
for 5 years were enrolled into vein graft surveillance
programs.21 Approval to develop the database was
granted by the Caldicott Guardian in both centers.
Infrainguinal vein bypass grafts were performed
with a variety of techniques including reversed and
in situ bypass grafts, with the ipsilateral long saphe-
nous vein being the conduit of choice. If unsuitable,
the contralateral long saphenous vein was used, fol-
lowed by the short saphenous and arm veins, if
required. Patientswere then enrolled into a vein graft
surveillance program, with each visit involving
duplex ultrasound and the measurement of ABPI.
Based on the duplex ultrasound result, we used a
modification of Rutherford’s recommendations to
the Society of Vascular Surgery to classify grafts
into mild, moderate, or critical stenosis and grafts
that were occluded (Table I). The frequency of sur-
veillance visits (6 weeks, 3, 6, 9, 12, 18, 24 months),
duplex ultrasound scanning protocol, and criteria for
intervention were similar in both vascular surgical
units. Data from these 2 units were used to develop
a decision tree model to identify vein grafts at high
risk of developing stenosis or occlusion.
Patient demographics, type of operation, conduit,
and follow-up information were recorded in a
computerized database (Microsoft Excel, Seattle,
WA). Data analysis was performed retrospectively.
Results were analyzed and reported in accordance
with the reporting standards of the Society for
Vascular Surgery and the North American Chapter
of the International Society for Cardiovascular
Surgery.22Study End PointsThe primary end point for the study was develop-
ment of severe vein graft stenosis or graft occlusion
during postoperative follow-up, while risk of ampu-
tation was the secondary end point of the study.
Cox regression analysis was used in parallel to the
decision tree analysis to identify potential factors
associated with infrainguinal vein bypass graft fail-
ure, using Statistical Package for Social Sciences
version 12 (SPSS, Chicago, IL) software. Patency
and limb loss rates were determined using
KaplaneMeier analysis.Decision Tree AnalysisA Classification and Regression Tree Model (CART)
was used to identify patients who are likely to
Table I. Duplex ultrasound classificationdmodified
from recommendations by Rutherford et al. 1997,
Society of Vascular Surgery22
PSV at the site of stenosis
Poststenotic
PSV ratio
Drop in
ABPI
Absolute
value (cm/sec)
PSV
ratio
Mild stenosis <200 <2 >0.5 <0.15
Moderate
stenosis
200e300 2e3 0.5e0.4 <0.15
Critical
stenosis
>300 >3 <0.4 >0.15
Occluded N/A
Poststenotic PSV of blood flow in the graft downstream from the
stenotic lesion.
N/A, not applicable; PSV, peak systolic velocity; ABPI, ankle
brachial pressure index.
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Fig. 1. Distribution of duplex scanned stenoses and flow-
related abnormalities along the length of the graft.
184 McBride et al. Annals of Vascular Surgerydevelop significant vein graft stenosis or occlusion
(within 2 years of duplex ultrasound follow-up),
with the aim of identifying patients who would
benefit from more intensive duplex ultrasound-
based follow-up. The variables used were clinical
and duplex ultrasound findings, which were avail-
able at the time of the first postoperative assessment.
The Gini coefficient was used to assess heterogene-
ity in the distribution of patients from the parent
node to children nodes. The Gini coefficient is zero
when all observations at a node belong to one level
of a dependent variable and is 0.5 when observa-
tions are equally distributed in various levels of a
dependent variable. The best split on a variable
will be the one that minimizes the Gini coefficient.
This process continues until a termination criterion
is met.
The level of significance of each variable will be
adjusted by Bonferroni’s correction, where the deci-
sion tree is first fitted to the data, with themost com-
plex topography and the greatest number of nodes
and hence accuracy. Prediction at each node is
made based on the weight of observations in each
category of the dependent variable and misclassifi-
cation cost. The CART then undergoes a process of
pruning, during which the terminal nodes will be
deleted only if its elimination causes a misclassifica-
tion cost which is significantly lower than the reduc-
tion in complexity. This process continues to reach
the root node. The optimal CART is selected as the
final predictive model. The optimal CART selected
was one that prioritized sensitivity over specificity,
as its purpose was to relate the decision or an attri-
bute to its consequences while maintaining the
simplest topography.20
The aim of themodel was to repeatedly divide pa-
tients into subgroups, each of which consisted ofpatients with or without severe vein graft stenosis
or occlusion thereby stratifying patients into high-
risk groups who should undergo duplex
ultrasound-based surveillance and low-risk groups
who do not require such intensive follow-up. The
CART model was then used to describe the possible
pathways of different cohorts during the first 2 years
of vein graft surveillance.RESULTS
There were 796 infrainguinal vein graft bypasses
performed in 760 patients, of whom 501 (66%)
weremen and 259 (34%)were women. Themedian
age of the patientswas 72 years (range 37e92 years).
Three hundred sixty-seven patients (48.2%) were
current smokers, 308 (42.9%) had diabetes, and
67 (8.8%) had chronic renal failure.
Critical limb ischemia was the primary indication
for surgery (n ¼ 619, 77.7%), with the remaining
patients undergoing infrainguinal bypass proce-
dures for intermittent claudication (n ¼ 124,
15.7%) or popliteal artery aneurysms (n ¼ 53,
6.7%). In 21 patients the indication was short dis-
tance claudication with occasional rest pain but no
tissue loss. Six hundred ninety-six grafts (87.4%)
had their origin at the femoral artery in the groin,
25 (3.1%) had their origin at the external iliac ar-
tery, and 54 (6.8%) had the proximal anastomosis
from the superficial femoral artery. The distal anas-
tomoses were to the above-knee popliteal in 275 by-
passes (34.5%), below-knee popliteal in 313
(39.3%), and crural arteries in 208 (26.1%). Seven
hundred thirty-three bypasses (92.1%) were
reversed vein grafts and 63 (7.9%) were in situ
vein graft bypasses.
We utilized uninterrupted ipsilateral or contralat-
eral long saphenous vein as the venous conduit in
729 bypasses (91.5%). In 34 bypasses (4.3%),
Fig. 2. Decision tree based on patient profile and first
postoperative graft surveillance assessments. The table
outlines the Gini coefficient* and the accuracy of predic-
tion** for each node. The Gini coefficient* relates the
performance of the node in portioning the patients based
on the eventual outcome. The accuracy of prediction** is
the accuracy of predicting the eventual outcome based
on a single node.
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while in 22 (2.8%), short saphenous venous
conduit was used; in 11 patients (1.4%) upper
limb veins were used to perform the bypass
procedure.
The first postoperative vein graft surveillance
scan was performed at a median of 6 weeks (range
4e9 weeks). By the time of this scan, 64 grafts had
occluded and were excluded from further study,
leaving 732 vein grafts, which were entered into a
surveillance program.
Figure 1 illustrates the distribution of critical,
moderate, and mild stenosis within the bypass
grafts. Two-thirds of critical stenosis occurred in
the proximal third of the graft. The CART model
stratified 299 grafts (40.8%) as low-risk and 433
(59.2%) as high-risk grafts (Fig. 2).During the vein graft surveillance period, 279
(35.1%) grafts developed a significant flow distur-
bance (moderate or critical), of which 126 (45.2%)
were classified as critical vein graft stenosis. The ma-
jority of all significant flow disturbances, 249
(89.2%), were present in the first follow-up scan.
Ninety-nine (78.6%) grafts with a critical stenosis
were intervened upon, using open surgical tech-
niques in 23 grafts and endovascular intervention
in 76. A further 27 grafts were not intervened
upon or occluded before scheduled intervention.
Overall, 30-month primary patency, primary-
assisted patency, and secondary patency rates were
76.2%, 83.6%, and 85.3%, respectively (excluding
the 64 grafts that occluded before the first clinic
visit). The results of Cox regression analysis of po-
tential risk factors associated with infrainguinal
Table II. Cox regression analysis of potential
factors associated with infrainguinal vein graft
bypass graft revision
Variable Hazard ratio (95% CI)
Significance
(P value)
Age 1.03 (0.62e1.36) 0.81
Gender 0.98 (0.71e1.10) 0.72
Critical ischemia 1.41 (0.79e2.60) 0.18
Diabetes 2.86 (1.65e4.97) 0.002
Smoking (within
3 months of bypass)
2.613 (1.51e4.53) 0.006
Previous failed
ipsilateral bypass
2.51 (1.41e4.32) 0.008
Nonreversed or in situ
saphenous vein
0.87 (0.51e1.21) 0.52
Nonsingle segment
saphenous vein
0.79 (0.36e1.80) 0.63
Infragenicular distal
anastomosis
2.40 (1.31e4.47) 0.01
Renal failure 0.80 (0.36e1.80) 0.6
Significant flow
abnormalities on
early postoperative
duplex ultrasound
scan
3.22 (1.63e4.69) <0.001
Fig. 3. The receiver operator characteristic curve for the
decision tree.
186 McBride et al. Annals of Vascular Surgeryvein graft bypass graft stenosis or occlusion are
shown in Table II.Decision Tree AnalysisSeven hundred thirty-six patients were classified
through 5 items into 10 different categories with
2-year stenosis or occlusion rates ranging from 5%
to 95%.
Figure 2 illustrates the final topography of the de-
cision tree and the proportion of patients assigned to
each group. The receiver operator characteristic
(ROC) curve for the decision tree is shown in
Figure 3. The model was able to stratify high-risk
grafts that were at risk from significant vein graft ste-
nosis or occlusion with good accuracy. Area under
the ROC curve for prediction of graft stenosis or oc-
clusion was 0.88 (95% confidence Interval [CI]
0.81e0.94), and the sensitivity of the decision tree
for prediction of graft stenosis or occlusion was
92% (95%CI 89e93). The specificity of the decision
tree for prediction of graft stenosis or occlusion was
75% (95% CI 69e82).
The decision tree has a negative predictive value
of 97%, reassuring clinicians that patients catego-
rized as low risk have a low incidence of graft failure
and limb loss following the early postoperative
duplex ultrasound scan and review.Figure 4 illustrates the KaplaneMeier survival
curves for primary graft patency and amputation
rates for grafts that have been classified as high
and low risk based on the model. They show that
grafts classified as high risk had significantly lower
primary patency rate (log rank 186, P < 0.001)
and were associated with higher risk of amputation
(log rank 118, P < 0.001) during follow-up.DISCUSSION
The surveillance of infrainguinal vein bypass grafts
remains a controversial issue. A significant propor-
tion of these grafts will develop graft-threatening
stenosis during the course of the first postoperative
year.6,17,23e26 If left untreated these stenoses are
associated with a 3 to 6-fold increase in graft occlu-
sion.4,17,27,28 The outcome for an occluded graft is
bleak, with secondary patency rates significantly
reduced compared with revision of a patent but
failing graft.19,29 This, together with the good out-
comes achieved following corrective intervention
for graft stenosis, lends support for a process of active
identification of failing vein grafts to improve the
long-term patency and limb salvage rates for
infrainguinal bypass surgery.17,23,30e32 This is in
contrast to prosthetic grafts where duplex
ultrasound-based surveillance is poor at detecting
lesions before occlusion.32
Duplex ultrasound-based surveillance of infrain-
guinal vein grafts has been widely used to identify
grafts at risk of failure. This is despite the fact that
the largest randomized controlled trial (Vein Graft
Surveillance Trial [VGST]) on the subject revealed
no significant improvement in limb salvage or
quality-of-life in patients who had undergone
Fig. 4. (A) Kaplan-Meier survival curve showing the
primary patency rate in the grafts that have been selected
to be high risk versus low risk by the decision tree. (B)
KaplaneMeier survival curve showing amputation rates
in the grafts that have been selected to be high risk versus
low risk by the decision tree.
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compared with clinical follow-up.16 In VGST, pa-
tients were randomized following the first postoper-
ative review which was conducted 4e12 weeks
postoperatively. This early postoperative review
involved a duplex ultrasound scan for both study
and control populations, to assess graft patency
before enrollment into the VGST trial.
We have previously demonstrated that the 6-
week scan is essential in identifying grafts at risk of
failure, with 33% of grafts displaying a significant
flow abnormality at this time. This finding has
been reinforced by a number of studies, reporting
incidence of vein graft stenosis up to 40%, within
the early postoperative period.7,8,33 As well as indi-
cating an early threat to patency, detection of abnor-
malities early in the life of the vein graft predict the
natural history of that graft and the outlook for the
limb in the medium and longer term. In this study,
the vast majority (89.2%) of grafts that occluded
or required intervention exhibited significant flow
disturbances by the time of the early postoperative
review, although in the majority these flow abnor-
malities were not severe enough to require inter-
vention and in some patients mild and moderate
flow abnormalities regressed during follow-up.
Graft surveillance programs are resource inten-
sive, yet their value among certain groups of
patients is indisputable. By defining high- andlow-risk groups, resources can be used to target
those who will benefit from more intensive surveil-
lance and safely improve the cost effectives of vein
graft surveillance programs. Mills et al.24 suggested
that grafts with a normal early duplex ultrasound
scan require a less concentrated surveillance pro-
gram, as they exhibit a low incidence of stenosis
development or occlusion. Although 59.7% of our
patients were categorized as high risk, 40.3% of pa-
tients could have been discharged from hospital-
based follow-up, at a significant saving to vascular
departments’ budgets. It must be remembered that
the primary indication for intervention in both this
study and in the United Kingdom is critical
ischemia, which defines a high-risk group of pa-
tients in itself.
The size and quality of the venous conduit avail-
able for bypass are important factors affecting the
outcome of infrainguinal bypass.15 Although the
use of smaller veins does not invariably result in
graft failure, grafts with suboptimal vein are at
increased risk of occlusion. Preoperative duplex ul-
trasound assessment of quality of venous conduit
would be a potentially valuable information for in-
clusion in a predictive model. Regrettably, the
quality of vein used was not routinely collected
in one of the vascular units involved in the study;
therefore it could not be included in the decision
tree model.
188 McBride et al. Annals of Vascular SurgeryMultiple reports have indicated that although
some cardiovascular risk factors increase the risk of
amputation and mortality, they do not directly in-
fluence vein graft patency.34e38 A decision tree
tool has the benefit of creating a method of identi-
fying high-risk grafts using pertinent risk factors,
which are then subjected to an intensive duplex
ultrasound-based graft surveillance program.
Once the high-risk group is identified, the next
stage is to attempt to identify and correct lesions
responsible for graft failure. This process is best
achieved using intensive duplex ultrasound-based
surveillance, as vein graft stenosis is often asymp-
tomatic for most of its natural history. The
KaplaneMeier curves (Fig. 4) clearly illustrate
that grafts selected as low risk by the decision
tree model have good long-term primary patency
and reinforce why intensive graft surveillance
should be targeted to the high-risk group. Howev-
er, within the high-risk group there remains a 50%
limb loss rate.
There are well-established standards for the
development of clinical decision rules.39 The present
decision tree fulfills the standards required for the
development of a clinical decision rule before imple-
mentation. It is recommended that each variable
and the rule as a whole be assessed for interobserver
agreement. However, each category in our decision
tree analysis is highly reproducible as all are objec-
tive in nature. Therefore, it is anticipated that
different clinicians will categorize patients as high
or low risk using this rule with a high degree of ac-
curacy. This is currently being established through
external validation in a new population of patients.
There are limitations to the decision tree analysis. In
this and all recent studies on infrainguinal vein graft
surveillance, stenoses thought to threaten graft
patency have undergone prophylactic revision.
Therefore, the natural history of vein graft stenosis
cannot accurately be determined, as all subsequent
studies have a selected subgroup of patients and
these selected groups may not be fully representa-
tive of the population.CONCLUSION
In conclusion, a clinical decision rule based on
readily available clinical data and the findings of sig-
nificant flow abnormalities on an early postopera-
tive duplex ultrasound scan successfully identifies
grafts at high risk of failure. Implementation of
such a decision tree will allow the resources of a
graft surveillance program to be channeled toward
patients and grafts which are at highest risk offailure and avoid a large number of unnecessary
duplex ultrasound scans.
Thanks go to the support of the vascular technicians from the
Royal Infirmary of Edinburgh and Ninewells Hospital Dundee
for the scanning of patients.REFERENCES
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216Validation of a Decision Tree to Streamline
Infrainguinal Vein Graft SurveillanceReza Mofidi,1 Olivia M.B. McBride,2 Barnabas R. Green,1 Tracey Gatenby,1 Paul Walker,3
and Simon Milburn,3 Middlesbrough, and Edinburgh, United KingdomBackground: Duplex ultrasound (DU)ebased graft surveillance remains controversial. The aim
of this study was to assess the ability of a recently proposed decision tree in identifying high-risk
grafts which would benefit from DU-based surveillance.
Materials and Methods: Consecutive patients undergoing infrainguinal vein graft bypass from
January 2008 to December 2015 were identified from the National Vascular registry and enrolled
in a duplex surveillance program. An early postoperative DU was performed at a median of
6 weeks (range: 4e9 weeks). Grafts were classified into high risk or low risk based on the find-
ings of the earliest postoperative scan and 4 established risk factors for graft failure (diabetes,
smoking, infragenicular distal anastomosis, and revision bypass surgery) using a classification
and regression tree (CRT). The accuracy of the CRT model was evaluated using area under
receiver operator characteristic (AROC) curve.
Results: About 278 vein graft bypasses were performed; 29 grafts had occluded by the first sur-
veillance visit; 249 vein grafts were entered into surveillance. Sixty-four (23%) developed critical
stenosis. Overall 30-month primary patency, primary-assisted patency, and secondary patency
rates were 71.2%, 77.2%, and 80.1%, respectively. AROC for prediction of graft stenosis or oc-
clusion was 83% (95% confidence interval [CI]: 78e87%). The sensitivity and specificity of the
CRT model for prediction of graft stenosis or occlusion were 95% (95% CI: 88e98%) and 52.2%
(95% CI: 45e60%).
Conclusions: A prediction model based on commonly recorded clinical variables and early
postoperative DU scan is accurate at identifying grafts which are at high risk of failure. These
high-risk grafts may benefit from DU-based surveillance.INTRODUCTION
Despite advances in endovascular techniques, surgi-
cal infrainguinal lower limb revascularization re-
mains the gold standard treatment for lower limb
ischemia.1 Maintaining patency of infrainguinal
vein bypass grafts has been a challenging task for
vascular surgeons as these grafts are prone to the
development of stenosis which may precipitate fail-
ure of the bypass.2,3nt of Vascular Surgery, The James Cook University Hos-
rough, UK.
nt of Vascular Surgery, Royal Infirmary of Edinburgh,
K.
nt of Interventional Radiology, The James Cook Univer-
iddlesbrough, UK.Features associated with the development of vein
graft stenosis are recognizable by DuplexUltrasound
(DU) scanning which has been widely used for graft
surveillance. The rationale for graft surveillance is
that correction of stenotic lesions improves graft
patency and reduces the risk of amputation.2,3
Nonetheless, DU-based vein graft surveillance re-
mains controversial as repetitive ultrasound exami-
nations over long periods of time is expensive and
time consuming, and many of the scanned graftsCorrespondence to: Reza Mofidi, Department of Vascular Surgery,
The James Cook University Hospital, Marton Road Middlesbrough,
TS4 3BW, UK; E-mail: rezamofidi@nhs.net
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lance cycle, thus questioning the validity of routine
scanning.4 The difficulty, however, is that graft ste-
nosis which may lead to graft failure and possible
limb loss is often clinically asymptomatic but could
be detected on DU.5e8 Therefore ,there remains
much room for rationalization of vein graft
surveillance.
Decision tree analysis is a decision support and
machine-learning paradigm that is based on deci-
sion theory. It strives to correctly classify members
of a population based on several dichotomous vari-
ables.9,10 Decision (classification) trees are often
used as a clinical decision support tool where
they map clinical and therapeutic decisions and
the consequences of these decisions in a graph or
tree like manner, from which a therapeutic algo-
rithm can be created. Such a model is ideally suited
to the problem of identifying grafts that are at the
highest risk of developing graft stenosis and failure.
McBride et al.11 have designed such a decision tree
that was accurate at stratifying high-risk infrain-
guinal vein grafts that would benefit from DU sur-
veillance from low-risk grafts which could be
followed up clinically. The aim of this study is to
assess the external validity of this decision tree
model in a contemporary population of patients
from a different tertiary vascular surgical
department.
METHODS
Consecutive patients who underwent lower limb
bypass procedures between January 2008 and
December 2015 in a regional tertiary referral
vascular department were identified from the Na-
tional Vascular Registry (NVR).12 The NVR was
established to measure the quality and outcomes
of care for patients who undergomajor vascular sur-
gery in the United Kingdom.12 Its primary purpose is
to provide comparative figures on the performance
of vascular services in National Health Service
hospitals and local benchmarking and quality
improvement. To that end, it collects detailed infor-
mation about the patients who undergo vascular
procedures, including co-morbidities and athero-
sclerotic risk factors, indications for surgery proced-
ures performed, and outcomes of treatment.12
Anonymized data can be obtained from the NVR
for analysis under strict information governance
guidelines. Data collected on the NVR were cross-
referenced and supplemented by information ob-
tained from the hospital administrative, radiolog-
ical, and laboratory databases. The study was
registered with the audit department of South TeesHospitals National Health Service Foundation Trust.
Approval to perform the data analysis was obtained
before the commencement of the study.
Infrainguinal vein bypass grafts were performed
with a variety of techniques including reversed
and in situ bypass grafts, with the ipsilateral long
saphenous vein being the conduit of choice. If un-
suitable, the contralateral long saphenous vein
was used, followed by the short saphenous and
arm veins, if required. Patients were then enrolled
into a vein graft surveillance program, with each
visit involving DU and the measurement of ankle
brachial pressure index. Based on the DU result,
we used a modification of Rutherford’s recommen-
dations to the Society of Vascular Surgery to classify
stenotic lesions into mild, moderate, or critical ste-
nosis and grafts that were occluded.
Patient demographics, type of operation, conduit,
and follow-up information were recorded in a
computerized database (Excel; Microsoft, Redmond,
WA). Statistical analysis was performed using the
Statistical Package for Social Sciences, version 12
(SPSS, Inc., Chicago, IL). Results were analyzed
and reported in accordance with the reporting stan-
dards of the Society for Vascular Surgery and the
North American Chapter of the International Soci-
ety for Cardiovascular Surgery.13 Primary outcome
measures were compliance with vein graft surveil-
lance, stenosis, need for reintervention, graft
patency, and amputation rate. The differences in
patency and limb salvage rates between high- and
low-risk grafts were determined using Kaplan-
Meier analysis.DECISION TREE ANALYSIS
A Classification and Regression Tree (CRT) model
was used to identify patients who were likely to
develop significant vein graft stenosis or occlusion
(within 2 years of ultrasound follow-up), with the
aim of identifying patients who would benefit
from more intensive DU follow-up. The design,
development, and validation of this decision tree
have been previously reported.11 Precision Tree
(version 7) decision tree analysis software (Palisades
Corporation, Middlesex, United Kingdom) was
used to map the decision tree. The topography of
the decision tree used is illustrated on Figure 1.
The ability of CRT model in correctly classifying
infrainguinal vein grafts into high-and low-risk
grafts was expressed using sensitivity, specificity,
positive, and negative predictive values as well as
area under receiver-operator characteristic curves
(AROC).
Fig. 1. Decision tree based on patient profile and first
postoperative graft surveillance assessments. Grafts
which had been occluded by the time the first postoper-
ative scan had been performed were excluded as these
grafts would not benefit from surveillance. Grafts classi-
fied as high risk: 154 (61.8%). Grafts classified as low
risk: 95 (38.2%). Fem, femoral.
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Between January 1, 2008, and December 31, 2015,
278 infra inguinal vein grafts were performed.
The median age of the patients was 68 years (range
29e89 years). One hundred seventeen patients
(42%) were current smokers, 121 (43.5%) had dia-
betes, and 34 (12.2%) had chronic kidney disease
stage 4 or 5. Critical limb ischemia was the primary
indication for surgery (n ¼ 226, 81.3%), with the
remainder of patients undergoing infrainguinal
bypass procedures for intermittent claudication
(n ¼ 31, 11%) or popliteal artery aneurysms
(n ¼ 21, 7.6%). Two hundred eleven patients
were already on statin or started statin treatment
during the index episode of care, and 232 patients
(83.5%) were on antiplatelet agents, and 21
(7.6%) were fully anticoagulated with warfarin or
low-molecular weight heparin on discharge. The
median duration of hospital stay was 12 days (range
3e73 days).
Two hundred forty-one grafts (86.7%) had their
origin at the common femoral artery, 5 (1.8%)
had their origin at the external iliac artery, 18
(6.5%) had the proximal anastomosis from the su-
perficial femoral artery, and 14 (5%) grafts had their
origins from popliteal artery. The distal anastomoses
were to the above-knee popliteal in 98 bypasses
(35.2%), the below-knee popliteal in 88 (31.7%),and crural or pedal arteries in 92 (33%). Two hun-
dred and twenty bypasses (79%) were reversed
vein grafts, and 58 (21%) were in situ vein graft
bypasses.
The first postoperative vein graft surveillance
scan was performed at a median of 6 weeks (range
4e12 weeks). By the time of this scan, 29 grafts
(10.4%) had occluded and were excluded from
further analysis leaving a further 249 which were
entered into graft surveillance.
During vein graft surveillance, 81 grafts (29.1%)
developed significant flow abnormalities of which
64 (23%) were classified as or progressed to severe
vein graft stenosis. Forty-five grafts (70.3%) were
intervened upon using a combination of endovascu-
lar (n¼ 38) and surgical techniques (n¼ 6) to main-
tain graft patency; a further 19 grafts were either not
intervened upon or occluded before scheduled
endovascular or surgical intervention. Figure 2
illustrates DU and angiographic images of vein graft
stenosis both prior and after endovascular interven-
tion. A total of 19 grafts (42.2%) developed recur-
rent stenosis of which 14 underwent repeat
attempt at endovascular correction with technical
success (standard balloon angioplasty in 6 grafts,
drug eluting balloon angioplasty in 5 grafts, and
treatment with a covered stent in 3 grafts) and 2 un-
derwent surgical correction; 2 occluded before sur-
gical intervention, and 1 was not intervened upon
Fig. 2. Tight proximal graft stenosis identified on duplex
US (A), with angiographic views of the same stenosis
before and after angiographic treatment using drug
eluting 4 mm  4 mm  4 cm balloon angioplasty (B).
PTA, percutaneous transluminal angioplasty; PW, Power
Doppler Mode; ANAST, right proximal anastomosis.
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interventions on grafts which developed critical
graft stenosis was 1 (range: 1e3). Overall 30-
month primary patency, primary-assisted patency,
and secondary patency rates were 71.2%, 77.2%,
and 80.1%, respectively.
DECISION TREE ANALYSIS
Two hundred and forty-nine grafts were classified
through 5 items into 10 different categories with
2-year stenosis or occlusion rates ranging from 5 to
90%. Figure 1 illustrates the topography of the deci-
sion tree and the number of patients assigned to
each category.
Area under the receiver-operator characteristic
curve (AROC) for prediction of graft stenosis or
occlusion was 83% (95% confidence interval
[CI]: 78e87%); the sensitivity of the decisiontree for prediction of graft stenosis or occlusion
was 95% (95% CI: 88e98%). The specificity of
the decision tree for prediction of graft stenosis
or occlusion was 52.2% (95% CI: 45e60%).
The decision tree has a negative predictive value
of 96.3% (95% CI: 90e99%), reassuring clini-
cians, that patients categorized as low-risk have
a low incidence of graft failure and limb loss after
the early postoperative DU scan and clinical
assessment (Table I).
Figures 3 and 4 illustrate the Kaplan-Meier sur-
vival curves for primary graft patency and amputa-
tion rates for grafts that have been classified as
high- and low-risk based on the model. They show
that grafts classified as high-risk had significantly
lower primary patency rate (log rank ¼ 70,
P < 0.001) and were associated with higher risk of
amputation (log rank ¼ 42, P < 0.001) during
follow-up.
Table I. Indicators of accuracy of classification of
the CRT (decision tree) analysis for prediction of
development of vein graft stenosis or occlusion
within the first 2 years of follow-up
Value
Estimated
value
95%
confidence
intervals
Prevalence of high-risk grafts 0.29 0.24e0.35
Sensitivity 0.95 0.88e0.99
Specificity 0.52 0.45e0.60
Positive predictive value 0.45 0.38e0.54
Negative predictive value 0.96 0.90e0.99
Positive likelihood ratio 2.01 1.71e2.36
Negative likelihood ratio 0.079 0.26e0.24
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Avedis Donabedian, who is considered as the father
of health care improvement, defined delivery of
health care in terms of the triad of structures, pro-
cesses, and outcomes.14 Structure includes the ma-
terial and human resources as well as the
organizational structure within which care is deliv-
ered. The process denotes the steps involved in
providing care and outcomes are effects of care on
the health status of patients and populations.15
Care pathways involved in the delivery of care to pa-
tients with critical lower limb ischemia or disabling
claudication fall within the definition of the pro-
cesses which are followed to deliver safe and effec-
tive treatment to this cohort of patients. Care
pathways provide a portfolio approach for delivery
of care which requires exactly the same steps to be
followed in management of each cohort of patients
and have been credited with improving patient
safety in delivery of health care.16
Individualizing patient risk to inform the clini-
cians and patients as to the relative importance and
necessity of each step in the care pathway is a
compelling argument especially with regards to
identifying conditions which are likely to remain
asymptomatic until they cause a seminal event
such as vein graft stenosis, or planning prophylactic
procedures such as angioplasty, stenting, or surgical
revisionwhere the indication for intervention is pre-
vention of a future event, for example graft occlu-
sion and limb loss.17e19 Individualizing patient
care to suit their condition runs counter to following
a rigid vein graft surveillance care pathway which
involves the same step in follow-up for each patient
who has undergone infrainguinal bypass surgery us-
ing autologous vein as conduit. With regards to vein
graft surveillance, the situation is further compli-
cated by the fact that most grafts do not developstenosis, and there is no evidence that beyond the
early postoperative scan (performed at around 4e
6 weeks), further DU surveillance of vein grafts has
any impact on graft patency or amputation rates.4,5
On the other hand, there is compelling evidence
that vein graft stenosis can be reliably diagnosed
with duplex ultrasound examination4 and a second-
ary intervention does significantly improve graft
patency and lowers amputation rates in patients
who have undergone infrainguinal lower limb
revascularization using vein grafts.3 Rehfuss et al.3
reported a strong correlation between ultrasound
characteristics of vein grafts, in particular, flow
and velocity characteristics at the site of stenosis,
and the risk of graft failure.
Duplex ultrasoundebased graft surveillance is
resource intensive and requires repetitive scans of
grafts, many of which will not develop graft stenosis
during their surveillance cycle. By defining high-
and low-risk groups, the decision tree model allows
for resources to be focused on those whowill benefit
from more intensive surveillance and improve the
cost efficacy of vein graft surveillance. Mofidi et al.
reported that an early postoperative DU scan could
predict the natural history of a vein graft throughout
the screening cycle. Similarly, Mills et al.20 sug-
gested that grafts with a normal early DU scan
require a less concentrated surveillance, as they
exhibit a low incidence of stenosis development or
occlusion. However, development of vein graft ste-
nosis or occlusion is multifactorial in nature and
the implications of vein graft occlusion vary depend-
ing on what the indication for the procedure origi-
nally was. This would mean that a screening test
to identify high-risk grafts would also need to be
multifactorial in nature.
There are well-established standards for the
development of clinical decision rules.21 This would
include that the model is validated on an external
cohort of patients before implementation. The pre-
vious publication by McBride et al. developed the
classification and regression tree model for the iden-
tification of high-risk grafts, whereas this publica-
tion completes the cycle by externally validating
their proposed model in an unselected cohort of pa-
tients who were treated in a different hospital in a
different country. It is also recommended that
each variable is assessed for interobserver agree-
ment. However, each category in the decision tree
analysis is highly reproducible as all are objective
in nature. Therefore, it is anticipated that different
clinicians will categorize patients as high- or low-
risk using this rule with a high degree of accuracy.
In conclusion, this study validates the previous
findings of McBride et al. that a decision tree based
Fig. 4. Kaplan-Meier survival curve comparing amputa-
tion rates in patients who had undergone infra inguinal
bypass grafts which were predicted to be high risk (red)
using the decision tree model compared with amputation
rates in low risk grafts (black), (log rank ¼ 42, P < 0.001).
Fig. 3. Kaplan-Meier survival curve comparing primary assisted patency (y axis) of grafts which were predicted to be
high risk (red) using the decision tree model compared with low-risk grafts (black), (log rank ¼ 70, P < 0.001).
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222 Mofidi et al. Annals of Vascular Surgeryon readily available clinical data which are available
from the NVR and the findings of the early postoper-
ative DU successfully identifies grafts at high risk of
failure. Implementation of such a decision tree will
allow the resources of a graft surveillance program
to be channeled toward patients and grafts which
are at the highest risk of failure.REFERENCES
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Clinical Research
Prediction of the Exact Degree of Internal
Carotid Artery Stenosis Using an Artificial
Neural Network Based on Duplex Velocity
Measurements
Reza Mofidi, MB, MCh, FRCSI,1 Thomas I. Powell, MB, BCh, FFRRCSI,2
Anthony Brabazon, BCom, MSc, MBA,3 Denis Mehigan, MCh, FRCSI, FRCS(Ed),1
Stephen J. Sheehan, MD, FRCSI,2 Donal P. MacErlaine, FFRRCSI, FRCR,2 and
Thomas V. Keaveny, MCh, FRCSI,1 Dublin, Ireland
Duplex ultrasound criteria use a combination of velocity measurements to evaluate internal
carotid artery (ICA) stenosis. These evaluations divide ICA stenosis into broad categories. The
aim of this study was to design an artificial neural network (ANN) capable of predicting the exact
degree of ICA stenosis based on duplex velocity measurements. Consecutive patients with
significant carotid atherosclerosis underwent carotid duplex ultrasound and angiography. Peak
systolic and end-diastolic velocities in the ICA and common carotid artery were measured.
Multilayered perceptron ANNs were constructed and trained to predict the degree of ICA ste-
nosis and band the degree of ICA stenosis into 10% intervals based on these measurements.
The accuracy of the ANN models in predicting the degree of ICA stenosis and classifying the ICA
stenosis was compared with the angiographic degree of ICA stenosis and duplex velocity cri-
teria. A total of 208 carotid bifurcations were studied. ANNs were able to accurately predict the
degree of angiographic ICA stenosis (R2 = 0.9374, p < 0.0001) and band the ICA stenosis into
the predefined 10% intervals [sensitivity 97.3% (95% CI 90.7-99.3), specificity 97.7 % (95% CI
93.6-99.2), accuracy 97.5%]. The ANN model was more accurate [discriminant power
(DP) = 4.11] in banding the degree of ICA stenosis than duplex velocity criteria (DP = 1.67)
(p < 0.05). The accuracy of the ANN in correctly identifying >70% ICA stenosis was 98.4%
[sensitivity 96.4% (95% CI 93.8-99.3), specificity 98.7% (95% CI 93.4-99.8), DP = 4.21]. ANNs
can accurately predict the degree of ICA stenosis. With further refinement, ANNs could replace
velocity criteria in the assessment of ICA stenosis using duplex ultrasound.
INTRODUCTION
Randomised trials have confirmed the value of
carotid endarterectomy compared with the best
medical treatment for patients with significant
extracranial internal carotid artery (ICA) steno-
sis.1,2 These trials have required confirmation of
the degree of stenosis with contrast angiography,
which has been used as the gold standard for the
measurement of ICA stenosis and to confirm the
presence of ICA occlusion. However, angiography
has a significant morbidity and a low but significant
mortality rate.3 As the technology has improved
and experience has broadened, duplex ultrasound
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scanning has been found to provide sufficient
information for clinical decision making in patients
with ICA stenosis.4 This is performed by obtaining
peak systolic (PSV) and end-diastolic velocities
(EDV) at the stenosing lesion, ICA/common carotid
artery (CCA) velocity ratios, and subjective assess-
ment of the Doppler waveform at the site of max-
imal stenosis and the B-mode appearance of the
atherosclerotic plaque.5-8 Cut-off values for these
measurements are used to define the degree of ICA
stenosis. Whilst these cut-off values are calculated
using receiver operator characteristic curves, the
combination of these measurements is based on
empirical selection, with not enough statistical data
to support which values best represent the degree
of ICA stenosis,9 especially in the presence of con-
founding variables such as contralateral ICA
occlusion. With the increase in use of duplex
ultrasound, there has been a proliferation in the
number of duplex velocity criteria for measure-
ment of the degree of ICA stenosis. These classifi-
cations vary between laboratories both in their
method of calculation and in the range of degrees
of stenosis used to describe each stratification or
band.10,11
Banding of the degree of ICA stenosis using du-
plex criteria usually involves classification of the
degree of ICA stenosis into 20% bands. Earlier broad
categories did not allow an adequate estimation of
the degree of ICA stenosis to provide all the infor-
mation needed for clinical decision making in
accordance with the Asymptomatic Carotid Ath-
erosclerosis Study (ACAS) and the North American
Symptomatic Carotid Endarterectomy Trial (NAS-
CET).12 A recent paper by Filis et al.12 suggested that
it is possible to accurately band the degree of ICA
stenosis into 10% intervals for stratifying 50-100%
carotid stenosis. Although this duplex velocity cri-
terion does not estimate the exact degree of ICA
stenosis, it provides the closest clinical method with
which other models attempting to achieve a similar
degree of accuracy can be compared.
The aim of this study was to examine the
hypothesis that an artificial neural network
(ANN) based on the most commonly used duplex
velocity measurements is capable of measuring
the degree of ICA stenosis and to evaluate its
performance in correctly classifying the degree of
ICA stenosis with a comparable, clinically used
method.12
ANNs are a family of computational algorithms
which are modeled on the capabilities of the hu-
man nervous system.13-15 They permit recognition
of patterns in data that cannot be detected with
linear statistical analysis.
The neuron (node) is the basic computational
unit of an ANN. It receives a variety of inputs from
other neurons through connections that resemble
synaptic structure and has a binary (all or nothing)
output.13 This output is determined by the sum of
the inputs as well as the weight (synaptic strength)
attached to these input variables.15 The weight at-
tached to each node is altered through a period of
familiarization ‘‘training’’ until an optimal weight
which best describes the inﬂuence of the data set,
represented by the node, is reached. Each of the input
nodes corresponds to a single input variable. Initial
values are set for the ‘‘weights’’ associated with each
link in the network. Input data for which an output is
known are presented to the network. If the predicted
output from the model does not equal the known
output, the weights within the network are changed
so as to narrow this difference. This process continues
until the prediction errors are minimised. Once the
network is trained and validated, it may be used on
unseen data for prediction or classiﬁcation pur-
poses.15
A wide variety of neural network designs with
varying degrees of complexity have been de-
scribed.15 The simplest and most commonly used
form is the multilayered perceptron (MLP). The
structure of this neural network model is illustrated
in Figure 1.15
METHODS
Between April 1998 and April 2000, consecutive
patients who were admitted for assessment of
ICA stenosis were assessed. All patients under-
went carotid duplex ultrasound scanning as well
as intra-arterial digital subtraction angiography
(IADSA) for assessment of the degree of extra-
cranial carotid artery stenosis during the same
hospital stay (within 3 days). At the time, angi-
ography was routine practice in our department
for patients with severe ICA stenosis (prior to
carotid endarterectomy) or who had recent ocular
or hemispheric symptoms together with a sus-
pected ICA occlusion on previous duplex scan-
ning.
Carotid Duplex Scanning
Duplex ultrasound imaging was performed using
an Acuson 128 XP duplex ultrasound system with a
7.5 MHz linear array probe (Acuson, Mountain
View, CA) and a 60-degree angle of insonation.
PSV and EDV were measured through spectral
analysis at the stenotic portion of the ICA. Repre-
sentative recordings of PSV and EDV were also
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performed in a nonstenotic portion of the distal
CCA. ICA stenosis severity was graded using hae-
modynamic evaluation of index stenotic vessels
based on standard grading criteria.12 These evalu-
ations were performed retrospectively by two
experienced observers, who at the time of evalua-
tion were unaware of the identity of the patient,
clinical findings, and the angiographic measure-
ment of the degree of ICA stenosis.
Angiography
Standard IADSA was performed by retrograde
catheterization via the femoral arteries. Two pro-
jections of carotid bifurcation were obtained rou-
tinely. Digitally magnified views were used to
obtain the angiographic measurements.
Blinded angiographic evaluation was performed
by two observers (R.M. and T.P.). The diameter of
the ICA at the site of maximal stenosis and the
diameter of the poststenotic ICA were measured
using precision Vernier calipers to the nearest 0.1
mm. The degree of stenosis was obtained by com-
paring the residual angiographic lumen with the
diameter of the normal distal ICA.1
Interobserver agreement in the measurement of
ICA stenosis was assessed using linear regression
and Bland-Altman analysis.16
Neural Network Design
MLP ANN models with a back-propagation circuit
were constructed using Neuro-SolutionsTM version
4 software (NeuroDimension, Gainesville, FL). This
neural network design was selected because of its
good analytical power and relative simplicity of
design. The MLP models which were developed
had six input nodes, consisting of entries corre-
sponding to PSV and EDV in the ICA and preste-
notic CCA, presence of contralateral ICA occlusion,
and a bias node. The bias node performed a func-
tion similar to that of a regression constant in a
standard linear regression model. The neurons in
the hidden layer of these ANNs used a sigmoid
activation function, which ensures that node out-
put will lie in the range 0-1. The input data did not
undergo any preprocessing steps prior to input into
the neural network apart from randomisation of
data sets. Two sets of ANN models were created
(one of which had as its output the actual degree of
ICA stenosis, whilst the other had an output which
corresponded to the degree of ICA stenosis strati-
fied to bands of predefined 10% intervals).
The available data were randomly divided into
two mutually exclusive data sets. One of these was
used to train the model; the other was used to
validate the model by testing the out-of-sample
performance of the constructed MLP (assessment of
the accuracy of predictions of the trained ANN).
The data sets were organised into eight different
randomly selected re-cuts (reruns) of input data,
each used to train eight identical MLP models (four
identical MLPs for prediction of actual ICA stenosis
and four to stratify the stenosis according to 10
bands).
Training. The input variables used were PSV and
EDV in ICA as well as CCA and presence of con-
tralateral ICA occlusion. All of the input variables
apart from the presence of contralateral ICA
occlusion were continuous. Contralateral occlusion
was a categorical variable. Sixty percent of the data
set was used to train the neural network. The
Fig. 1. A simplified diagram
depicting MLP structure (for
simplicity, weights associated
with connections are not
shown).
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training rule was back-propagation of error.15 This
adjusts the weights associated with each node
during the training process until the mean squared
error was reduced to a minimum.
Validation. Forty percent of the available data set
was held out and not used for training of the neural
network model. These data were used to evaluate
the ability of the fully trained neural network to
predict the degree of angiographic stenosis from
which the neural network had been blinded. The
mean squared error was used to express the vari-
ation of the degree of predicted ICA stenosis com-
pared to the angiographic measurement of ICA
stenosis. A classification matrix was used to assess
the predictive ability of the neural network. The
accuracy of the neural network in correctly classi-
fying the degree of ICA stenosis was compared with
duplex velocity criteria alone.
Statistical Analysis
The degree of ICA stenosis predicted by the ANN
was compared with the angiographic measure-
ments using linear regression and Bland-Altman
analysis.
The accuracy, sensitivity (Sen), specificity
(Spec), and likelihood ratios for positive and neg-
ative tests were calculated for duplex velocity cri-
teria and the ANN. To compare the duplex velocity
criteria with the ANN in correct banding of the
degree of ICA stenosis, a measure of the discrimi-
nant power (DP) of a test was used:17
DP ¼ ð
ﬃﬃﬃ
3
p
Þ=pfln½Sen=ð1  SpecÞ þ ln½Spec=
ð1  SenÞg
McNemars test was used to compare the relative
accuracy of the ANN model and duplex velocity
criteria in correctly stratifying the degree of ICA
stenosis to 10% intervals.
RESULTS
Two hundred and eight carotid bifurcations in 104
patients were studied. Eighty-three patients had
ipsilateral symptoms prior to presentation (hemi-
spheric, 51; ocular, 27; both symptoms, 5), and 21
patients were asymptomatic. The mean age of
subjects was 70.1 years (standard devia-
tion = 10.11); 38 were female and 66 were male.
No patient was excluded due to inadequate angi-
ography or duplex ultrasound.
Seventeen carotid arteries were occluded. Car-
otid duplex examination was able to identify oc-
cluded ICA in all patients. In the remaining ICA
bifurcations, the median degree of ICA stenosis was
64% (range 0-99%). One hundred and forty-one
carotid bifurcations (68%) studied possessed ‡50%
degree of ICA stenosis and 114 (55%) had ‡70%
stenosis, as measured by angiography.
Interobserver Agreement
There was good agreement between the two
observers in the angiographic measurement of de-
gree of ICA stenosis (R2 = 0.95). Bland-Altman
analysis confirmed the high degree of interobserver
reproducibility of the angiographic measurement of
the degrees of ICA stenosis (Fig. 2).
Interobserver variability in determining the
correct banding for the degree of ICA stenosis was
acceptable (j = 0.79).
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Fig. 2. Bland-Altman
analysis applied to the
comparison between the
angiographic degrees of ICA
stenosis measured by the two
different observers.
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Duplex Velocity Criteria and the Degree of
ICA Stenosis
The overall agreement between the results of du-
plex ultrasound velocity measurement and angi-
ography in determining the correct banding for the
degree of ICA stenosis was 91.8% (191/208), with a
sensitivity of 89.7% [95% confidence interval (CI)
82.8-94] and specificity of 93.5% (95% CI 86.5-97)
(DP = 1.67).
The accuracy of duplex ultrasound criteria at
correctly identifying >70% ICA stenosis was
95.2%, with sensitivity of 96.3% (95% CI 90.9-
98.6), specificity of 94% (95% CI 87.5-97.3), and
DP of 3.3. Carotid duplex examination was also
able to identify over 50% ICA stenosis with rea-
sonable accuracy [sensitivity 96.38% (95% CI
89.9-97.5), specificity 91.6% (95% CI 82.8-96.1),
and accuracy 94.7% (DP = 3.09)].
Neural Network Analysis
Two hundred and eight data vectors were ran-
domly divided as follows: 124 (59.6%) were used
to train the neural network model, and 84 (40.4%)
were used for model validation and out-of-sample
testing.
Following completion of training, the ANN
model was able to predict the degree of ICA stenosis
with a high degree of accuracy (mean squared error
0.012); cross-validation confirmed the validity of
the ANN model at predicting the degree of ICA
stenosis (Fig. 3). Good correlation was observed
between the degree of ICA stenosis predicted by the
ANN and that measured angiographically
(R2 = 0.9374, p < 0.0001) (Fig. 4). Bland-Altman
analysis revealed a high degree of agreement be-
tween the results of ANN and angiographic mea-
surements (Fig. 5). Furthermore, the ANN model
was able to accurately band the ICA stenosis
according to the predefined 10% intervals with a
sensitivity of 97.3% (95% CI 90.7-99.3), a speci-
ficity of 97.7% (95% CI 93.6-99.2), and an overall
accuracy of 97.5%. The ANN model was signifi-
cantly more accurate at correctly banding the de-
gree of ICA stenosis. The DP of ANN was 4.11,
while that of duplex velocity criteria alone was 1.67
(McNemars test, p < 0.05).
The accuracy of the ANN at correctly identifying
>70% ICA stenosis was 98.4%, with sensitivity of
96.4% (95% CI 93.8-99.3), specificity of 98.7%
(95% CI 93.4-99.8), and DP of 4.21. This was
comparable to duplex velocity criteria (p = non-
significant). The accuracy of the ANN at correctly
identifying >50% ICA stenosis was 97.4%, with a
sensitivity of 97.8% (95% CI 93.8-99.3 and) spec-
ificity of 98.2% (95% CI 90.4-99.7), which was not
significantly better than the duplex velocity criteria
(p = nonsignificant). Table I illustrates the com-
parison between duplex velocity criteria and ANN
at identification of >50% and >70% stenosis as well
as correct banding of ICA stenosis for >50% ICA
stenosis.
The use of ANN was associated with altered
clinical decision in 2.9% of cases (5/208) compared
with angiographic findings. This was not signifi-
cantly different from the duplex velocity criteria,
use of which was associated with altered clinical
decision in eight carotid bifurcations (3.8%) com-
pared with angiography (p = NS).
DISCUSSION
Duplex scanning is the principal method of imaging
carotid bifurcation disease,18 owing to its nonin-
vasive nature and widespread availability. It has
been shown that carotid endarterectomy can be
0
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Fig. 3. The training curve of
the ANN used for banding the
degree of ICA stenosis
showing the minimization of
mean squared error (MSE, y
axis) during the training
process (x axis = number of
epochs). The solid line
represents the training
process and the broken line,
cross-validation.
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safely performed without preoperative angiogra-
phy.4,19
Proliferation of duplex velocity criteria has re-
sulted in lack of uniformity in the measurement of
ICA stenosis using duplex imaging, in contrast to
the standardized nature of angiographic assessment
of ICA stenosis during randomised controlled trials,
upon which the efficacy of carotid endarterectomy
is based.1,2 The randomised controlled trials which
form the evidence base for the management of
symptomatic and asymptomatic carotid athero-
sclerosis have identified different threshold values
for ICA stenosis as representing the indication to
perform carotid endarterectomy.20-22 Several pre-
vious authors have changed their velocity criteria
in order to comply with these studies.23,24
With respect to symptomatic patients, both
NASCET and the European Carotid Surgery Trial
(ECST) have demonstrated a gradient effect of
benefit with increasing degree of stenosis.20,22
Therefore, in patients with moderate degrees of
stenosis (50-70%), knowing the exact degree of
stenosis in conjunction with preoperative clinical
risk factors may influence decision making with
regard to surgery.12 Such information is of value
in follow-up of patients who are treated conser-
vatively and do not undergo carotid endarterec-
tomy.
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In order to better stratify the degree of ICA
stenosis measured with duplex ultrasound, Filis
et al.12 developed velocity criteria with 10%
interval categories for >50% ICA stenosis. They
reported that such criteria have similar accuracy
to the old 20% intervals. Using the duplex
velocity criteria described by Filis et al., we found
good degree of accuracy and interobserver
agreement for the stratification of 50-100% ICA
stenosis (into 10% bands); therefore, it was
adapted retrospectively by us for comparison
against the ANN model.
The use of ANNs represents a novel approach in
the assessment of degree of ICA stenosis. Neural
network algorithms have been applied to a variety
of clinical conditions where complex relationships
within the data set preclude the use of conventional
linear statistical analysis.25 Accurate measurement
of the degree of ICA stenosis using velocity of blood
flow contains an inherent degree of variability. This
variability increases with progressively lower de-
grees of stenosis in the ICA.26,27 It would be
impossible to account for this variability through
conventional statistical models. ANNs can be used
to separate background noise (variability) from
information embedded in the data set. ANN algo-
rithms can be built into new duplex devices. In this
way, after selection of the appropriate sample vol-
ume by the operator, the machine could automat-
ically calculate the duplex parameters for predicting
the probability of threshold ICA stenosis or measure
the exact degree of ICA stenosis.
Our results suggest that ANNs have an accept-
able degree of accuracy in predicting the exact de-
gree of ICA stenosis and represent a modest but
significant improvement in classification of ICA
stenosis into 10% bands. Carotid duplex criteria
have been proven to be excellent tools in identifi-
cation of threshold ICA stenosis at the clinically
significant 70% level used for identification of
surgical candidates amongst patients with symp-
tomatic disease5-8 and 60% stenosis screening for
asymptomatic carotid artery stenosis.23,24 In this
study, we did not find a significant difference in the
accuracy of ANN in the identification of patients
with clinically significant ICA stenosis compared
with carotid duplex criteria.
Other approaches have been adapted as alterna-
tives to duplex velocity criteria. Zbornikova and Jo-
hansson28 found that multivariate regression based
on PSV, EDV, and pulse pressure was more accurate
than univariate analysis based on each variable at
identifying >50% ICA stenosis and suggested that
this could replace duplex velocity criteria in the
identification of candidates for carotid endarterec-
tomy.28 More recently, Hwang et al.9 used a multiple
regression model to predict the exact degree of ICA
stenosis using duplex velocity measurements as
independent input variables. They found a reason-
able correlation between the predicted and actual
degrees of ICA stenosis. Apart from the current
study, the publication by Hwang et al.9 is the only
study in the literature which attempts to measure
the exact degree of ICA stenosis using duplex vari-
Table I. Comparison between accuracy, sensitivity, specificity, positive predictive value (PPV), and neg-
ative predictive value (NPV) of duplex velocity criteria and ANN at identification of >50% and >70%
stenosis as well as correct banding of ICA stenosis
Identification of >70% stenosis (p = NS)
Modality Accuracy Sensitivity Specificity PPV NPV
Duplex velocity criteria 95.2 96.3 (90.9-98.6) 94 (87.5-97.3) 96.4 93.5
ANN 98.4 96.4 (93.8-99.3) 98.7 (93.4-99.8) 99.2 94
Identification of >50% stenosis (p = NS)
Modality Accuracy Sensitivity Specificity PPV NPV
Duplex velocity criteria 94.7 96.4 (89.9-97.5) 91.6 (82.8-96.1) 96.5 91.2
ANN 97.8 97.4 (93.8-99.3) 98.2 (90.4-99.7) 98.2 93.9
Correct 10% banding for stratifying 50-100% stenosis (p < 0.05)
Modality Accuracy Sensitivity Specificity DP DOR
Duplex velocity criteria 91.8 89.7 (82.8-94) 93.5 (86.5-97) 1.67 125 (48-323)
ANN 97.5 97.3 (90.7-99.3) 97.7 (93.6-99.2) 4.11 1,872 (306-11,431)
NS, nonsignificant; DOR, diagnostic odds ratio (95% CI in parentheses).
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ables. Their work suggests that a linear regression
model based on the equation ICA steno-
sis = 20.2PSV )7.4EDV + 0.4SCR + 8.5SCR [where
SCR is (peak) systolic carotid ratio] can be used to
predict the exact degree of ICA stenosis, albeit with a
moderate degree of correlation with angiographic
controls (correlation coefficient = 0.75). Such a
model, whilst novel, does not offer an improvement
over duplex velocity criteria12 or an ANN.
Direct measurement of the residual lumen
using a combination of B-mode ultrasound and
colour flow imaging components of duplex
investigation has been used to measure ICA ste-
nosis.29,30 These measurements have been found
to correlate well with angiographic measur-
ments29 and examination of endarterectomy
specimens.30 However, it is important to point out
that B-mode ultrasound and angiography mea-
sure the degree of vessel stenosis in different
ways: duplex ultrasound assesses stenosis by per-
centage area reduction, whereas angiography
measures the percentage reduction in luminal
diameter. Therefore, despite close correlation, the
two values are not interchangeable.
In our study, data analysis was performed using
a neural network with a simple design and five
input variables (PSV and EDV measurements in the
ICA, CCA, and the presence of contralateral ICA
occlusion). The reason for limiting the number of
input variables and using simple neural network
topography was to avoid complexity in the design
of the neural network and the resultant data
analysis. Nonetheless, it was able to predict the
degree of ICA stenosis with a high level of accuracy.
We did not analyse the influence of factors such
as heart rate, presence of cardiac arrhythmias, and
systemic blood pressure, which are known to be
responsible for alteration of haemodynamic find-
ings in the carotid bulb region. These findings are
hard to characterise in the linear assessment of the
degree of ICA stenosis but would be ideally suited
to ANN analysis. Their addition would significantly
increase the complexity of the neural network
model, which would require a larger pool of sub-
jects to train and validate. However, it is likely that
the future introduction of these data into the ANN
model would improve its predictive ability in the
assessment of ICA stenosis.
Previous authors have suggested that duplex
velocity profiles may overestimate the degree of
ICA stenosis in the presence of contralateral
occlusion.31,32 This is difficult to adjust for when
duplex velocity criteria are used alone. However,
such an adjustment is possible in an ANN model in
the form of another input variable (node).
This study suggests that using ANN analysis it is
possible to predict the exact degree of ICA stenosis
using Doppler velocity parameters. We believe that
with further refinement and the addition of new
input variables ANNs can be used to perform this
task in a standardized manner.
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Abstract
Aim: The aim of this study was to assess the ability of artificial neural network (ANN) in predicting survival in patients undergoing surgical
resection for carcinoma of oesophagus and oesophago-gastric junction.
Methods: From January 1995 to August 2004 patients who underwent surgery for oesophageal and gastric carcinoma were identified.
Biographical data, body mass index and pathological minimal cancer dataset were used to design an ANN. Post-operative survival was
assessed at 1 and 3 years. Sixty percent of data was used to train and validate the ANN and 40% was used to evaluate the accuracy of trained
ANN in predicting survival. This was compared with Union Internacional Contra la Cancrum UICC TNM classification system.
Results: Two hundred and sixteen patients underwent resectional surgery for oesophageal and OGJ carcinoma. The accuracy of the ANN in
predicting survival at 1 and 3 years was 88% (sensitivity: 92.3%, specificity: 84.5%, DPZ2.3) and 91.5% (sensitivity of 94.61%, specificity:
88%, DPZ2.72), respectively. These figures were significantly better than 1- and 3-year survival predictions using the UICC TNM
classification system 71.6% (sensitivity of 66.4%, specificity: 75.5%, and DP!1) and 74.7% (sensitivity of 70.5%, specificity: 74.9%,
DP!1), respectively (P!0.01) (P!0.05).
Conclusion: ANNs are superior to the UICC TNM classification system in correlating with survival following resection of carcinoma of
oesophagus and OG junction and can become valuable tools in the management of patients with oesophageal carcinoma.
q 2006 Elsevier Ltd. All rights reserved.
Keywords: Oesophageal carcinoma; Survival; Artificial neural networkIntroduction
Union International Contra Cancrum (UICC) TNM
classification system remains the most widely used method
of staging for patients with oesophageal and OG junction
carcinoma.1 The TNM classification system is based on
anatomical extent of the disease, therefore, its ability as a
predictive model is limited.2 Apart from the TNM stage of
the lesion, other factors, which are amenable to pre-
operative assessment, are known to influence survival
following resection with curative intent.3 These include
tumour length measured on contrast swallow,4,5 tumour
differentiation6 and the presence of submucosal lymphocy-
tic infiltration7 as well as involvement of the resection
margins.8 Addition of these variables to a predictive model0748-7983/$ - see front matter q 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ejso.2006.02.020
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* Corresponding author. Tel.:C44 131 2257346; fax:C44 131 2282661.
E-mail address: rmofidi@doctors.net.uk (R. Mofidi).for oesophageal carcinoma based on conventional statistical
models would significantly increase its complexity and limit
its clinical utility.
ANNs have been increasingly used in medicine as
decision support aids,9 for analysing radiological and
histological images10,11 and to predict outcome from using
complex multivariable prognostic indicators such as
patients with cancer.12–17
Artificial neural networks ANN are a family of data
analysis algorithms. Their structure and function is designed
to resemble biological nervous systems.18 This novel design
provides the ability to identify patterns within data that are
associated with a particular outcome from a large population
and apply the findings to an individual subject. ANNs are
composed of data processing units, which like their
biological counterparts are named neurons.18 The units are
heavily interconnected to each other by weighted connec-
tions similar to synapses. During the process of training the
ANN is introduced to a series of defining characteristics,
which are associated with a particular outcome. By2006) 533–539 www.ejso.com
R. Mofidi et al. / EJSO 32 (2006) 533–539534performing repetitive cycles of training the weights
associated with the synaptic connection are adjusted in
order achieve the best predictive ability, after this the ANN
should be able to accurately perform predictions on input
data to which it was blinded during training. ANNs are
useful in performing for interpreting data where the data is
abundant, contradictory, biased or complex.19
The aim of this study was to assess the performance of an
ANN based in a population of patients with carcinoma of the
oesophagus and OG junction who have undergone surgical
resection with curative intent and assess its ability in
predicting 1- and 3-year disease free survival.
Methods
All patients who had undergone resection of carcinoma
of the oesophagus and gastro–oesophageal junction in a
specialist oesophago-gastric surgery unit between January
1995 and August 2004 were identified.20 The surgical
approach included a level 2 abdominal lymphadenectomy
and extended en bloc mediastinal lymphadenectomy in all
patients.
Neural network design
Three-layered multilayer perceptron (MLP) ANN
models, with back propagation circuit were constructed
using Neuro-Solutionse version-4 neural network software
(NeuroDimension, Inc., Gainesville, FL, USA). This is aFigure 1. A simplified diagram depicting the structure of a multilayered perceptron
input from the previous layers of neurons or input variables. Each neuron (repres
constant in conventional statistical models. The neuron converts the sum of weighte
weights associated with each synaptic connection are adjusted through the back psimple neural network design in which the neurons are
arranged in parallel layers and each layer is fully connected
to the previous layer through synaptic connections, leading
to a single predictive outcome. The ANNs were trained
through back propagation of error, which is a process by
which the error of prediction is minimized by adjusting the
weights associated with the synaptic connections in the
hidden layers of the ANN (Fig. 1).
Two sets of artificial neural network models were created
one set of ANNs was used to predict disease survival at 1
year, the other with disease free survival at 3 years. The
input data did not undergo any pre-processing steps prior to
input into the neural network. The available data were
randomly assigned into two mutually exclusive datasets.
One of these was used to ‘train’ the model, a second used to
assess the accuracy of predictions of the trained ANN. Sixty
percent of the available data were used to train each neural
network. Forty percent of the data was withheld from the
ANN during the training process and was used for cross
validation of the ANN. In order to minimize bias based on
selection of cases for training and evaluation datasets,
panels of 10 identical ANNs were used for each prediction
(disease free survival at 1 and 3 years). These ANNs were
trained and evaluated independently by different, randomly
selected, partitions of the dataset. The values pertaining to
the accuracy of prediction were reported as average output
for the ANN panel together with 95% confidence intervals.
The number of training iterations (runs) was kept to eight
the training process was considered complete at the end of(MLP). Neurons are arranged in layers (hidden layers) and receive synaptic
ented by a circle) has a transfer function, which is equivalent to regression
d inputs into a binary (all or nothing) output. During the training process the
ropagation of error.
Table 1
Pathological characteristics of the resected specimen (NZ216)
pN stage
N0 85
N1 131
pM stage (coeliac node involvement)
M0 209
M1 7
Submucosal lymphatic invasion
Absent 137
Present 79
Vascular invasion
Absent 154
Present 62
Neural involvement
Absent 168
Present 48
Type of resection
R0 169
R1 36
R2 11
R. Mofidi et al. / EJSO 32 (2006) 533–539 535eight iterations, if the mean squared error of predictions was
less than 0.025.
Variable selection
The optimum variables used to construct the artificial
neural network were selected from 42 potential input
variables available to the ANN using sensitivity anal-
ysis.21,22 Sensitivity analysis is a method for identifying the
predictive value of input variables in formulating a correct
outcome prediction. During the process of sensitivity
analysis, the network learning is disabled such that the
weights associated with the synaptic connections are not
affected. The inputs to the network are shifted slightly and
the corresponding change in the output is reported as a
percentage. The values that cause the highest percentage of
change are selected to create the model.21
Using sensitivity analysis, input variables are categorized
according to their ability in influencing outcome. The
optimal number of variables for developing the ANN was
assessed during backward variable selection, a process
whereby the variables with the least predictive value are
consecutively removed and the accuracy of prediction of the
ANN model is evaluated by receiver operator characteristic
analysis, until the ANN with the optimum accuracy of
prediction is reached.21
The predictive power of the UICC TNM classification
system in assessing disease free survival at 1 and 3 years
was analysed using stepwise linear discriminant analysis.
The variables used to create this model are the T, N and M
stage as well as clearness of the resection margins (R0: clear
margins, R1: microscopically involved margins, R2:
macroscopic residual disease).
The accuracy, sensitivity, specificity,23 positive and
negative predictive values24 as wall as likelihood ratios25
were calculated for the UICC TNM staging system and
ANN as predictors of disease free survival. To compare the
TNM classification with ANN in predicting disease free
survival a measure of the discriminant power (DP) of a test
was used,26 where:
DPZð ﬃﬃﬃ3p Þ=ðPðLN½SEN=1KSPECCLN½SPEC=1KSENÞÞ
where LN, natural logarithm; SEN, sensitivity; SPEC,
specificity of each of the tests.
McNemar’s test was used to compare the relative
accuracy of the ANN model and UICC TNM staging as
predictors of disease free survival following potential
curative resection.
Results
Patient population
Two hundred and sixteen patients underwent resectional
surgery for oesophageal and OG junction carcinoma ofwhom 155 were male and 61 were female. Median age of
the patients was 64 years (range: 30–82). Median ASA
grade and BMI were 2 (range: 1–3) and 23 (range: 14–36),
respectively. One hundred and sixty-one patients underwent
primary surgical resection of the lesion and 55 received
neoadjuvant, cisplatin and 5-flourouracil based chemother-
apy prior to the definitive surgical procedure. One patient
underwent Argon laser ablation of an early adenocarcinoma
of OG junction followed by subsequent definitive surgical
resection. One-year follow-up data was available in 198
patients and 126 patients had 3-year follow-up data
available.
Histological findings of the resected specimen
One hundred and thirty-six patients presented with
adenocarcinoma and 73 patients with squamous cell
carcinoma, seven patients had other histological types
(three small cell carcinoma, four undifferentiated).
Table 1 describes the pathological feature of the lesions
based on the examination of the histological specimen. A
median of 21 (range: 4–44) lymph nodes were retrieved
from each specimen for analysis. The median number of
histologically positive nodes was 2 (range: 0–21). Post-
operative in hospital mortality was 15 patients. Median
follow-up duration was 27 months (range: 2–64). The
Kaplan–Meier survival curves based on the UICC classifi-
cation are shown in Fig. 2.
Artificial neural network analysis
Table 2 illustrates the sample size and composition of
training and evaluation datasets for the panel of neural
networks used to predict disease free survival at 1 and 3
years. Using sensitivity analysis 14 input variables were
Figure 2. Kaplan–Meier survival curves based on the UICC classification
(log-rank test, P!0.01).
Table 3
Input variables used to construct the ANN models
Variable Data format Sensitivity (%)
1-Year 3-Year
Age Absolute value 1.67 1.46
BMI Absolute value 0.91 0.86
American Society of Anaes-
thesiology ASA score
1–4 1.31 0.89
Presence of dysphagia Y/N 1.04 1.53
Histological type Adenocarcinoma 0.76 0.84
Squamous cell
Other
Differentiation Well 1.31 1.22
Moderate
Poor
T stage T1 1.89 2.13
T2
T3
T4
Number of positive nodes Number 1.87 2.21
Total nodes retrieved Number 1.05 1.04
Coeliac node involvement Y/N 2.01 1.97
Margin involvement Y/N 1.99 1.83
Lympho-vascular involve-
ment
Y/N 1.32 1.55
Neural invasion Y/N 1.13 1.21
Neoadjuvant chemotherapy Y/N 1.08 1.26
Sensitivity of each variable for 1- and 3-year survival. These variables were
selected through sensitivity analysis. These variables were selected through
sensitivity analysis.
R. Mofidi et al. / EJSO 32 (2006) 533–539536selected to construct the ANN. Table 3 illustrates the input
values which were selected through sensitivity analysis to
construct the ANN as well as their sensitivity for prediction
of disease free survival at 1 and 3 years. Fig. 3 shows the
change in the accuracy of area under ROC curve in response
to the reduction in the number of input variables.
The process of ANN training was smooth with
satisfactory minimization of MSE. The mean squared
error (MSE) reached at the completion of training of the
ANN for prediction of survival at 1 year was 0.0082, whilst
the final training MSE for prediction of 3-year survival was
0.006. Fig. 4 shows the learning curve of the artificial neural
network used for prediction of survival at 3 years with
minimization of mean squared error during training process.
ANN was able to accurately predict disease free survival
at 1 year (accuracy: 88%, DPZ2.3). This was significantly
more accurate than the 1-year survival prediction using the
UICC TNM classification system (accuracy: 71.6%, DP!1)
(P!0.01) (Table 4).
The ANN panel was significantly more accurate at
predicting survival at 3 years after surgery (accuracy:Table 2
The sample size and composition of training and out of sample testing sets
for the panel of neural networks used to predict survival at 1 and 3 years
Training Testing
1-Year 3-Year 1-Year 3-Year
N 119 73 79 53
Age (range) 64 (41–80) 64.5 (30–82) 63 (36–78) 62 (42–77)
Stage I 15 9 10 7
Stage IIA 32 20 21 14
Stage IIB 14 8 9 6
Stage III 55 33 35 24
Stage IV 3 4 3 3
R0 93 55 61 41
R1 19 12 14 8
R2 7 6 4 4
Survival (%) 85 38 56 2791.5%, DPZ2.72) than the UICC TNM classification
system (accuracy: 74.7%, DP!1) (P!0.05) (Table 4).Discussion
The use of artificial neural network is a relatively novel
approach for the prediction of outcome in patients with
carcinomas of oesophagus and OG junction. In this study,Figure 3. Changes in the accuracy of the ANN survival at 1-year (red line)
and 3-year (black line) (shown as the area under ROC curve), plotted
against the number of input variables used to create the ANN. With the
reduction in the number of variables there is a progressive increase in the
accuracy of the ANN (Y-axis) until the optimum number of variables is
reached after which further reduction of the input variables results in
diminished accuracy of ANN. The error bars indicate 5% confidence
intervals.
Figure 4. Learning curve of the artificial neural network model designed to
predict survival from carcinoma of oesophagus and OG junction at 3-year.
Minimization of mean squared error (MSE) (Y-axis) during the training
process (X-axisZnumber of epochs). Each epoch of training relates to input
of data derived from a single patient.
R. Mofidi et al. / EJSO 32 (2006) 533–539 537the use of an artificial neural network with a simple design
using clinical and pathological variables, which are readily
available clinically was associated with significant improve-
ment in early and 3-year outcome predictions compared
with UICC TNM system. Artificial neural networks have
been applied to other neoplastic processes and have been
found to compare favorably with conventional statistical
models or clinical judgment.14
Superior accuracy of ANN models is partly related to
superiority of analytical model and partly to the increased
number of input variables used to develop the ANN. Most
clinical analytical models such as TNM staging are heavily
weighted towards the histopathological interpretation of the
anatomical extent of disease. The ANN model in this study
selected the appropriate input variables using sensitivity
analysis. This by itself may be responsible for improved
accuracy. A large-scale study by examining cancer specific
5-year survival in breast and colorectal carcinoma found
that the ANN models constructed using TNM stagingTable 4
Prediction of survival at 1 and 3 years following surgery using the UICC
TNM classification system (stepwise linear discriminant analysis) and
ANN model
Prediction of 1-year
survival
Prediction of 3-year
survival
ANN TNM ANN TNM
Sensitivity 92.3 66.4 94.6 70.5
Specificity 84.5 75.5 88 74.9
PPV 93.1 85.1 89.9 75.8
NPV 83 47.7 92.9 70.3
Positive likelihood ratio 5.9 2.56 8 2.8
Negative likelihood ratio 0.08 0.45 0.07 0.38
Accuracy 88 71.6 91.5 74.7
Discriminant power 2.3 !1 2.72 !1
PPV, positive predictive value; NPV, negative predictive value.system alone significantly improved the predictive accuracy
of TNM staging system.27
Despite the fact that ANNs are well suited to outcome
prediction, to date their routine clinical use has been limited
to the management of prostatic carcinoma.28 Some of the
resistance to the use of ANNs in the clinical setting relates to
the fact that their introduction as predictive models involves
addition of new nomenclature and methodology, with which
the clinicians are not familiar. In addition, clinical use of
ANNs is tempered by the innate suspicion of a computer
based system that cannot explain its reasoning. Interest-
ingly, there is a lot less reluctance in accepting the result of
ANN analysis in dealing with problems such as gene
filtering to study gene expression in at risk populations that
due to their complexity defy conventional statistics13,29 or
image analysis where data analysis is a simulation of a
cognitive process performed by a trained observer.10,11 In
these situations, the approach towards ANN is pragmatic
and result orientated and based on adequate validation of the
model without attempts at understanding the reasoning on
case-by-case basis.
This is not to say that the development of an ANN model
for outcome prediction in patients with invasive cancer is
not without its potential pitfalls. A complex ANN with a
large number of input variables can be very accurate at
identifying patterns within the training dataset. This can
result in over fitting of the model, whereby the ANN
identifies patterns peculiar to the training dataset that does
not represent the larger population of patients. This is
overcome by limiting the iterations of training and using
adequately sized samples of patients for training and
validation of the ANN. Model instability is another potential
source of inaccuracy, where identical independently trained
ANNs can have varying predictions for individual patients.
To minimize this, we used a panel of 10 ANNs trained on
randomly selected subsections of data. The training and
evaluation samples were randomly selected and were
representative of the patient population (Table 3). The
correct selection of input variables is also important, as a
large number of potential input variables are often available
in presence of limited number of training and evaluation
cases. This is a potential source of model instability. In this
study, variable selection was performed through the wells
established process of sensitivity analysis, which limited the
number of input variables and selected the optimum
combination of variables, which was associated with the
most accurate predictions (Fig. 2). In this study, external
validation of the ANNmodel was performed using a random
selection of cases from the study population, which was
withheld from the ANN during the training process. Whilst
this is adequate to validate the concept, prior to clinical use
any ANN will need to be validated on prospectively
collected data in the patient population for which it is
being considered.15,16
Sato et al. used ANNs to predict outcome in patients who
have undergone resection of oesophageal carcinoma.30 The
R. Mofidi et al. / EJSO 32 (2006) 533–539538ANN used in that study was designed using 60 and 65
clinical, pathological, biological and genetic variables and
predicted survival at 1 and 5 years. The ANN was trained
and evaluated using 418 patients who had undergone
resection with curative intent from 1983 to 2001. The
ANN was found to be an accurate predictor of survival and
superior to conventional statistical techniques.30 The major
shortcoming of the predictive model developed by Sato and
colleagues is the large number of variables used. This is in
direct contrast to the simplicity of conventional staging
systems and would limit clinical utility.
The current study used post-operative pathological
staging variables to create the ANN. The motivation for
selecting pathological staging data was to train the ANN
using input variables, which are reliable predictors of
survival. One specific problem associated with such an
approach arises in relation with patients who receive pre-
operative neoadjuvant chemotherapy as the histological
findings in this group of patients may have been down
staged as a result of chemotherapy. This is an important
group of patients who tend to have relatively advanced
lesions and their exclusion would have resulted in the ANN
model being unrepresentative and adversely effect its use in
general population of patients. Pre-operative neoadjuvant
chemotherapy was one of the variables used to train the
ANN. Although neoadjuvant chemotherapy selected as an
input variable through sensitivity analysis, rather than being
selected by authors. Regardless of its method of selection as
an input variable, its addition should improve the predictive
power of the ANN by introducing the interaction between
staging variables and pre-operative chemotherapy to the
process of predicting outcome at 1 and 3 years.
In clinical practice, the most important decisions
regarding patient management are made pre-operatively.
Therefore, the next area which needs to be examined, is the
ability of ANN in predicting survival based on pre-operative
patient and disease specific variables including endoscopic
ultrasound31–33 as well as multislice computerized tom-
ography. Pre-operative staging data can be used to train an
ANN in order to predict survival and aid decision-making
regarding therapy, or with appropriate training predict who
will respond to a particular therapy such as neoadjuvant
chemotherapy.
Additional searches for prognostic variables for oeso-
phageal carcinoma have identified cellular and histological
markers of prognostic significance.34–39 These variables
could easily be incorporated into the design of an ANN in
order to improve its accuracy.
This study has identified the potential value of ANNs in
predicting post-operative disease free survival from carci-
noma of oesophagus and OG junction following surgery
with curative intent. Further work is required if it is to be
used as decision support aid pre-operatively. Such an
artificial neural network needs to be trained prospectively
and as part of a multicenter observational study and
validated prospectively on pre-operatively collected clinicaland imaging investigations. Information provided by such a
model can be used to streamline patient management and
ultimately improve survival rates from carcinomas of
oesophagus and OG junction.References
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